Nurses Revision

Nurses Revision

nursesrevision@gmail.com

Resuscitation of a newborn

Resuscitation

Neonatal Resuscitation Lecture Notes
Neonatal Resuscitation Lecture Notes
  • Neonatal Resuscitation refers to a series of interventions initiated immediately after birth to support the establishment of breathing and circulation in a newborn who is not breathing effectively or has inadequate circulation.
  • Resuscitation is a means of restoring life to a baby from the state of asphyxia (Devi, Upendra, and Bard, 2017).

Asphyxia in a newborn refers to a condition where there is impaired blood gas exchange, leading to a progressive decrease in oxygen (hypoxemia) and an increase in carbon dioxide (hypercarbia), often resulting in acidosis.

  • More simply, it is about "helping a baby to breathe," which is the most critical physiological adjustment required at birth.
The Importance of Neonatal Resuscitation:
  1. High Vulnerability of the Neonatal Period: The first 28 days of life is called neonatal period and incontrovertibly, it is the most vulnerable and high risk time in life because of the highest mortality and morbidity that occur in this period. The day of birth is the riskiest time to a baby" (Sajjad, 2012; and WHO, 2015). A significant proportion of neonatal deaths occur on the first day of life, many of which are attributable to birth asphyxia.
  2. Prevention of Mortality: Effective and timely resuscitation can directly prevent death in newborns who fail to transition successfully from intrauterine to extrauterine life.
  3. Prevention of Morbidity and Long-Term Disability: Prevent brain injury and other organ damage resulting from prolonged oxygen deprivation. Timely resuscitation minimizes the duration of hypoxemia and acidosis, thereby reducing the risk of such devastating outcomes.
  4. Enabling Physiological Transition: Birth involves a physiological transition from relying on the placenta for gas exchange to establishing independent pulmonary respiration and circulatory changes. Approximately 85% of newborns transition successfully without intervention. However, about 10-15% require some assistance, and about 1% require extensive resuscitative measures. Resuscitation provides the necessary support for these babies to make this critical transition.
  5. Global Health Impact: Improving access to and quality of neonatal resuscitation services is a key strategy for achieving global maternal and child health targets, particularly in low-resource settings where the burden of birth asphyxia is highest.
Goals of Neonatal Resuscitation (Aims of Management):
  1. Initiate and/or Restore Respiration/Breathing: This is the most immediate and primary goal, as establishing effective breathing is fundamental to oxygenation.
  2. Establish Adequate Circulation: While not explicitly listed as a separate aim in your text, it's intrinsically linked to respiration. Effective breathing improves oxygenation, which then supports heart function and systemic circulation.
  3. Prevent Infection: Although not a direct resuscitation step, ensuring aseptic technique during resuscitation and appropriate post-resuscitation care are vital to prevent secondary complications in a vulnerable neonate.
  4. Prevent Other Complications: This is a broad goal encompassing the prevention of brain injury (HIE), organ dysfunction, and ensuring overall physiological stability.
  5. Prevent Hypothermia: Maintaining the newborn's temperature is critical from birth, throughout resuscitation, and into post-resuscitation care, as hypothermia can worsen acidosis and impair resuscitation efforts.
Risk Factors for Resuscitation
I. Common Maternal Risk Factors:

These factors are related to the mother's health, pregnancy complications, or circumstances surrounding the birth.

  • Advanced Maternal Age: (e.g., usually >35 years)
  • Maternal Illnesses/Conditions:
    • Diabetes (gestational or pre-existing)
    • Hypertension (e.g., pre-eclampsia, eclampsia, chronic hypertension)
    • Cardiac or renal disease
    • Thyroid disease
    • Anemia
    • Infections (e.g., Group B Streptococcus, herpes simplex virus, HIV)
  • Substance Abuse:
    • Opioid use (can cause neonatal abstinence syndrome)
    • Alcohol abuse
    • Smoking
  • Medications:
    • Maternal sedatives/analgesics administered close to delivery (can cause neonatal respiratory depression).
    • Magnesium sulfate administration (for pre-eclampsia, can cause neonatal respiratory and neuromuscular depression).
  • Lack of Antenatal Care: Poor or no antenatal care prevents the identification and management of potential risks.
    • II. Common Fetal/Intrapartum Risk Factors:

    These factors are directly related to the fetus or events occurring during labor and delivery.

  • Prematurity: The most significant risk factor. Premature infants have immature lungs, poor temperature control, and vulnerable brains.
    • Extremely preterm (<28 weeks)
    • Very preterm (28-32 weeks)
    • Moderate to late preterm (32-37 weeks)
  • Post-term Pregnancy: (>42 weeks gestation), associated with placental insufficiency.
  • Multiple Gestation: (Twins, triplets, etc.) increases the risk of prematurity, growth restriction, and delivery complications.
  • Abnormal Fetal Heart Rate (FHR) Pattern:
    • Persistent bradycardia
    • Repetitive late decelerations
    • Prolonged decelerations
    • Loss of variability, indicating fetal distress.
  • Meconium-Stained Amniotic Fluid: (especially thick meconium), indicates fetal stress and risk of meconium aspiration syndrome.
  • Prolonged Rupture of Membranes (PROM): Increases risk of infection.
  • Chorioamnionitis: (Infection of the amniotic fluid and membranes), leads to neonatal sepsis and respiratory distress.
  • Abnormal Presentation: (e.g., breech, transverse lie), often requires C-section and can be associated with birth trauma.
  • Placental Abnormalities:
    • Placenta previa
    • Abruptio placentae (premature separation of the placenta)
    • Vasa previa, leading to fetal hemorrhage and hypoxia.
  • Cord Complications:
    • Nuchal cord (cord around the neck)
    • Cord prolapse (cord falling through the cervix before the baby)
    • True knot in the cord.
  • Fetal Anomalies: Congenital malformations affecting respiratory, cardiac, or neurological systems.
  • Intrapartum Complications:
    • Prolonged labor
    • Precipitous labor (very rapid labor)
    • Forceps or vacuum extraction delivery
    • Cesarean section (especially elective C-section without labor, as it can be associated with transient tachypnea of the newborn).
    • Shoulder dystocia.
  • Fetal Growth Restriction (FGR) / Small for Gestational Age (SGA): Indicates placental insufficiency and compromised fetal reserves.
  • Lack of Fetal Movement: Reported by mother.
    • Initial Steps of Newborn Care and Assessment at Birth

    This objective focuses on the immediate actions taken when a baby is born, particularly during the critical first minute of life—often referred to as the "Golden Minute." This period is crucial for assessing the newborn's transition and initiating any necessary interventions quickly to prevent adverse outcomes.

    Principles of Management.
    • Temperature regulation. Ensure adequate warmth for the baby to prevent hypothermia which leads to decreased metabolic which cause additional stress to the baby.
    • Ensure adequate oxygenation to the baby to prevent hypoxia by administration of oxygen and monitoring oxygen perfusion. An endotracheal tube should be inserted and oxygen administered
    • Prevention of hypoglycemia by regular monitoring blood glucose and if risk for hypoglycemia is identified administer dextrose as per prescription.
    I. Preparation for Birth: Ensuring Readiness

    Before any birth, and especially when risk factors (as discussed previously) are present, it is paramount to ensure the resuscitation area is prepared and all necessary equipment is immediately available and functional.

    A. Essential Equipment and Supplies :
  • Personal Protective Equipment:
    • Surgical gloves (minimum for resuscitator).
    • Other PPE (gowns, masks, eye protection) as per institutional policy.
  • Warmth Management:
    • Radiant warmer or heat lamp (integrated into the resuscitation table).
    • Pre-warmed towels or blankets.
    • Temperature probe/sensor (to monitor infant's temperature).
    • Plastic wrap/bag (for extremely preterm infants).
  • Airway and Suction:
    • Bulb syringe.
    • Suction catheters (e.g., 6F, 8F, 10F) with mechanical suction apparatus (set to 80-100 mmHg).
    • Meconium aspirator (if meconium is present and baby is non-vigorous, though routine use has decreased).
  • Ventilation Equipment:
    • Self-inflating bag, flow-inflating bag, or T-piece resuscitator.
    • Face masks (various sizes: preterm, term, full-term/neonate).
    • Oxygen source (blender if available to provide specific FiO2, flowmeter).
    • Nasal prongs/cannula (for oxygen administration post-resuscitation).
  • Intubation Equipment:
    • Laryngoscope with straight blades (e.g., Miller 0, 1 for term/preterm).
    • Spare laryngoscope handle and bulbs.
    • Endotracheal tubes (ETTs): range of sizes (e.g., 2.5, 3.0, 3.5, 4.0 mm internal diameter).
    • Stylet (for ETT insertion).
    • CO2 detector (colorimetric or capnography) for confirming ETT placement.
    • Scissors, tape/ETT holder for securing ETT.
    • Naso-gastric/oro-gastric tube (e.g., 8F) for gastric decompression after prolonged PPV.
  • Circulation and Medication Equipment:
    • Syringes (various sizes: 1mL, 3mL, 5mL, 10mL, 20mL).
    • Needles/blunt fill devices.
    • Umbilical venous catheterization tray (for rapid vascular access if medications are needed).
    • Sterile water and normal saline (for flushing).
    • Pediatric stethoscope.
  • Medications (Prepared and Labeled):
    • Adrenaline (Epinephrine) 1:10,000 solution:
    • Volume Expanders: 0.9% Normal Saline or Ringer's Lactate.
    • Dextrose 10%: For hypoglycemia management post-resuscitation.
    • Sodium Bicarbonate 4.2%: For prolonged resuscitation with documented metabolic acidosis.
  • Monitoring and Documentation:
    • Timer (clock watch).
    • Pulse oximeter with neonatal probe (pre-ductal placement, right hand/wrist).
    • Displayed charts for resuscitation steps (e.g., NRP algorithm).
    • Mothers' chart/patient notes.
    • B. Resuscitation Environment:
    • Resuscitation table: Stable, readily accessible, with radiant warmer.
    • Light source: Adequate, adjustable lighting.
    • Proximity: Situated near the delivery area for immediate access.
    II. Immediate Assessment at Birth: The "Golden Minute"

    Upon delivery, a rapid assessment is made to determine if the newborn requires routine care or resuscitation. This assessment should take no longer than 30 seconds to allow for timely intervention within the first minute of life.

    A. Three Key Questions for Rapid Assessment:

    The decision to proceed with routine care or to initiate resuscitation is based on answering these three questions quickly:

    1. Is the baby term gestation? (i.e., ≥ 37 weeks)
    2. Does the baby have good tone? (i.e., flexed limbs, active movement)
    3. Is the baby breathing or crying? (i.e., strong, regular respiration, not gasping or apneic)
    B. Decision Pathway:
    • YES to all three questions: Proceed with Routine Care (provide warmth, dry, skin-to-skin, observe).
    • NO to any of these questions: Proceed immediately to the Initial Steps of Stabilization.
    III. Steps for Resuscitation: The T-A-B-C's of Resuscitation

    If the newborn does not meet the criteria for routine care, the following initial steps of stabilization must be performed quickly and effectively, ideally within the first 30-60 seconds after birth (the "Golden Minute").

    A. Step 1: Temperature (T)
  • Provide Warmth and Dry:
    • Place the naked newborn under a pre-heated radiant warmer.
    • Dry the baby thoroughly with pre-warmed towels/blankets. This removes amniotic fluid, which prevents evaporative heat loss, and provides tactile stimulation.
    • Remove any wet cloth after drying.
    • B. Step 2: Airway (A)
  • Position and Clear Airway:
    • Position baby’s head in a neutral or slightly extended “sniffing position”.
    • Place a small towel roll under the baby’s shoulders to help maintain this position, ensuring the airway is open.
    • Clear the airway (if necessary): Suction blood or mucus from the mouth and then the nose using a bulb syringe or suction catheter ONLY if secretions are obstructing breathing or the baby is gasping.
    • C. Step 3: Breathing (B)
  • Assess Breathing and Heart Rate: After completing the initial steps of warmth, drying, positioning, and suctioning (if needed), reassess the newborn.
    • Look for effective breathing (regular, sustained respiratory effort, no gasping).
    • Assess Heart Rate (HR): Auscultate the chest with a stethoscope or palpate the umbilical cord stump for 6 seconds and multiply by 10.
  • Intervention for Breathing Issues:

    If the baby is apneic (not breathing) or gasping, OR if the Heart Rate is less than 100 bpm despite initial steps: Begin Positive-Pressure Ventilation (PPV).

    • Stand at the baby's head.
    • Apply an appropriately sized mask to the baby’s face, ensuring it covers the mouth and nose to form a good seal.
    • Give five initial inflation breaths (each 2-3 seconds duration). This aims to establish functional residual capacity in the lungs.
    • Observe response by looking for chest movements (chest rising) and listen for increasing heart rate.
    • Troubleshooting: If the chest does not rise, reapply the mask, reposition the baby’s head, and consider suctioning again (MR. SOPA mnemonic: Mask adjustment, Reposition airway, Suction mouth and nose, Open mouth, Pressure increase, Alternate airway).
    • Continue ventilating at a rate of 30-40 breaths per minute.
    • Intubation consideration: If PPV with a mask is ineffective, prolonged, or if specific conditions require it, intubation should be considered earlier than 20 minutes. Intubation provides a more secure airway for ventilation and allows for direct tracheal suction if needed.

    • D. Step 4: Circulation (C) / External Cardiac Massage (Chest Compressions)
  • Indication for Chest Compressions:
    • Chest compressions should be initiated if the heart rate is less than 60 beats per minute (bpm) AFTER at least 30 seconds of effective positive-pressure ventilation (PPV).
  • Technique:
    • The preferred method is the Two-Thumb Encircling Technique: Wrap your hands around the baby’s torso, placing both thumbs over the lower third of the sternum (just below an imaginary line between the nipples).
    • Alternatively, the two-finger technique can be used if one resuscitator is present or if the encircling method is not feasible.
  • Rate and Ratio:
    • Chest compressions are performed at a rate of 90 compressions per minute, coordinated with 30 ventilations per minute.
    • This provides a ratio of 3 compressions to 1 ventilation, aiming for 120 "events" (compressions + breaths) per minute.
  • Depth:
    • Compress the chest approximately one-third of the anterior-posterior diameter of the chest. Allow for complete recoil after each compression.
    • E. Step 5: Drugs (D)
  • Indication for Medications:
    • Medications are generally reserved for when the heart rate remains below 60 bpm despite effective ventilation and chest compressions.
    • Establish vascular access ( umbilical venous catheter - UVC) prior to medication administration.
  • Adrenaline (Epinephrine):
    • Indication: Heart rate remains < 60 bpm despite at least 30 seconds of effective PPV and at least 60 seconds of effective chest compressions coordinated with PPV.
    • Dose: 0.01 to 0.03 mg/kg IV (intravenous) or IO (intraosseous) of a 1:10,000 solution.
    • Repeat: May be repeated every 3-5 minutes if needed.
  • Volume Expanders (e.g., Normal Saline 0.9%):
    • Indication: Suspected hypovolemia (e.g., pallor, poor perfusion, weak pulse, lack of response to resuscitation efforts) and heart rate remains < 60 bpm despite ventilation, compressions, and epinephrine.
    • Dose: 10 mL/kg IV over 5-10 minutes.
  • Dextrose 10%:
    • Indication: Not typically given during acute resuscitation unless documented hypoglycemia. Administered after stabilization if blood glucose is low (<2.5 mmol/L).
    • Dose: 2 mL/kg of 10% dextrose solution IV.
  • Sodium Bicarbonate 4.2%:
    • Indication: For prolonged resuscitation or documented metabolic acidosis. Not a first-line drug.
    • Dose: 2 mEq/kg (equivalent to 4 mL/kg of 4.2% solution) IV slowly.
    • F. Post-Resuscitation Monitoring and Ongoing Care:
  • Continue to monitor response to resuscitation closely. (This includes heart rate, breathing, oxygen saturation, and clinical appearance).
  • APGAR Score: The Apgar score is assessed at 1 and 5 minutes after birth, and every 5 minutes thereafter if the score is less than 7, until 20 minutes of age. It's a snapshot of the baby's condition and response to resuscitation.
  • If the baby responds to resuscitation and stabilizes, keep the baby warm and transfer to a special care unit (e.g., NICU, SCN) for ongoing monitoring and supportive care.
  • If the baby is breathing well and stable:
    • Encourage skin-to-skin contact with the mother.
    • Encourage breastfeeding.
    • Provide reassurance to the mother and family.
  • Discontinuation of Resuscitation:
    • If there is no detectable heart rate after 10-20 minutes of complete and adequate resuscitation efforts, discontinuation of resuscitation should be considered in consultation with the medical team and family.
    • Principles and Techniques of Positive-Pressure Ventilation (PPV)

    Positive-Pressure Ventilation (PPV) is the most critical and frequently performed intervention in neonatal resuscitation. Its primary goal is to establish functional residual capacity (FRC) in the lungs and provide oxygenation and ventilation to newborns who are apneic (not breathing), gasping, or have a heart rate below 100 beats per minute (bpm) despite initial steps. Effective PPV can rapidly improve heart rate, oxygen saturation, and clinical condition, often preventing the need for more advanced interventions like chest compressions or medications.

    I. Principles of Effective PPV

    The success of PPV hinges on three key principles:

    1. Effective Mask Seal: The mask must form a tight, leak-free seal around the baby's mouth and nose to ensure that the delivered positive pressure enters the lungs and does not escape.
    2. Open Airway: The baby's airway must be properly positioned (sniffing position) to allow air to flow freely into the trachea and lungs. Obstructions (e.g., secretions, incorrect head position) will render PPV ineffective.
    3. Adequate Pressure and Rate: Sufficient pressure is needed to inflate the lungs, but excessive pressure must be avoided to prevent lung injury. The rate of ventilation must be appropriate to ensure both oxygenation and CO2 removal.
    II. Indications for PPV

    PPV is indicated when a newborn is:

    • Apneic: Not breathing at all.
    • Gasping: Irregular, ineffective breaths.
    • Heart Rate < 100 bpm: Despite the initial steps of warmth, drying, positioning, and clearing the airway (if necessary).
    III. Equipment for PPV

    The primary equipment used for PPV includes:

    1. Ventilation Device:
      • Self-inflating Bag: The most common device. It refills automatically after each squeeze and requires an oxygen source for supplemental oxygen. It will deliver room air if no oxygen is attached.
      • Flow-inflating Bag (Anesthesia Bag): Requires a compressed gas source and a tight mask seal to inflate. Allows for precise control of pressure and oxygen concentration but requires more skill.
      • T-piece Resuscitator (e.g., Neopuff): A gas-powered, flow-controlled device that delivers consistent peak inspiratory pressure (PIP) and positive end-expiratory pressure (PEEP). Often preferred for its precision and consistency.
    2. Face Mask:
      • Proper size is crucial. Masks are available in various sizes (preterm, term/neonate). The mask should cover the bridge of the nose, the mouth, and the chin without extending over the eyes or compressing the neck.
      • Transparent masks allow for visualization of the baby's mouth and color.
    3. Oxygen Source:
      • Oxygen blender (if available) allows for delivery of specific oxygen concentrations (FiO2).
      • Flowmeter (usually set to 5-10 L/min for resuscitation).
    4. Pulse Oximeter:
      • Essential for monitoring oxygen saturation (SpO2) and heart rate during PPV. The probe should be placed on the right wrist or hand (pre-ductal site).
    IV. Techniques for Administering PPV
    A. Positioning the Baby and Mask Application:
    1. Position the baby: Place the baby on their back under the radiant warmer, with the head in a neutral or slightly extended "sniffing position" (as detailed in Objective 3). A rolled towel under the shoulders can help.
    2. Select the correct mask size: Ensure it covers the nose and mouth without touching the eyes or overhanging the chin.
    3. Apply the mask:
      • Position yourself at the baby's head.
      • Place the mask gently but firmly on the baby's face.
      • Use the "C-E grip" (or similar): The "C" is formed by the thumb and index finger pressing the mask edges to the face, while the "E" is formed by the remaining fingers lifting the jaw forward to maintain an open airway. Avoid pressing on the baby's soft tissues under the chin, which can obstruct the airway.
    B. Initial Breaths (Inflation Breaths / Ventilating Breaths):
    1. Initial Breaths: Begin with 5 breaths, each lasting 2-3 seconds. These are sometimes called "inflation breaths" or "ventilating breaths" as they are crucial for clearing fluid from the lungs and establishing functional residual capacity.
    2. Pressure: The initial pressure required can vary.
      • For a term baby, initial pressures of 20-25 cm H2O may be sufficient.
      • For preterm babies or those with very stiff lungs, higher pressures (e.g., 25-30 cm H2O) may be needed to achieve initial chest rise.
      • Many devices have pressure gauges; familiarize yourself with how to achieve the target pressure.
    3. Observe for Chest Rise: The most important indicator of effective ventilation is a gentle, symmetrical rise and fall of the chest with each breath.
      • If no chest rise: Immediately re-evaluate the mask seal, reposition the airway, and consider clearing secretions (MR. SOPA mnemonic - discussed below).
    C. Ongoing PPV:
    1. Rate: After the initial 5 breaths, continue PPV at a rate of 30-40 breaths per minute (approximately one breath every 1.5-2 seconds).
    2. Pressure: Adjust pressure as needed to achieve gentle chest rise. Once the lungs are open, less pressure is often required.
    3. Oxygen Concentration (FiO2):
      • For term infants: Start with 21% (room air).
      • For preterm infants (<35 weeks): Start with 21-30% oxygen.
      • Adjust oxygen based on pulse oximetry readings. Target SpO2 values increase over the first 10 minutes of life (e.g., 60-65% at 1 min, 80-85% at 5 min, 85-95% at 10 min).
    D. Assessing Response to PPV:

    Reassess the baby approximately every 30 seconds during PPV.

    1. Heart Rate (HR): The most important indicator. PPV is effective if the HR is increasing, especially if it rises above 100 bpm.
    2. Breathing: Look for spontaneous breathing efforts.
    3. Oxygen Saturation (SpO2): Monitor with a pulse oximeter.
    4. Color: Observe the baby's color (pinker is good).
    5. Tone: Increased activity and muscle tone.
    V. Troubleshooting Ineffective PPV (MR. SOPA)

    If PPV is not resulting in a rising heart rate or visible chest movement, quickly go through the following troubleshooting steps:

    • M - Mask adjustment: Reapply the mask to achieve a better seal.
    • R - Reposition airway: Adjust the head position to ensure an open airway.
    • S - Suction mouth and nose: Clear any secretions that may be blocking the airway.
    • O - Open mouth: Gently open the baby's mouth, sometimes just a finger's width, to facilitate airflow.
    • P - Pressure increase: Gradually increase the inspiratory pressure (e.g., by 5-10 cm H2O increments) until chest rise is observed.
    • A - Alternate airway: If PPV remains ineffective despite all the above, consider advanced airway interventions such as endotracheal intubation.
    VI. Discontinuing PPV

    PPV can be gradually discontinued when the baby meets the following criteria:

    • Heart rate is consistently > 100 bpm.
    • The baby is breathing spontaneously and effectively.
    • Oxygen saturation is within the target range for age on minimal or no supplemental oxygen.

    Discontinuation can be done by gradually decreasing the rate of PPV while observing the baby's spontaneous breathing, or by stopping completely if the baby is breathing strongly and effectively.

    Principles and Techniques of Chest Compressions in Neonatal Resuscitation

    Chest compressions are an intervention in neonatal resuscitation, indicated when a newborn's heart rate remains dangerously low despite effective positive-pressure ventilation (PPV). The primary goal of chest compressions is to maintain blood flow to the vital organs, particularly the heart and brain, until the baby's own heart can resume an effective rhythm. This intervention is always performed in conjunction with PPV.

    I. Principles of Effective Chest Compressions

    For chest compressions to be effective, several principles must be adhered to:

    1. Correct Indication: Compressions are only started after a defined period of effective PPV has failed to raise the heart rate.
    2. Proper Location: Compressions must be delivered over the correct anatomical landmark (sternum) to be effective and minimize injury.
    3. Adequate Depth: Compressions must be deep enough to create adequate blood flow but not so deep as to cause trauma.
    4. Appropriate Rate: The rate must be fast enough to maintain perfusion, but allow for proper coordination with ventilations.
    5. Complete Recoil: Allowing the chest to fully recoil between compressions is essential for adequate cardiac filling and coronary perfusion.
    6. Coordination with Ventilation: Chest compressions must be perfectly coordinated with PPV to ensure both circulation and oxygenation.
    II. Indications for Chest Compressions

    Chest compressions are indicated when:

    • The newborn's heart rate is below 60 beats per minute (bpm).
    • This low heart rate persists despite at least 30 seconds of effective positive-pressure ventilation (PPV), confirmed by visible chest rise.
    III. Techniques for Administering Chest Compressions

    There are two main techniques for performing chest compressions in newborns:

    1. Two-Thumb Encircling Technique (Preferred):
      • Position: The resuscitator stands at the foot end of the baby (or to the side if more convenient for the team). Both hands encircle the baby's torso.
      • Hand Placement: Place both thumbs side-by-side or one over the other (depending on baby size and hand size) on the lower third of the sternum, just below an imaginary line connecting the nipples.
      • Compression: Use the pads of the thumbs to compress the sternum. The fingers support the baby's back, providing counter-pressure and stability.
      • Advantages: This technique generally produces higher peak systolic blood pressure, better coronary artery perfusion pressure, and less fatigue for the resuscitator compared to the two-finger technique. It also allows for continuous ventilation.
    2. Two-Finger Technique (Alternative):
      • Position: The resuscitator is positioned to the side of the baby.
      • Hand Placement: Place the tips of the index and middle fingers (or middle and ring fingers) of one hand on the lower third of the sternum, just below an imaginary line connecting the nipples.
      • Compression: Use the tips of these two fingers to compress the sternum. The other hand can be placed under the baby's back for support.
      • Advantages: This technique is often used if there is only one resuscitator or if vascular access is being obtained via the umbilical cord while compressions are ongoing.
      • Disadvantages: Can be more tiring, may produce less effective blood flow, and may interfere with effective ventilation if not coordinated properly.
    IV. Location, Depth, Rate, and Coordination
    A. Location of Compressions:
    • On the lower third of the sternum, just below an imaginary line connecting the nipples. Avoid compressing over the xiphoid process (bottom tip of the sternum) as this can cause liver injury.
    B. Depth of Compressions:
    • Compress the sternum to a depth of approximately one-third of the anterior-posterior (AP) diameter of the chest.
    • This depth ensures adequate cardiac output while minimizing the risk of injury. Allow for complete release and recoil of the chest wall after each compression to allow for cardiac refilling.
    C. Rate of Compressions:
    • Compressions should be delivered at a rate of 90 compressions per minute.
    • This requires a rapid, rhythmic pace: "One-and-two-and-three-and-breathe..."
    D. Coordination with Ventilation (3:1 Ratio):
    • Chest compressions are always coordinated with PPV. The established ratio is 3 compressions to 1 ventilation.
    • This means 90 compressions and 30 ventilations per minute, totaling 120 "events" (compressions + breaths) per minute.
    • Technique: "One-and-two-and-three-and-BREATH..." The "BREATH" should coincide with the release phase of the third compression. The resuscitator performing compressions should pause briefly (for approximately 0.5-1 second) to allow the ventilation to be delivered effectively.
    V. Assessing Response to Chest Compressions
    • Heart Rate: Reassess the heart rate after 60 seconds of coordinated chest compressions and PPV.
      • If the heart rate is ≥ 60 bpm, chest compressions can be discontinued, and PPV can be continued until the heart rate is ≥ 100 bpm and the baby has effective spontaneous breathing.
      • If the heart rate remains < 60 bpm despite 60 seconds of coordinated compressions and PPV (which have been deemed effective), then medications (epinephrine) should be considered and administered as per Objective 3.
    VI. Discontinuing Chest Compressions
    • Chest compressions should be discontinued once the newborn's heart rate is consistently 60 bpm or greater.
    • Continue PPV until the heart rate is consistently ≥ 100 bpm and the baby has effective spontaneous breathing.
    Role and Administration of Medications in Neonatal Resuscitation

    Medications are the final step in the neonatal resuscitation algorithm and are rarely needed when ventilation and chest compressions are performed effectively. The primary goal of medication administration in this context is to support cardiovascular function and improve heart rate when other resuscitative efforts have failed. Access for medication administration is established via the umbilical vein.

    I. General Principles of Medication Administration
    1. Last Resort: Medications are indicated only after adequate ventilation and effective chest compressions have been performed for a sufficient duration (usually at least 60-90 seconds after starting compressions) and the heart rate remains below 60 bpm.
    2. Vascular Access: Rapid and reliable vascular access is crucial. The preferred route is the umbilical venous catheter (UVC). Intraosseous (IO) access can be an alternative if UVC placement is delayed or unsuccessful. Intratracheal (IT) administration of epinephrine is less effective and not the preferred route, but may be used as a temporizing measure if vascular access is not immediately available.
    3. Dilution and Administration: Medications should be prepared in appropriate concentrations and administered swiftly but carefully. Always flush the line after administration.
    4. Team Communication: Clear communication among the resuscitation team regarding medication preparation, dosage, route, and time of administration is essential to avoid errors.
    II. Key Medications in Neonatal Resuscitation
    A. Epinephrine (Adrenaline)
  • Role: A catecholamine that increases heart rate, myocardial contractility, and peripheral vasoconstriction. It is the primary drug used to improve heart rate during neonatal resuscitation.
  • Indication:
    • Heart rate remains < 60 bpm despite at least 30 seconds of effective positive-pressure ventilation (PPV).
    • AND at least 60 seconds of effective chest compressions coordinated with PPV.
  • Preparation:
    • Concentration for IV/IO use: 1:10,000 solution (0.1 mg/mL).
  • Dosage:
    • Intravenous (IV) / Intraosseous (IO): 0.01 to 0.03 mg/kg.
      • This corresponds to 0.1 to 0.3 mL/kg of the 1:10,000 solution.
    • Intratracheal (IT) (if no IV/IO access): 0.05 to 0.1 mg/kg.
      • This corresponds to 0.5 to 1.0 mL/kg of the 1:10,000 solution. Note: The IT route is less reliable, and higher doses are needed due to poor absorption. It should be considered a temporizing measure while obtaining IV/IO access.
  • Administration: Administer rapidly (over 1-3 seconds) via IV/IO route, followed by a flush (e.g., 0.5-1 mL normal saline).
  • Repeat Dosing: May be repeated every 3-5 minutes if the heart rate remains < 60 bpm.
    • B. Volume Expanders (e.g., Normal Saline 0.9% or Ringer's Lactate)
  • Role: Used to treat hypovolemic shock (low blood volume) and improve blood pressure and perfusion.
  • Indication:
    • Suspected acute blood loss (e.g., placental abruption, fetomaternal hemorrhage).
    • Signs of shock (pallor, poor perfusion, weak pulses, persistent bradycardia) that do not respond to other resuscitative measures, especially if accompanied by evidence of hypovolemia.
  • Preparation: Normal Saline 0.9% or Ringer's Lactate.
  • Dosage:
    • IV/IO: 10 mL/kg.
  • Administration: Administer slowly over 5-10 minutes. Rapid administration can lead to complications.
  • Repeat Dosing: May be repeated once or twice if signs of hypovolemia persist and the heart rate remains low.
    • C. Sodium Bicarbonate (4.2%)
  • Role: Used to correct severe metabolic acidosis, which can develop during prolonged resuscitation and impair cardiac function.
  • Indication:
    • Prolonged resuscitation with documented metabolic acidosis.
  • Preparation: 4.2% Sodium Bicarbonate (0.5 mEq/mL).
  • Dosage:
    • IV/IO: 2 mEq/kg (which is 4 mL/kg of the 4.2% solution).
  • Administration: Administer very slowly, over at least 5-10 minutes, to avoid rapid shifts in pH and hyperosmolality. Administer only after adequate ventilation has been established.
    • D. Dextrose (10%)
  • Role: To correct hypoglycemia (low blood sugar).
  • Indication:
    • Hypoglycemia is not typically an acute issue during the immediate resuscitation phase.
    • Indicated if hypoglycemia is suspected or confirmed after resuscitation, or if the baby has risk factors for hypoglycemia (e.g., prematurity, small for gestational age, maternal diabetes).
  • Preparation: 10% Dextrose solution.
  • Dosage:
    • IV/IO: 2 mL/kg.
  • Administration: Administer over 5-10 minutes.
    • III. Medications Generally Not Recommended for Acute Neonatal Resuscitation
  • Naloxone:
    • Role: An opioid antagonist.
    • Why not recommended in acute resuscitation: While it reverses opioid-induced respiratory depression, its onset of action is delayed compared to PPV. PPV is the primary treatment for respiratory depression regardless of cause. Administering naloxone too early or to an opioid-dependent infant can precipitate acute withdrawal and seizures. It should only be considered after successful resuscitation for suspected opioid depression if the baby has a good heart rate but poor respiratory effort.
  • Calcium Gluconate:
    • Role: Used to treat hypocalcemia.
    • Why not recommended: Rarely indicated in acute neonatal resuscitation. Its use is reserved for specific conditions like documented hypocalcemia, hyperkalemia, or magnesium toxicity, which are typically not acute issues in the delivery room.
  • Atropine:
    • Role: Anticholinergic, can increase heart rate.
    • Why not recommended: Not used in neonatal resuscitation. Bradycardia in newborns is almost always due to hypoxia, and correcting hypoxia with PPV is the treatment.
    • IV. Securing Vascular Access: Umbilical Venous Catheter (UVC)
  • Procedure: A sterile procedure performed when medications or volume expanders are indicated.
    1. Cleanse the umbilical cord stump.
    2. Cut the cord cleanly about 1-2 cm from the skin.
    3. Identify the umbilical vein (larger, thin-walled, usually at the 12 o'clock position) and the two smaller, thick-walled umbilical arteries.
    4. Insert a catheter (e.g., 3.5F or 5F) into the umbilical vein for a short distance (2-4 cm) until blood can be aspirated easily. Advance no further than necessary to get a free flow of blood, to avoid advancing into the portal circulation.
    5. Secure the catheter.
  • Importance: Provides a rapid and reliable route for medication administration and volume expansion during ongoing resuscitation.
    • Post-Resuscitation Care and Monitoring of the Newborn

    Post-resuscitation care is a phase aimed at stabilizing the newborn, preventing secondary complications, and optimizing long-term outcomes. Even after successful resuscitation and stabilization of vital signs, newborns remain at risk for various issues related to the initial hypoxic-ischemic event and the interventions performed. Therefore, meticulous monitoring and supportive care are essential.

    I. Immediate Post-Resuscitation Stabilization (First Hours)

    Once resuscitation efforts lead to stable vital signs (heart rate >100 bpm, effective spontaneous breathing, SpO2 within target range), the focus shifts to maintaining this stability.

    A. Thermal Regulation:
    • Maintain normothermia: Continue to monitor temperature closely and use appropriate warming devices (radiant warmer, incubator). Avoid both hypothermia (which increases oxygen consumption and metabolic acidosis) and hyperthermia.
    • Target Temperature: Maintain core body temperature between 36.5°C and 37.5°C.
    B. Respiratory Support:
    • Weaning from PPV/Oxygen: If the baby is breathing effectively, gradually wean from supplemental oxygen as tolerated, guided by pulse oximetry.
      • Goal SpO2: Aim for age-appropriate target oxygen saturations (e.g., 90-95% by 10 minutes, then >92% once stable).
    • Monitor for Respiratory Distress: Observe for signs of tachypnea, grunting, retractions, nasal flaring, and cyanosis. Provide continuous positive airway pressure (CPAP) or mechanical ventilation if needed.
    • Chest X-ray: Consider a chest X-ray to assess lung expansion, rule out pneumothorax, or confirm endotracheal tube (ETT) position if intubated.
    C. Cardiovascular Support:
    • Continuous Cardiac Monitoring: Monitor heart rate and rhythm continuously.
    • Blood Pressure: Monitor blood pressure. Hypotension may require volume expansion or inotropic support.
    • Perfusion: Assess capillary refill time, skin color, and peripheral pulses as indicators of systemic perfusion.
    D. Fluid and Electrolyte Management:
    • Intravenous Fluids: Begin IV fluids (e.g., Dextrose 10% at 60-80 mL/kg/day) to prevent hypoglycemia and dehydration, especially if oral feeding is delayed.
    • Electrolytes: Monitor electrolytes and correct any imbalances.
    E. Glucose Management:
    • Blood Glucose Monitoring: Perform frequent blood glucose checks (e.g., every 1-2 hours initially) to detect and manage hypoglycemia or hyperglycemia.
    • Treatment of Hypoglycemia: Administer IV dextrose bolus (2 mL/kg of 10% dextrose) followed by a continuous infusion if needed.
    F. Acid-Base Balance:
    • Arterial Blood Gas (ABG): Obtain ABG to assess acid-base status, oxygenation, and ventilation. Correct significant acidosis as needed, although resolution often occurs with adequate ventilation and perfusion.
    II. Ongoing Monitoring and Assessment (First 24-72 Hours)

    Newborns who have undergone resuscitation require close observation and specialized care in a Neonatal Intensive Care Unit (NICU) or Special Care Nursery (SCN).

    A. Neurological Assessment:
    • Hypoxic-Ischemic Encephalopathy (HIE): This is a major concern. Assess for signs of neurological injury:
      • Level of consciousness: Lethargy, irritability, seizures.
      • Muscle tone and reflexes: Hypotonia, hypertonia, abnormal reflexes.
      • Feeding difficulties.
    • Therapeutic Hypothermia: If criteria for moderate to severe HIE are met in term or near-term infants, therapeutic hypothermia (cooling) should be initiated within 6 hours of birth. This neuroprotective intervention aims to reduce brain injury.
    B. Organ System Monitoring:
    • Renal: Monitor urine output, creatinine, and electrolytes for signs of acute kidney injury.
    • Gastrointestinal: Monitor for feeding intolerance, abdominal distension, and signs of necrotizing enterocolitis (NEC), especially in preterm infants or those with severe hypoxia-ischemia.
    • Hematologic: Monitor for coagulation abnormalities (DIC) and anemia.
    C. Infection Control:
    • Newborns who undergo resuscitation may be at higher risk for infection, particularly if invasive procedures (e.g., UVC placement) were performed.
    • Monitor for signs of sepsis and consider antibiotic therapy if clinically indicated.
    III. Documentation and Communication
    • Detailed Documentation: Maintain meticulous records of the resuscitation event, including:
      • Time of birth and start/end of resuscitation.
      • Initial assessment.
      • All interventions (PPV, compressions, medications: dose, route, time).
      • Baby's response to interventions (HR, SpO2, breathing, tone).
      • Personnel involved.
    • Communication with Parents: Provide timely, empathetic, and clear communication with the parents about the events, the baby's condition, ongoing care plan, and prognosis. Answer their questions honestly.
    APGAR Score Reference
    SCORE 0 points 1 point 2 points
    Appearance (Skin color) Cyanotic / Pale all over Peripheral cyanosis only Pink
    Pulse (Heart rate) 0 <100 100-140
    Grimace (Reflex irritability) No response to stimulation Grimace or weak cry when stimulated Cry when stimulated
    Activity (Tone) Floppy Some flexion Well flexed and resisting extension
    Respiration Apneic Slow, irregular breathing Strong cry
    IV. Apgar Scoring
  • Purpose: The Apgar score is a rapid method to summarize the newborn's condition at 1 and 5 minutes after birth. It is a guide to the baby's response to the birth process and resuscitation, not an indicator of long-term neurological outcome.
  • Scoring:
    • Appearance (color)
    • Pulse (heart rate)
    • Grimace (reflex irritability)
    • Activity (muscle tone)
    • Respiration (breathing effort)
  • Interpretation:
    • Scores of 7-10 are generally reassuring.
    • Scores of 4-6 indicate moderate depression.
    • Scores of 0-3 indicate severe depression.
  • Repeat Scoring: If the 5-minute Apgar score is < 7, the score should be repeated every 5 minutes until 20 minutes of age, or until the score is consistently > 7.
    • V. Transfer and Referral
    • If comprehensive NICU care or specific therapies (like therapeutic hypothermia) are not available at the birth facility, prompt and safe transfer to an appropriate higher-level facility is crucial.

    Resuscitation Read More »

    Obstetric Anatomy

    Obstetric Anatomy Q & A

    Obstetric Anatomy Q & A

    Obstetric Anatomy, Obstetrics is the field of study concentrated on pregnancy, childbirth and the postpartum period
    Question 1
     

    (a) Describe the vagina.

    (b) Outline indications of vaginal examination.

    (c) What information must you note on vaginal examination?

    (d) List contraindications of vaginal examination

    SOLUTIONS.

    1. A vagina is a muscular fibrous canal which forms the part of the internal female reproductive organs

    Situation

    It is a canal which extends from the vestibule below to the cervix above running in an upward and backward direction between the planes of the pelvic brim.

    Shape

    It is a potential tube which runs upwards and backwards with its walls in close contact but can be separated during coitus, menstruation, vaginal examination and child birth.

    Size

    The anterior wall measures 7.5cm

    The posterior wall is longer and it measures 10cm.This is because the uterus enters the vagina at an angle of 90 degrees and bends forwards towards the anterior wall hence it encroaches on it

    Structure 

    Gross structure

    Superiorly; the upper end of the vagina is known as the vault, where the cervix protrudes into the vault it forms circular recess known as fournices.

    The vagina is made up of four fournices that is to say; The anterior fornix which is smaller and fairly deep The 2 lateral fournices which are shallow

    The posterior fornix which is the longest and deepest

    The lower end of the vagina is narrow and inferiorly we find the vulva_hymen enclosing the vaginal opening only present in virgins. If hymen is ruptured it leaves tags of membranes referred to as carunculae mytiformes. Vaginal orifice is also called introitus.

    Microscopic structure

    It is made up of four layers;

    1. Squamous epithelium arranged in folds known as rugae and makes the inner most layer of the vagina, the rugae increase the surface area and offer the vagina ability to stretch when need be for example during coitus and child
    2. Vascular connective tissue layer which is rich in blood vessels, nerves and lymphatics and is found just beneath the epithelium.
    3. Muscular layer. This is thin but a strong layer which is divided into two; the weak inner circular and strong outer longitudinal fibres.
    4. The pelvic fascial which is made up of loose connective It forms the outer protective coat and is continuous with the pelvic fascia.

    Blood supply (arterial)

    obstetric anatomy blood supply

    The vagina is supplied by the branches of internal iliac artery which include vaginal artery and uterine artery

    Venous drainage

    By the corresponding veins ie branches of internal iliac veins which include vaginal veins and uterine veins.

    Lymphatic drainage

    Into the inguinal, the iliac and the sacro glands

    Nerve supply

    By the sympathetic and parasympathetic nerves which are branches from the lee Franken lanser plexus

    Contents of the vagina

    It doesn‘t contain any glands but its kept moist by cervical mucus and a transudation from the underlying blood vessels through the epithelium.

    Its media is acidic (PH 3.8 to 4.5) and this is made possible by presence of lactic acid after action of doderleins bacilli on glycogen

    Relationships of the vagina

    obstetric anatomy relation

    Anteriorly

    Below, the base of the bladder rests on the upper ½ of the vagina and the urethra is embedded in the lower ½.

    Posteriorly

    Pouch of Douglas above, the rectum medial and perineal body below Laterally

    Pubococcygeous muscles below and pubic fascial containing the uterus above Inferiorly

    The structure of the vulva Superiorly

    The cervix and the fournices

    Functions of the vagina

    1. Exit from menstrual flow
    2. Entrance for spermatozoa
    3. Exit for products of conception
    4. Supports the uterus
    5. Prevents ascending infection due to acidic PH
    6. For assessing the pelvis
    7. Drug administration

    PART B

    Indications of vaginal examination

    Indications can be divided into during pregnancy, labour and puerperium

    During pregnancy

    • To confirm pregnancy using hegars, jacquemiers and osianders signs
    • To rule out abnormalities in genital organs g. polyps, cervical erosion and cancer of the cervix
    • To rule out causes of bleeding in early weeks

    During labour

    First stage of labour

    • To diagnose onset of labour
    • To determine progress of labour by finding out degree of cervical dilatation
    • To note state of membranes
    • To confirm presentation, position and engagement of head
    • To assess moulding
    • To exclude cord prolapse when membranes rupture
    • To note dilatation before giving a narcotic

    Second stage of labour

    • To confirm second stage of labour
    • To note cause of delay in second stage of labour
    • To confirm presentation of second twin before rupturing membranes

    Third stage of labour

    • To determine cause of postpartum haemorrhage
    • Incase of retained placenta, to detect cause of retained placenta and exclude construction ring
    • To detect condition of birth canal following child birth

    During puerperium

    • To rule out cause of secondary PPH
    • At 6-8weeks after delivery, to detect if the reproductive organs have gone back to their pregravida state.
    1. Information to note on vaginal examination

    On inspection

    State of the vulva, note any abnormal discharges like pus, blood, abnormal growths like warts,  oedema and scars.

    On examination

    Note condition of the vagina

    Normally the vaginal walls feel warm and moist and dilatable. If dry may be a sign of infection or obstruction.

    State of the cervix

    If thin, thick, whether soft or rigid and whether its well applied to the presenting part.

    Note dilatation and cervical effacement.

    State of the membranes

    Whether intact or ruptured. If ruptured check colour and smell of liquor

    Presentation and presenting part

    Note level of presenting part in the pelvis

    Confirm position by finding or palpating sutures and fontanelles and relate them to the maternal pelvis.

    Note moulding.

    Do internal pelvic assessment and note

    • -sacro promontary if protruding
    • -hollow of the sacrum if well curved
    • -sciatic notches if well rounded
    • -ischial spines if prominent
    • -sub pubic arch-if it accommodates 2 ½ to 3 fingers
    • -inter tuberous diameter if it accommodates 4 knuckles

    Contraindications of vaginal examination

    • Ante partum haemorrhage
    • Threatened abortion
    • Elective caesarean section

    a) Describe

    b) Outline the formation of the

    c) List variations of the placenta

    SOLUTIONS

    1. Describe Fertilization

     Fertilization is the fusion of the male gamete (sperm) and female gamete (ovum)

    Fertilization occurs when the female gamete fuse to form a zygote during the time of intercourse, about 300 million spermatozoa are deposited into the vagina.

    Some sperms cannot survive the acidic media of the vaginal secretions so the weak ones die and only the strong ones survive.

    The surviving sperms continue moving forwards this is made possible by the special arrangement of the mucus lining of the cervix (arborvitae) which prevents back flow of sperms.

    Sperms continue their journey but still the weak ones continue to die off. Movement is slowed down by the presence of hair like projections called cilia and more eradication of weak sperms continues. And if ovulation had taken place within 48 hours and the ovum is still viable the two gametes will meet in the ampulla and fusion will take place hence fertilization.

    b) Outline the Formation of the Placenta 

    Placenta is a vital organ of communication between the mother and the fetus.

    It‘s a maternal-fetal organ which begins developing at implantation of the blastocyst and is delivered with the fetus at birth.

    Formations of the placenta

    • Maternal surface

    This is the surface next to the uterus

    Its dark red in color due to presence of maternal blood and it has 18-20 lobes which are collections of chronic villi each cotyledon is separated from the other by tissues.

    •       Fetal surface

    This is the surface next to the fetus

    It has a shiny surface due to presence of amniotic membrane

    c). List variations of the placenta / abnormalities of the placenta

    • Succenturiate lobe

    This occurs due to abnormalities in development and it is the most significant abnormality. The additional lobule separates from the main part of the placenta.

    • Circumvallated placenta

    It is an opaque ring seen on the fetal surface of the placenta and this is due to doubling back of the chorion and amnion

    • Bi-partite placenta or bi-lobed placenta

    This placenta has two complete and separate parts each with a branch of umbilical cord vessels which later join to form one cord.

    • Battledore insertion of the cord

    In this the placentas cord is inserted at the edge/margin of the placenta and the placenta has an appearance of a table tennis bat in shape.

    1. Velamentous insertion of the cord

    The cord is inserted into the fetal membranes some distance away from the edge of the placenta.

    The diagram below shows the different variations of the placenta discussed above.

    placenta variations

    a) Describe the non-pregnant

    b) What changes take place in this organ during pregnancy?

     

    Description of the non pregnant uterus

    • This is a hollow muscular pear /ovacado shaped

    Situation

    • It is situated in the true pelvis between the urinary bladder and the

    Size

    • It is 5cm, long 5cm wide, and 2.5cm thick so each wall is 1.25cm thick.

    Position

    • The uterus is anteverted (bends forward) and anteflexed (bends on itself)

    Shape

    •  The uterus is pear shaped (avocado) with the upper part bigger than the lower part .

    Description of the non pregnant uterus

     
      

    Gross structure

    This is made up of the following

    • The body.

     This forms the upper part of the whole uterus.

    • Fundus

     This is a raised area between the insertion of the uterine tubes.

    • Cornua

    Upper outer angles of the uterus where the uterine tubes are inserted. This is made up of the following

    • Cavity

    This is a potential space between the anterior and posterior uterine walls.

    It is triangular in shape.

    • Isthmus

    This is a narrow area between the body of the uterus and the cervix.

    • Cervix or neck

    This forms other lower third of the whole uterus into the

    Microscopic structure

    Endometrium

    • this is a layer of ciliated mucus
    • It changes constantly with the menstrual cycle
    • It lines the uterine cavity and shades off during menstruation up to the basal
    • The cervical endometrium does not change during menstruations

    Myometrium

    • Middle layer and is formed by different muscle fibres.
    • Longitudinal fibres ;mainly found in the upper part of the uterus .
    • Oblique muscle fibres ;mainly found in the fundus
    • Circular muscle fibres which are located at the cornua and they prevent contractions extending to the uterine tubes.
    • Some are found around the cervix which help in dilatation during labour.

    Perimetrium

    • It is a serous membrane which is a continuation of the peritoneum
    • It covers the outer aspect of the uterus.
    • It bends upwards to form the uterovesco pouch anteriorly and the pouch of dauglous posterioly

    Blood supply

    • By uterine arteries which are the branches of the internal iliac artery and they supply the lower ovarian arteries the branches of the abdominal aorta and supply the upper parts.

    Nerve supply

    • By sympathetic and parasympathetic
    • Lymph drains into internal illiac glands

    Supports

    • The uterus is supported by pelvic floor muscles and maintained in position by ligaments.
    • Transverse ligament
    • Utero sacral ligament
    • Pubo cervical ligament
    • Broad ligament
    • Round ligament and,
    • Ovarian ligament.

    Relations of the Body of the Uterus

     

    • Anteriorly:The bladder and vesco-uterine pouch.
    • Posteriorly: The pouch of douglas
    • Laterally: The broad ligament on each side uterine tubes and ovaries.
    • Superiorly: intestines
    • Inferiorly :vagina

    Functions of the uterus

    • It shades the endometrium during menstruation
    • To prepare a bed for the fertilized ovum
    • It shelters the fetus during pregnancy
    • It expels the products of conception at term
    • To involute following childbirth

    (B) THE PHYSIOLOGICAL CHANGES THAT OCCUR IN UTERUS DURING PREGNANCY

    Pregnancy

     Is the growth and the development of a fertilized ovum from the time of conception until its expulsion. In normal pregnancy expulsion of the fetus takes place at term. Thus, 38-42 weeks of gestation with an average of 40 weeks.

    • Physiological changes that take place during and pregnancy are associated with and caused by the effects of specific hormones.
    • These are temporary adaptations of the body that helps to meet the demands of the fetus.
     
      

    CHANGE IN THE UTERINE SIZE DURING PREGNANCY.

    The body of the uterus

     After conception, the body develops to provide a nutritive and a protective environment into which the fetus will grow and develop.

    Size: 7.5x5x2.5- 30×23 x20 (cm) 

    Weight: changes from 60 to 1000gm 

    Uterine shape and situation.

    • The uterus changes to a globular shape to accommodate the growing fetus, increasing amounts of liquor and placental tissues.
    • The lowest part of the uterus elongates 3 times its original length during the first trimester, giving the appearance of a stalk below the globular segment. This is the beginning of the upper and lower uterine
    • By 12th week of pregnancy, the uterus rises out of the pelvis and becomes upright. It is no longer anteverted and ante flexed. It is about the size of a grape fruit and may be palpated abdominally above the symphysis pubis.
    • By 16th week, the conceptus has grown enough to put pressure on the isthmus, causing it to open out so that the uterus become more globular n shape.
    • By 20th week of pregnancy, the uterus becomes spherical in shape and has a thicker, and more rounded fundus. As the uterus continues to rise in the abdomen, the uterine tubes, being ristricted by attachments to the broad ligaments, become progressively more At 20th week the fundus of the uterus may be palpated at or just below the umblicus.
    • At 30th week, the lower uterine segment can be It is the portion of the uterus above the internal os of the cervix. The fundus can be palpated midway between the umblicus and the xiphisternum.
    • The uterus reaches the level of the xisphisternum by the 38th A reduction in fundal height , known as lightening, may occur at the end of pregnancy when the fetus sinks into the lower pole of the uterus.

    Decidua

     The decidua is the name given to the endometrium during pregnancy. Estrogen and progesterone produced by the corpus luteum, causes decidua to become thicker and richer and more vascular at the fundus and in the upper body of the uterus, which are the usual site for implantation.

    The decidua provides a glycogen rich environment for the blastocyst until the placenta is formed.

     

    Myometrium.

    • It is made up of smooth muscle fibres, held together by connective These muscle fibres grow up to 15 to 20 times their non pregnant length.
    • The hypertrophy and hyperplasia of the uterine muscle is due to the effect of estrogen and
    • The uterus continues to grow in this way for the first three months, after which the growth is related to the distension by the growing
    • The wall of the myometrium become thicker during the first few months of pregnancy, and as gestation advances, the walls become thinner owing to the gross enlargement of the uterus being only 5 cm thick or less at term.
    • These prelabor contractions are associated with the ―ripening of the cervix‖ and eventually becomes the contractions of labor as the effects of estrogen supersede those of progesterone e. progesterone normally suppresses myometrial activity.
    • During pregnancy, the muscle layers become more differentiated and organized and organized for their part in expelling the fetus.
    • The thickness of the upper uterine acts as a piston to force the fetus into the receptive, passive lower uterine segment.

    Contractions of these muscles fibres is necessary to entrap and enmesh bleeding vessels and ligate them after the placenta is delivered.

    • The inner circular layer is thin and forms sphincters around the openings at the cornua, and around the lower uterine segment and

    Blood vessels

     

    • The uterine blood vessels increase in diameter and new vessels develop under the influence of estrogen. the blood supply through the uterine and ovarian arteries increase to about 750mls per minute at term to keep pace with its growth and also to meet its needs of the functioning placenta.

    The cervix

    • The cervix remains tightly closed during pregnancy , providing protection to the fetus and resistance to the pressure from above when the woman is in a standing up
    • The mucus secreted by the endo cervical cells become thicker and more viscous during The thicken mucus then forms a plug called the operculum, which provides protection from ascending infections.
    • Cervical vascularity increases during pregnancy, giving the cervix a bluish color if viewed through a speculum.
    • The cervix remains 5cm long throughout pregnancy.
    • In late pregnancy, softening or ripening of the cervix occurs making it more distensible. The muscles of the fundus enhance tension in the outer longitudinal layer of muscles of the cervix contributing to the process of effacement.

    Obstetric Anatomy Q & A Read More »

    Ectopic Pregnancy

    Ectopic Pregnancy

    ECTOPIC PREGNANCY

    Ectopic pregnancy is a gestation that implants outside of the endometrial cavity. 

    Ectopic pregnancy is an implantation of a fertilized ovum outside the uterine cavity.

    An ectopic pregnancy most often occurs in a fallopian tube. This type of ectopic pregnancy is called a tubal pregnancy.

     

     An ectopic pregnancy is estimated to occur in 1 of every 80 spontaneously conceived pregnancies.

    Ectopic Pregnancy anatomical location

    ANATOMICAL LOCATION OF ECTOPIC PREGNANCY

    Tubal (99%)

    • Ectopic Pregnancy occurs anywhere in the fallopian tube.
    • The most common site is the ampulla.
    • Interstitial (cornual) pregnancies occur in the most proximal tubal segment, which runs through the uterine cornua. This type of ectopic pregnancy can grow to be quite large, and rupture may cause massive haemorrhage.

    Ovarian (0.5%)

    • Ectopic Pregnancy occurs in the ovary.

    Abdominal (less than 0.1%)

    • Ectopic Pregnancy occurs in the abdomen.
    • With possible adherence to the peritoneum, visceral surfaces, or omentum

    Cervical (0.1%)

    • Ectopic Pregnancy occurs in the cervix.
    • A cervical ectopic, in which the pregnancy implants on the cervix itself, is very rare. Most cervical pregnancies will result in miscarriage. The risk of bleeding, either with spontaneous miscarriage, or for those which require surgical intervention, is much higher

    Heterotopic Pregnancy

    • This is a very rare type of multiple pregnancy, in which one viable pregnancy develops within the uterus, and another fertilised egg is implanted elsewhere as an ectopic pregnancy. 
    • It occurs in less than 1 in 30,000 naturally occurring pregnancies, and is slightly more common in couples who conceive through assisted conception.
    • Both intrauterine and ectopic pregnancies may occur concomitantly.

    Caesarean Scar Pregnancy

    • Rarely, the ectopic pregnancy can be located at the site of the scar from a previous Caesarean section. This occurs in 1 in 1,800 pregnancies.

    Cornual/Interstitial

    • Interstitial ectopic pregnancies are those which occur in the tissue of the Fallopian tube that lies within the muscular wall of the uterus. 
    • It can be quite difficult to diagnose through ultrasound, and may need laparoscopic (keyhole) surgery to confirm the diagnosis.

    Other less common sites of ectopic implantation are the ovary,  or a rudimentary uterine horn. Rarely, an ectopic may be intraligamentous or in the peritoneal cavity

    CAUSES AND RISK FACTORS FOR ECTOPIC PREGNANCY

    CAUSES AND RISK FACTORS FOR ECTOPIC PREGNANCY

    The occurrence of ectopic pregnancy has been associated with abnormal function of the fallopian tubes. Normally, the tubes facilitate collection and transport of the oocyte and embryo into the uterus. The integrity of the fimbria, lumen, and ciliated mucosa appears to be important for transport. Conditions thought to prevent or retard migration of the fertilized ovum to the uterus increase the risk for an ectopic pregnancy.

    Abnormal Function of Fallopian Tubes: 

    • Normal function of the fallopian tubes, involving the integrity of fimbria, lumen, and ciliated mucosa, is crucial for the proper transport of the oocyte and embryo into the uterus.
    • Conditions hindering migration of the fertilized ovum to the uterus elevate the risk of ectopic pregnancy.

    Pelvic Inflammatory Disease (PID):

    • Inflammation and scarring from PID affect intra and extra luminal structures, impairing normal tubal function.
    • Severe damage may result in complete tubal blockage and infertility.

    Tubal Surgery and Related Procedures:

    • Tubal surgeries, bilateral tubal ligation, and tubal reanastomosis may lead to scarring, narrowing, or false passage formation.
    • Other pelvic and abdominal surgeries may cause peritubal adhesions, although not directly associated with ectopic pregnancy.

    Chlamydia, Gonorrhea, Endometriosis, and Salpingitis:

    • Infections, especially Chlamydia and gonorrhoea, which causes PID, contribute to inflammation and scarring.
    • Conditions like endometriosis and salpingitis increase the risk of ectopic pregnancy.

    Artificial Reproductive Techniques:

    • In-vitro fertilization and gamete intrafallopian transfer have been linked to an increased risk of ectopic pregnancy.
    • Retrograde embryo migration is considered a possible mechanism.

    Delayed Fertilization:

    • Possible transmigration of the oocyte to the contralateral tube and slowed tubal transport can delay the passage of the morula to the endometrial cavity.

    Chromosomal and Structural Anomalies of the Conceptus:

    • Anomalies in the chromosomes or structure of the conceptus may predispose individuals to ectopic pregnancy.

    Developmental Abnormalities of the Tube:

    • Abnormalities like diverticula, accessory ostia, and hypoplasia in the tube can elevate the risk of ectopic pregnancy.
    • Exposure to diethylstilbestrol increases the risk four to five times.

    RISK FACTORS FOR ECTOPIC PREGNANCY:

    • Increased Maternal Age: Advanced maternal age is identified as a risk factor for ectopic pregnancy.
    • History of Previous Ectopic Pregnancy: Individuals with a history of ectopic pregnancy have a 15% to 20% risk of recurrence in subsequent pregnancies, in either the same or opposite tube.
    • History of Infertility: Infertile couples exhibit an increased proportion of ectopic pregnancies compared to the total number of pregnancies, regardless of the cause of infertility.
    • Contraceptive Methods: Certain contraceptive methods carry a higher risk, including Progestasert IUD (15%), intrauterine devices (5%), and diaphragms. Oral contraceptives have a 1% risk, while intrauterine devices are highly effective at preventing intrauterine pregnancy, making any pregnancy in an IUD user more likely to be tubal.
    • Progestin-only Contraceptives: Users of progestin-only oral contraceptives and injectable progestins face an increased risk of ectopic pregnancy if pregnancy occurs, possibly due to altered tubal motility.
    • Peritubal Adhesions: Adhesions following post-abortal or puerperal infections, appendicitis, or endometriosis contribute to the risk of ectopic pregnancy.
    • Cigarette Smoking: Studies indicate that cigarette smoking causes tubal ciliary dysfunction, contributing to the risk of ectopic pregnancy.
    • Endometriosis: Endometriosis can make the uterus unsuitable for implantation, increasing the likelihood of ectopic pregnancy.

    WHY AN ECTOPIC PREGNANCY HAPPENS?

    Pathophysiology of an Ectopic Pregnancy.

    • Fertilization occurs at the usual distal third of the fallopian tube.
    • After the union, zygote begins to divide and grow.
    • However, due to an obstruction by several factors (see Risk Factors), the zygote cannot travel through the length of the tube.
    • It lodges on that constricted part and implantation takes place at that area instead of the uterus.

    In a normal pregnancy, an egg is fertilized by sperm in one of the fallopian tube which connect the ovaries to the womb .The fertilized egg moves and implants itself into the womb lining endometrial ,where it grows and develops 

    So for an ectopic pregnancy, it occurs when a fertilized egg implants itself outside the womb.

    CLINICAL PRESENTATION OF ECTOPIC PREGNANCY

    An ectopic pregnancy does not cause noticeable symptoms and is only detected during routine pregnancy testing. However, most women do have symptoms and these usually become apparent between 5 to 14 weeks of gestation.

    The Classic Triad of symptoms of ectopic pregnancy consists of

    • Amenorrhea,
    • Vaginal bleeding, and
    • Lower abdominal pain. 

    Acutely ruptured ectopic pregnancy.

     This clinical scenario represents a surgical emergency. The patient who has experienced rupture of her ectopic pregnancy will most likely have:

    On History Taking:

    • History of amenorrhoea 6 – 10 weeks.
    • Patient complains of a feeling of fainting, dizziness, thirst, light vaginal bleeding and pelvic pain.
    • Abdominal distension, Guarding and rebound tenderness.
    • Patient complains of acute abdominal pain localized in the iliac fossa which is colicky in nature.
    • She may also complain of ipsilateral shoulder pain from phrenic nerve irritation due to hemoperitoneum from the blood in her abdomen and it occurs in up to 25% of patients.

    On Examination:

    • Signs of pregnancy are present.eg darkening of areolar.
    • Signs of shock e.g. cold clammy skin, rapid thread pulse, low blood pressure and low temperature
    • Patient is anxious and restless
    • Pallor of mucous membranes

    On Palpation:

    • Abdominal tenderness especially on the affected side.
    • Abdominal muscles become rigid due to mother guarding against pain.
    • Abdominal distention due to presence of blood in the abdominal cavity.

    On Vaginal Examination:

    • Amount of bleeding does not correspond to the mother’s condition.
    • Tenderness on movement of the cervix and a mass is felt in the lateral fornix.
    • Painful mass in the pouch of Douglas.
    • Dark brown blood on the examining finger.

    DIAGNOSIS OF ECTOPIC PREGNANCY

    Ultrasound Confirmation: Utilization of ultrasound imaging as a primary diagnostic tool(golden standard).

    •  An ultrasound would reveal an empty uterus and free fluid (blood) in the peritoneal cavity. The diagnosis of ectopic pregnancy may be confirmed by the absence of intrauterine pregnancy (IUP) on ultrasound in a woman with a level of HCG sufficient to normal pregnancy, the absence of intrauterine pregnancy on ultrasound examination is diagnostic for ectopic pregnancy if the gestational age is known for certain or if the HCG level is >2500 IU per ml.
    • Cordocentesis(Percutaneous umbilical cord blood sampling) , Aspiration of fluid from the cul-de-sac for evidence of intra-abdominal bleeding. It is a technique by which a needle attached to a syringe is inserted transvaginally through the posterior vaginal fornix into the pouch of Douglas to detect any fluid within the peritoneal cavity.

    • Laparoscopy: Commonly performed surgical procedure for diagnosis. Follows symptoms of bleeding and a positive pregnancy test.
    • Positive Pregnancy Test: Presence of human chorionic gonadotropin (hCG) in the blood or urine.
    • Cullen’s Sign: Specific clinical manifestation suggesting a ruptured ectopic pregnancy. Periumbilical bruising due to blood tracking from the ruptured fallopian tube.

    Cullen's Sign ectopic

    • Magnetic Resonance Imaging. This is also another way to detect the presence of ectopic pregnancy and it is safer than undergoing a CT scan for pregnant women.
    • Hematocrit and Haemoglobin Levels: Routine blood tests to assess for signs of anaemia due to internal bleeding.

    DIFFERENTIAL DIAGNOSIS OF ECTOPIC PREGNANCY.

    Gynecologic problems

    • Threatened or incomplete abortion 
    • Ruptured corpus luteum cyst 
    • Endometriosis
    • Gestational trophoblastic diseases 
    • Ruptured corpus luteal cyst
    • Dysfunctional uterine bleeding
    • Acute pelvic inflammatory disease 
    • Adnexal torsion 
    • Degenerating leiomyoma (especially in pregnancy)
    • Salpingitis

    Non Gynecologic Problems 

    • Acute appendicitis
    • Pyelonephritis 
    • Pancreatitis

    MANAGEMENT OF ECTOPIC PREGNANCY.

    Management has two modalities:

    • Surgical approach.
    • Medical approach.

    In maternity center

    Aims

    1. To prevent shock
    2. To relieve pain
    3. To reassure the patient
    • Admission: The patient is admitted temporarily in a gynecological ward in a well-made warm bed.
    • Histories: These are taken including personal, social, surgical, medical, obstetrical history, how the condition started etc
    • Examination: This is carried out from head to toe to rule out anaemia, dehydration, shocketc
    • Observation:  Temperature, pulse, respiration and blood pressure are taken and recorded to assess functioning of vital organs.  The foot of the bed should be raised to allow blood to move to vital centres.
    •  Send for transport as soon as possible and inform the patient and relatives about the decision made and why it is necessary.

    Treatment

    • Put up intravenous infusion of normal saline to prevent or treat shock.. This is to elevate low blood pressure.
    • Administer morphine or pethidine to relieve pain as prescribed.
    • Nursing care: The vulva is swabbed and a clean pad is applied.
    • Send the patient to hospital with a written note stating when the patient reported to the centre, condition on admission and at time leaving and treatment given.

    In the Hospital

    Aims:

    • To treat anaemia
    • To prevent or treat shock
    • To reassure the patient
    • To prevent complications

    It  is a gynaecological emergency, requiring swift action. 

    Management

    Admission: Admit the patient to a well-ventilated room and a warm admission bed. Establish a good nurse-patient relationship.

    Histories: Take comprehensive history, including personal data, presenting complaints, and obstetrical and medical history.

    General Examination: Perform a head-to-toe examination to rule out anaemia, shock, dehydration, etc.

    Observations: Monitor vital signs like temperature, pulse, respiration, and blood pressure. Inform the doctor about the patient.

    Investigations: Conduct investigations as required by the doctor, including Hb, grouping and cross-match, ultrasound scan, and urinalysis.

    Resuscitation:

    • Administer intravenous fluids (e.g., normal saline) and maintain a fluid balance chart.
    • Consider blood transfusion based on haemoglobin results.
    • Provide pain relief with analgesics like morphine as prescribed by the doctor.
    • The doctor will determine the operation.

    Preparation for Theatre:

    1. Explain the nature of the operation and obtain informed consent.
    2. Reassure the patient to allay anxiety.
    3. Inform theatre staff.
    4. Pass an intravenous line for infusion.
    5. Perform vulva swabbing to minimize infections.
    6. Catheterization is done, and a fluid balance chart is started.
    7. Pass a naso-gastric tube for aspiration of gastric contents or administer an anti-acid like magnesium trisilicate to alkalize stomach contents and prevent aspiration into the lungs.
    8. Pre-medication is given, such as atropine to dry secretions.
    9. Repeat vital observations and compare with baseline observations, recording all findings.
    10. Compile clinical charts and notes, dress the patient in a gown, and transport her carefully to the theatre.
    11. In the theatre, give a full report to the theatre nurse about the patient.
    12. Book about 1-2 units of blood.
    SURGICAL APPROACH

    Surgical treatment of ectopic pregnancy has the advantage of taking care of the ectopic immediately. It is suitable for emergency care of ectopic pregnancy.  It is critical to establish large-bore intravenous lines and to start fluid resuscitation.  

    Salpingectomy, the removal of the fallopian tube containing the ectopic pregnancy, is the treatment of choice in the following situations:

    • Future childbearing is not desired.
    • The tube is severely damaged.
    • Bleeding cannot be controlled.
    • The ectopic is in a fallopian tube where an ectopic occurred previously.

    Linear salpingostomy, the removal of the gestation through a linear incision in the fallopian tube, may be performed if future fertility is desired.

    • This procedure is associated with a persistent ectopic pregnancy rate of 3% to 20%.
    • Therefore, serial quantitative HCG values must be followed to ensure resolution.

    Operative laparoscopy may be performed to confirm the diagnosis of ectopic pregnancy and to remove the abnormal gestation via salpingectomy or salpingostomy.  This method is used in hemodynamically stable patients. Advantages of this technique over laparotomy include:

    • Shorter hospital stay
    • Faster postoperative recovery
    • Better cosmetic result
    • Potentially shorter operative time

    Laparotomy is reserved for hemodynamically unstable patients who require emergent surgery for a ruptured ectopic pregnancy. This method may also be appropriate when laparoscopy is contraindicated or technically challenging because of extensive adhesive disease from prior surgery.

    Cornual resection, may be performed when an interstitial pregnancy occurs. The interstitial portion of the tube is removed via wedge resection into the uterine cornua. Cornual ectopic pregnancies have a higher failure rate with methotrexate and a surgical approach may be more effective.

    Oophorectomy is indicated only when an ovarian ectopic pregnancy occurs and salvage of the affected ovary is not possible.

    Post-Operative Care:

    Post-operative Bed Preparation: Set up the bed with all necessary accessories ready to receive the patient.

    Patient Transfer: Inform ward staff, and two qualified nurses go to the theatre to collect the patient. In theatre, receive a full report from the anaesthetist and theatre nurse in a recovery room, reporting the patient’s condition.

    Confirm the Report:

    • Check airway, breathing, and circulation.
    • Take vital observations.
    • Observe the site of operation for bleeding.
    • Observe the catheter to see if it is draining well and in a good position.

    Patient Transfer to Ward: After confirming, gently wheel the patient to the ward in a recumbent position with the head turned to one side, observing the airway.

    On Ward: Lift the patient from the trolley carefully to a well-made post-operative bed near the nurse’s station for close observations.

    • Place the patient in a recumbent position with the head turned to one side for drainage of secretions and to prevent the falling back of the tongue.
    • Conduct observations and record vital signs (temperature, respiration, blood pressure, and pulse) every 1/4, 1/2, 1, 2 hours as per surgeon’s instructions. Adjust the duration based on patient stabilization. Continue observations until the patient is discharged.
    • Observe the site of operation for bleeding.
    • Observe the catheter for drainage, color, and the quantity of urine passed.
    • Maintain a fluid balance chart and balance it every 24 hours to rule out renal failure.
    • On regaining consciousness, welcome the patient from the theatre, sponge the face, change the theatre gown, conduct mouthwash to remove the anesthetic smell, and offer a pillow.

    Fluid/Hydration:

    • Continue intravenous fluid (e.g., 0.9%) to replace lost fluids.
    • Observe IV infusion, including cannular site for swelling and drip rate; correct any issues.
    • Monitor fluid intake and output to avoid overhydration.
    • Stop IV fluids when bowel sounds are heard, and the patient can take by mouth.
    • Remove the cannula when necessary, e.g., if the patient has completed intravenous drugs.

    Drug Therapy:

    • Administer prescribed strong analgesics (e.g., pethidine for 48 hours, then switch to mild analgesics like diclofenac 50-100mg tds).
    • Administer prescribed antibiotics (e.g., x-pen 2mu qid for 72 hours, then change to oral antibiotics if necessary, such as amoxyl 250-500mg tds for 5 days).
    • Monitor the patient for side effects of the drugs given.
    • Provide supportive drugs like ferrous and folic acid to prevent anemia.

    Wound Care:

    • Observe the wound for bleeding and add more dressing if needed. Change the dressing if soiled and check for signs of infections.
    • Conduct daily wound dressing.
    • Remove stitches on the 7th and 8th day alternately.

    Physiology:

    • Encourage the patient to do deep breathing exercises to prevent chest complications like hypostatic pneumonia.
    • Encourage passive exercises, such as limb movement, and later active exercises like walking around to prevent deep vein thrombosis.
    • Provide psychotherapy for continuous reassurance.

    Diet:

    • Conduct a digestion test, and if positive with bowel sounds heard, start the patient on small sips of water.
    • Introduce soft foods according to tolerance, rich in proteins for tissue repair, roughages to prevent constipation, and carbohydrates for energy.
    • Note: The nasogastric tube is removed as long as the patient can take orally without any complaint.

    Hygiene:

    • Conduct a bed bath on the first day of operation when the patient is still weak, and later assist her to the bathroom.
    • Conduct mouth care to prevent neglected mouth complaints like stomatitis, halitosis, etc.
    • Ensure that the patient’s clothing, bed linen, and the surrounding environment are clean.

    Bowel and Bladder Care:

    • If urine is clear in 24-48 hours, remove the urethral catheter and encourage the patient to pass urine.
    • Encourage the patient to pass stool, offer privacy, and provide foods rich in roughages to prevent constipation.
    • In case of constipation and failed conservative measures, give purgatives such as bisacodyl 5-10mg o.d or nocte.

    Rest and Sleep:

    • Keep the patient in a quiet, well-ventilated room.
    • Restrict visitors, avoid bright light to create a conducive environment for the patient to sleep and rest.

    Advice on Discharge: When the patient is fit for discharge, advise on:

    • Having enough rest at home.
    • Avoiding heavy lifting to prevent straining the abdominal muscles.
    • Coming back for review on appointed dates.
    • Attending ANC clinics when pregnant.
    • Bringing the husband for treatment if the cause of ectopic pregnancy was PIDs.
    • Completing the prescribed medications.

    In case of Unruptured Ectopic Pregnancy, Medical Approach can be used.

    MEDICAL APPROACH

    Methotrexate, a chemotherapeutic agent, has been used successfully to treat small, unruptured ectopic pregnancies. This approach has the advantage that it avoids surgery, but the patient must be counselled that it may take 3 to 4 weeks for the ectopic to resolve with methotrexate therapy. Early diagnosis is very paramount for successful management. 

    Mechanism of action

    • Methotrexate is a folic acid antagonist that interferes with DNA synthesis. Its action is principally directed at rapidly dividing cells, such as trophoblastic cells.
    • Once an ectopic pregnancy has been confirmed, 50 mg/m2 is administered intramuscularly in a single or multiple doses with folic acid.
    • Serial HCG levels are followed every 2 to 4 days after treatment until the HCG level starts to decrease. This is to ensure resolution of the pregnancy
    • If a 15% reduction is not achieved during the first week, or in subsequent weeks a plateau occurs, then an additional injection of Methotrexate is given or surgical exploration is advocated.
    • Decreased success has been noted with ectopic pregnancies of greater than 3.5 cm, with fetal cardiac activity, or with high HCG levels (greater than 5000).
    • After treatment failures, surgical management is usually necessary. 
    • After an ectopic gestation, pregnancy should be avoided for at least 3 months to allow for the fallopian tube architecture to normalize.
    • Contraception should be provided

    Side effects (approximately 5% of patients).

    1.  Mild gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and stomatitis are typical. 
    2. Potential life-threatening complications include pneumonitis, thrombocytopenia, neutropenia, elevated liver function tests, and renal failure.

    Contraindications,

    • Women who are breastfeeding 
    • Immunodeficiency, 
    • Liver disease, renal disease, 
    • Blood disorders, 
    • Peptic ulcer disease,
    • Active pulmonary disease should not receive methotrexate.

    Criteria for medical management of ectopic pregnancy

    Criteria for receiving methotrexate(MTX) (Absolute indications)

    Contraindications to medical therapy (Absolute contraindications)

    • Hemodynamically stable without active bleeding or signs of hemoperitoneum 

    • Non Laparoscopic diagnosis 

    • Patient desires future fertility 

    • General anaesthesia poses a significant risk 

    • Patient is able to return for follow-up care 

    • No contraindications to MTX

    Relative indications

    • Unruptured mass ≤3.5 cm at its greatest dimension 

    • No fetal cardiac motion detected 

    • Patients whose hCG level does not exceed a predetermined value (6000-15,000 mIU/Ml

    • Breastfeeding 

    • Laboratory evidence of immunodeficiency 

    • Alcoholism, alcoholic liver disease, or other chronic liver disease 

    • Preexisting blood dyscrasias, such as bone marrow hypoplasia, leukopenia, thrombocytopenia or significant anaemia 

    • Known sensitivity to MTX 

    • Active pulmonary disease 

    • Peptic ulcer disease  Hepatic, renal, or hematologic dysfunction

    Relative contraindications

    • Gestational sac =3.5 cm 

    • Embryonic cardiac motion

    COMPLICATIONS OF ECTOPIC PREGNANCY

    The most common complication is rupture with internal haemorrhage which may lead to hypovolemic shock. Death from rupture is rare in women who have access to modern medical facilities.

    • Infertility
    • Recurrence 
    • Severe haemorrhage leading to shock 
    • Anaemia due to bleeding.
    • Infections following operation.
    • Adhesions due to scar formation during healing process.
    • Re-occurrence of another ectopic pregnancy.
    • Infertility if both tubes are affected.

    Nursing Diagnosis

    1. Risk for Deficient Fluid Volume related to bleeding from a ruptured ectopic pregnancy.
    2. Fatigue related to early loss of pregnancy secondary to ectopic pregnancy.

    Nursing Interventions

    1. Upon arrival at the emergency room, place the woman flat in bed.
    2. Assess the vital signs to establish baseline data and determine if the patient is under shock.
    3. Maintain accurate intake and output to establish the patient’s renal function.

    Evaluation

    1. The goal of the evaluation is to ensure that maternal blood loss is replaced and the bleeding would stop.
    2. The patient must maintain adequate fluid volume at a functional level as evidenced by normal urine output at 30-60mL/hr and a normal specific gravity between the ranges of 1.010 to 1.021.
    3. Vital signs, especially the blood pressure and pulse rate, should be stable and within the normal range.
    4. Patient must exhibit moist mucous membranes, good skin turgor, and adequate capillary refill.

    Ectopic Pregnancy Read More »

    Family Planning Counseling

    Family Planning Counseling

    Family Planning Counseling

    Family Planning Counseling is a continuous process that you as health care provider, as a counselor provide to help clients and people in the community or health facility make and arrive at informed choices about the size of their family (i.e. the number of children they wish to have)

    Counseling is a face to face communication that you have with your client or couple in order to help them arrive at involuntary and informed decisions.

    Informed choice is defined as involuntary choice or decision based on the knowledge relevant to the choice or decision.

    In order to allow people to make an informed choice about family planning, you must make them aware of all available methods and advantages and disadvantages plus side effects of each .

    They should know how to use the chosen method safely and effectively as well as understanding possible side effects.

    Aims of Counseling 

    • The primary objective of counseling in the context of family planning is to help people decide the number of children they wish to have and when to have them.
    • To help clients choose voluntarily, the method that is personally and medically appropriate to them.
    • To ensure they understand how to use their chosen method correctly for safe and effective contraceptive protection  
    • To clear rumors and misconceptions a client may have about family planning methods

    Types of Family Planning Counseling.

    There  are varieties of approaches for different types of family planning counseling:

    • Individual counseling 
    • Couple counseling 
    • Group counseling and information sharing
    Individual counseling 

    This is a counseling approach that involves only one client. it involves individual privacy and confidentiality during communication or counseling with you.

    It is mostly important when dealing with confidential matters that relate to family planning and other reproductive health issues . E.g.in HIV couples, the woman wants to use family planning but the husband does not.

     

    Couple counseling 

    Couples counseling refers to counseling sessions in which a woman and her partner are present in discussions with the provider. 

    However, it must be recognized that couples counseling requires special sensitivity and skills to deal with gender related issues.

     

    Group counseling and information sharing

    This is counseling approach involving a group of many people.

    It is used when individual counseling is not possible or there are people in the village who are more comfortable in a group.

    It is a cost effective of information sharing and answering general questions but people are not likely to share their more personal concerns with you in this situation.

    General principles of counseling

    • Privacy-find a quiet place to talk
    • Take sufficient time
    • Maintain confidentiality
    • Conduct a discussion in a helpful atmosphere
    • Keep it simple-use words people in your village will understand
    • First things first –do not cause confusion by giving too much information 
    • Say if again –repeat the most important instructions
    • Use available visual aids like posters and flip charts etc.

    Characteristics of a good counselor

    The most important characteristics of a good counselor are:

    • Respect the dignity of others
    • Respect the clients’ concerns and ideas
    • Be non-judgmental and open 
    • Show that you are being an active listener
    • Be empathetic and caring
    • Be honest and sensitive

    Overview of stages of counseling

    General counseling

    This is the first contact of family planning counseling .it involves counseling on general issues to address the client’s needs and concerns.

    The counselor needs to talk about the following:

    • To give general information about family planning methods
    • To clear up any mistaken belief or myths about specific family planning methods 
    • Give information on other sexual and reproductive health issues like; STD’s, HIV and infertility

    All these will make the client arrive at the informed decision on the best contraceptive method to use.

    Method-specific counseling

    The information is given about the chosen method.

    The following points are considered:

    • Examination for fitness (screening) (Blood pressure, weights, age and other health parameters)
    • Instruct on how and when to use given method
    • Tell the client when to return for follow-up and ask them to repeat what you have said on key information.

    BRAIDED,

    Family planning counseling the BRAIDED approach, the acronym BRAIDED can help to remember what to talk about when counseling clients on specific methods.

    It stands for:

    B-Benefits of the method

    R-Risks of the method including consequences of the method failure

    A-Alternative to method, including abstinence and no method

    I-Inquiries about the method (Individual rights and responsibilities to ask)

    D-Decision to withdraw from a method without a penalty

    E-Explanation of the method chosen

    D-Documentation of the session for your own records

    Return follow-up 

    Follow-up counseling should always be arranged after the counseling process.

    The aims;

    • To discuss and manage any problem and side effects related to the given contraceptive method
    • It gives the opportunity to encourage the continued use of the chosen method unless problems exist.
    • It helps to find out whether the client has other concerns  and questions 

    Steps in family planning counseling GATHER approaches  

    The counseling process should follow a step-by –step process.

    GATHER acronym will help you remember the 6 steps for family planning counseling.

    G-Greet the client respectfully

    A-Ask them about their family planning needs

    T-Tell them about different contraceptive options and methods

    H-Help them to make decisions about choices of methods

    E-Explain and demonstrate how to use the methods 

    R-Return /Refer, schedule and carryout a return visit and follow-up

    It is important to give more emphasis to the points during counseling steps 

    Greet the client 

    • In the first case give your full attention to your client
    • Greet them in respective manner and introduce yourself to them often offering seats
    • Ask them how you can help them 
    • Tell them that you will not tell others what they have told you.
    • If the counseling takes place in health facility you have to explain what will happen during the visit describing physical examinations and laboratory tests if necessary
    • Conduct counseling in a place where no one can overhear your conversation

    Ask

    • Help them to talk about their needs, doubts, concerns, and any question they might have
    • If they are new ,use a standard check list or from your health management information system to write down their names, age ,marital status ,number of pregnancies ,number of births, number of living children ,current and past family planning use  and basic medical history
    • Explain that you are asking them the information in order to help you provide appropriate care
    • Keep questions simple and brief, and look at them as you speak

    Many people do not know diseases, ask specific questions,  say<< have you had any headache in the past 2 weeks? or have you had any genital itching? Or do you experience any pain when urinating?>> do not say <<have you had any disease in the recent past?>>

    If you have seen the client previously, ask if anything has changed since the last visit.

    Tell

    • Tell them about family planning method 
    • Tel them which methods available
    • Ask them which methods interest them and what they know about the method 
    • Briefly, describe each method of interest and explain how it works, its advantages, disadvantages and possible side effects.

     Help

    • Help them to choose a method of contraception, ask them about their plans and family situation, if they are uncertain about the future start with the present situation
    • Ask what the spouse /partner likes and wants to use
    • Ask if there is anything they cannot understand and repeat information when necessary
    • When the chosen method is not safe for them explain clearly why the method may not be appropriate and help them choose another method.
    • Check whether they have a clear decision and ask what method have you decided to use?

     

    Explain

    • Explain how to use a method after it has been chosen
    • Give supply if appropriate 
    • If the method cannot be given immediately, explain how, when and where it will be provided 
    • For the method like voluntary sterilization the client will have to sign consent form .the form says that; they want the method, have been informed about it, and understand the consent form.
    • Explain how to use the method 
    • Ask the client to repeat the instructions
    • Describe and possible side effects and warning signs and tell them what to do if they occur.
    • Ask them to repeat this information back to you 
    • Give them printed material about the method to take home if it is available
    • Tell them when to come back for a follow-up visit and to comeback sooner if they wish, or if side effects or warning signs occur

    Appoint a return visit follow-up at the follow-up visit

    • Ask the client if she is or they are still using a method or whether there have been any side effects or problems
    • Refer for treatment if severe side effects are present
    • Re assure the clients’ concerning minor side effects are not dangerous and suggest what can be done to relieve them 

    Rights of the client

    1. Information : to learn about their reproductive health ,contraception and abortion options
    2. Access : to obtain services regardless of religion, ethnicity, age, marital or economical status 
    3. Choice : to decide freely whether to use contraception and which method
    4. Safety : to have a safe abortion and to practice safe, effective contraception
    5. Privacy : to have a private environment during counseling process
    6. Confidentiality : to be assured that any personal information will remain confidential
    7. Dignity : to be treated with courtesy ,consideration and effectiveness 
    8. Comfort : to feel comfortable when receiving services 
    9. Continuity : to receive follow-up care and contraceptive services and supplies for as long as needed
    10. Opinion : to express views on the service offered. 

    Factors influencing family planning counseling outcomes

    Factor related to the health care provider

    • Effective communication
    • Technical knowledge and skills, attitudes and behaviors can influence in effectiveness of counseling process

    Factors related to the client

    • Client’s level of knowledge and understanding, what they choose to do may also be affected by the extent to which they trust and respect a service provider.
    • Personnel situation (e.g. .if the spouse or another family member has a difference to them)
    • External programmatic factors
    • In most health facilities the space or rooms for provision of family planning is integrated with other reproductive health services .This can make it very difficult for you to find a place where privacy and confidentiality can be maintained .

    Family Planning Counseling Read More »

    Hormonal Contraceptive Methods

    Hormonal Contraceptive Methods

    HORMONAL CONTRACEPTIVE METHODS

    Hormonal family planning refers to the use of hormonal methods to prevent pregnancy. 

    Hormonal contraceptive refers to birth control methods that act on the endocrine system (hormones).

    These methods involve the use of hormones, usually synthetic versions of those naturally produced by the body, to regulate a woman’s menstrual cycle and prevent ovulation (the release of an egg from the ovaries). By preventing ovulation, hormonal methods make it difficult for sperm to fertilize an egg and thus prevent pregnancy.

    These include;

    1. Oral contraceptive pills
    2. Implants
    3. Injectable contraceptive
    4. Emergency contraceptive pills

    Hormonal Methods:

    i. Oral Pills:

    Method

    Description

    Combined Oral Contraceptives

    Pills containing both oestrogen and progestin hormones

    Progesterone-Only Pills

    Pills containing only progestin hormone

    Emergency Contraceptive Pills

    Pills taken after unprotected sex to prevent pregnancy

    ii. Implants:

    Method

    Description

    Implanon (1 Rod Capsule)

    Subdermal contraceptive rod

    Jadelle (2 Rod Capsules)

    Subdermal contraceptive rods

    Norplant (6 Rod Capsules)

    Subdermal contraceptive rods

    iii. Injectable Contraceptives:

    Method

    Description

    Depo Provera

    Injectable contraceptive administered every three months

    Injector Plan

    Injectable contraceptive

    Sayana Press

    Injectable contraceptive

    Noristrate

    Injectable contraceptive

    iii. Emergency Contraceptives:

    Emergency Contraceptive

    Mechanism of Action

    Lofemenal/Microgynon 4BD for 1 day (Low Dose COC)

    Inhibits ovulation, thickens cervical mucus

    Eugynon (High Dose COC) 2BD for 1 day

    Inhibits ovulation, thickens cervical mucus

    Regular POP (Ovrette/Microval) at Recommended Dose

    Alters cervical mucus, inhibits sperm function

    Levonorgestrel 2 stat

    Delays ovulation, inhibits fertilization

    Postinar 2 BD for 1 day

    Alters cervical mucus, inhibits sperm function

    Vikela/Levonelle-2/Norlevo Plan B

    Delays ovulation, inhibits fertilization

    Oral Contraceptive Pills

    Oral Contraceptive Pills

    There are two main types of hormonal oral contraceptive formulations:

    1. Combined hormonal contraceptive methods which contain both oestrogen and progestin thus, they are called combined oral contraceptives (COCs)
    2. One which contains only progesterone or one of its synthetic analogues (Progestins) thus, it is called progestogen-only pills (POPs) method.

    Combined Oral Contraceptive Pills (COC)

    (i) Combined Oral Contraceptive Pills (COC)

    Combined oral contraceptives contain both oestrogen and progesterone. It achieves effects of both hormones. Oestrogen suppresses ovulation and progesterone creates unfavourable conditions for egg transport and thickening of the cervical mucus to impair sperm entrance into the canal.

    Examples
    • Lo-femenal
    • Pill Plan (Duofen)
    • Microgynon

    Mechanism of Action:

    Combined methods work by:

    • Suppressing ovulation (estrogenic effect)
    • Thickening cervical mucus, making it difficult for sperm to penetrate the uterus
    • Making the endometrium unsuitable for implantation of a fertilized egg (thin and atrophic due to constant progestogenic action)
    • Reducing sperm transport in the upper genital tract (fallopian tubes).

    Effectiveness:

    • 92 – 99.9% effective, depending on user compliance.
    • In very young women, typical effectiveness can be as high as 95.3%.
    • Failure rates decline with the duration of use and age of the user.
    • Failures may be due to method failure, client error, incomplete information from service providers, drug interactions, severe vomiting/diarrhoea, or expired pills.

    Advantages:

    • Very effective if taken correctly.
    • Effective immediately.
    • Easily reversible.
    • Few side effects.
    • Convenient and easy to use.
    • Does not interfere with intercourse.
    • Causes regular and predictable periods.
    • May improve anemia.
    • Reduces dysmenorrhea and premenstrual tension.
    • Protects against ovarian and endometrial cancer, and some causes of PID.
    • Reduces the risk of ovarian cysts, benign breast disease, and ectopic pregnancy.
    • Can be provided by trained non-medical staff.

    Disadvantages:

    • Effectiveness depends on daily pill intake, requiring strong motivation.
    • Increases chances of promiscuity.
    • Can cause Candida vulvitis and vaginitis.
    • May lead to thromboembolism and benign/malignant liver tumors.
    • Requires regular and dependable supply.
    • Reduces breast milk, especially in the first 6 months after delivery.
    • Not the most appropriate choice for lactating women unless no other method is available and there is a high risk of pregnancy.

    Indications:

    • Women requiring a highly effective method.
    • Women wanting an easily reversible method.
    • Non-breastfeeding women or breastfeeding women after 6 months.
    • Women who are anaemic with heavy menstrual bleeding.
    • Women with a history of ectopic pregnancy.
    • Nulliparous women.
    • Women with a history of benign, functional ovarian cysts.
    • Women with a family history of ovarian cancer.
    • Women with menstrual cycle symptoms or irregular menstrual cycles.

    Contraindications:

    • Absolute contraindications include cardiovascular diseases, liver disease, pregnancy, undiagnosed per vaginal bleeding, and oestrogen-dependent neoplasms.
    • Relative contraindications include obesity, varicosities, epilepsy, asthma, mood disorders, nursing mothers in the first 6 months, smoking, and gallbladder disease.

    Side Effects:

    • Major side effects include hypertension, venous thromboembolism, and cholestatic jaundice.
    • Minor side effects can be due to oestrogen, progestin, or both, including nausea, vomiting, headache, leg cramps, weight gain, chloasma & acne, breakthrough bleeding, hypomenorrhea, amenorrhea, leucorrhea, and decreased libido.

    Danger Signs of COCs:

    • Acute abnormal pain.
    • Severe headaches with blurred vision.
    • Pain in the chest with difficulty in breathing.
    • Pain in the calf muscles.

    Indications for Withdraw:

    • Severe migraine.
    • Visual disturbance.
    • Sudden chest pain.
    • Severe cramps.
    • Excessive weight gain.
    • Severe depression.
    • Patient wanting pregnancy.
    • Awaiting major surgery.

    Drug Interaction:

    • Decreases effectiveness of methyldopa, oral anticoagulants, and oral hypoglycemics.
    • Increases effectiveness of B blockers, corticosteroids, diazepam, aminophylline, and alcohol.
    • Other drugs that increase COC metabolism include phenobarbitone, antiepileptics (except sodium valproate and clozapine), rifampicin, griseofulvin, spironolactone, and ketoconazole.

    WHO Medical Eligibility Criteria for Contraceptive Use. 

    Category 1: A condition for which there is no restriction for use of the contraceptive 

    Category 2: A condition where the advantages of using the method generally outweigh the theoretical or proven risks

    Category 3: A condition where the theoretical or proven risk outweigh the advantages of using the method.

    Category 4: A condition that represents unacceptable health risk if the contraceptive is used.

    Who can use only if more appropriate methods are not available (WHO class3) 

    • Women with high BP (greater than 160/100 but less than 180/110) and no vascular disease.
    • Women with symptomatic gall bladder disease.
    • Women age 35 yrs or older and light smokers (under 20 cigarettes a day)
    • Women taking drugs for epilepsy or anti-TB.
    • Women with unexplained vaginal bleeding (only if serious problem suspected)
    • Women who are fully b/feeding (6 wks to 6 months postpartum)
    • Women who are not b/feeding who are less than 3 weeks postpartum.
    • Women with h/o breast cancer and no current evidence of the disease.

    Who should not use COCs (WHO Class 4)

    • Women with hypertension: blood pressure diastolic above 110 mm Hg. The health risk/benefit ratio is dependent upon the severity of the condition
    • Women with current or history of cardiac disease (heart disease or stroke). Among women with underlying vascular disease due to thrombosis, the increased risk of thrombosis with COCs should be avoided; 
    • Women with thrombo-embolic disease (current and a history of or major surgery with prolonged immobilization). The increased risk of venous thromboembolism associated with COCs should have little impact on healthy women, but may have a big impact on women otherwise at risk for it;
    • Women within 2 weeks of child birth (Postnatal) and within 4 weeks or elective surgery;
    • Women with known or suspected cervical cancer. Theoretical concern that COC use may affect prognosis of the existing disease. In general, treatment of these conditions renders a woman sterile; 
    • Women who are pregnant. As no method is indicated, any health risk is considered unacceptable. However, there is no known harm from COCs; 
    • Women with undiagnosed breast lumps or breast cancer. Breast cancer is a hormonally sensitive tumor. The risk for progress of the condition may be increased among women with current or past history of breast cancer;
    • Women who are taking long-term drugs that could affect the pill’s efficacy. Commonly used liver enzyme inducers are likely to reduce the efficacy of COCs. Drugs which affect liver enzymes are the antibiotic rifampicin (note that other antibiotics will not affect pill efficacy), other drugs where another method should be used are:  —griseofulvin, and anticonvulsants (such as phenytoin, carbamazepine, barbiturates, and primidone).
    • Women with severe headache (recurrent, including migraine with focal neurological symptoms). Focal neurological symptoms may be an indication for an increased risk of stroke( or cerebrovascular accident (CVA) is sudden damage to brain  tissue caused either by a lack of blood supply or rupture of a blood vessel . The affected brain cells die and the parts of the body they control or receive sensory messages from ceaseto function.)
    • Women who are retarded or forgetful.
    • Women with sickle cell disease, as they have increased risk of thrombosis;
    • Women with trophoblast disease (current trophoblastic tumor)
    • Women who are to undergo major elective surgery with prolonged bed rest.

    Client Information

    • Start between 1st and 7th day of monthly period
    • Take pills daily at the same time – at bed time if possible
    • Do not miss taking the pill any day
    • If you start after the 7th day of monthly period; you need to use another FP method such condoms or to abstain from sex for one week.
    • Contraception is 7 days after initiation
    • You will have your monthly period when you are taking the brown pills. Do not stop taking the pills.

    If a client misses, they should do the following:

    • If you miss one white pill, take it as soon as you remember, then continue normally.
    • If you miss 2 white or more days in a row; take two pills each day until all missed pills are taken and you are back on schedule. You must also use a condom for the next 7 days.
    • If you miss the brown pill, no worry. Just skip and continue
    • If you keep forgetting – may need to change method
    Progesterone Only Pills (POP)

    ii)  Progesterone Only Pills (POP)

    Progestin-Only Pills are oral contraceptive pills which contain synthetic progestin and are taken orally every day at the same time of day to prevent pregnancy. 

    Mechanism of Action:

    • Reduces the frequency of ovulation.
    • Thickens cervical mucus, making it difficult for sperm to penetrate the uterus.
    • Partially inhibits ovulation.

    Types of POPs available in Uganda:

    1. Microval: 35 white pills, each containing 0.03 mg Levonorgestrel.
    2. Ovrette: 28 yellow pills, each containing 0.075 mg Norgestrel.

    Effectiveness:

    • Depends on user compliance.
    • Very effective if used correctly (83%-99%).
    • Crucial to take POPs at the same time every day, as effectiveness decreases even with a few hours’ delay.
    • In lactating women, POPs are nearly 100% effective, and they do not alter the quantity of milk.

    Advantages of POPs:

    • Do not suppress lactation.
    • No estrogenic side effects.
    • Suitable for women with hypertension, thrombotic, cardiac, and sickle cell diseases.
    • Can be started at any time of the menstrual cycle and in the early postpartum period.
    • Decreased menstrual cramps.
    • Decreased amount of bleeding during periods.
    • Decreased severity of anaemia.
    • Do not increase blood clotting.
    • Some protection against pelvic inflammatory disease (progestins make cervical mucus thicker, reducing the likelihood of infection reaching the uterus and tubes).

    Disadvantages of POPs:

    • Amenorrhea.
    • Must be taken at the same time every day.
    • Irregular periods, including spotting or bleeding between periods.
    • Prolonged or heavy vaginal bleeding.
    • For women who have had ectopic pregnancy, POPs do not prevent ectopic pregnancy as well as intrauterine pregnancy.
    • For women with a history of ovarian cysts, POPs do not protect against the development of future ovarian cysts.

    Indications:

    • Women of any reproductive age or parity seeking pregnancy protection.
    • Breastfeeding women (6 weeks or more postpartum).
    • Post-abortion women (may start immediately).
    • Women who smoke.
    • Women with high blood pressure, blood clotting problems, or sickle cell disease.
    • Women unable to take Combined Oral Contraceptives (COCs) but want to take Pills.

    Who should not use POPs (Class 3):

    • Women breastfeeding and less than 6 weeks postpartum.
    • Women with jaundice.
    • Women taking anti-epileptic and anti-TB medication.
    • Women with unexplained vaginal bleeding.
    • Women with breast cancer.
    • Women concerned about changes in their menstrual bleeding pattern.
    • Women unable to remember taking a pill every day (no more than 3 hours late).

    Who should not use POPs (Class 4):

    • Women known or suspected to be pregnant.
    • Women who are known or suspected to be pregnant. POPs should not be initiated if a woman is pregnant. However, there is no known harm to mother or fetus if POPs are used during pregnancy;
    • Signs of problems from POPs warranting immediate return to clinic
    • Severe lower abdominal pain.
    • Heavy bleeding (twice as long and as much).
    • Migraine headaches, repeated very painful headaches, or blurred vision.

    Signs of problems from POPs warranting immediate return to clinic:

    • Severe lower abdominal pain.
    • Heavy bleeding (twice as long and as much).
    • Migraine headaches, repeated very painful headaches, or blurred vision.

    Client Instructions:

    1. Start between the 1st and 7th day of the monthly period.
    2. If started after the 1st day of bleeding, abstain from intercourse or use another method for the next 48 hours.
    3. Take pills daily at the same time.
    4. Do not miss taking the pill any day.
    5. Return to the clinic for more pills before finishing the last pack.
    6. Severe diarrhoea or vomiting reduces pill effectiveness. Use a backup method or abstain from sex while taking the pills and for 48 hours after.
    7. If client misses taking pills:
    • If more than 3 hours late, take it as soon as remembered and the next pill at the usual time. Use a backup method or abstain for the next 48 hours.
    • If miss two or more days, take one as soon as remembered, continue as usual, and use a backup method or abstain for the next 48 hours.
    • If consistently forgetting, consider another method and seek counseling.

    Contraindications:

    1. Pregnancy: Progestin-Only Pills (POPs) should not be initiated if a woman is pregnant. 
    2. Unexplained vaginal bleeding: POPs are contraindicated in cases of unexplained vaginal bleeding, and immediate medical attention is advised to determine the cause.
    3. Recent history of breast cancer: Women with a recent history of breast cancer are advised against using POPs due to potential hormonal interactions that could affect cancer progression.
    4. Arterial diseases: Individuals with arterial diseases, such as a history of stroke or cardiovascular issues, should avoid POPs as they may pose additional risks to vascular health.
    5. Thromboembolic diseases: Those with a history of thromboembolic diseases, involving blood clotting, are at an increased risk when using POPs, making it a contraindicated option.
    6. Active hepatic diseases: Presence of active liver diseases is a contraindication, as POPs can impact liver function, and their use might exacerbate hepatic conditions.
    7. Hypertension: Women with hypertension are advised against using POPs, as the hormonal components may contribute to increased blood pressure.

    Side Effects:

    1. Amenorrhea: Some women may experience amenorrhea (absence of menstruation) as a side effect of POPs, which is generally considered a normal response to hormonal changes.
    2. Spotting: Spotting, or irregular bleeding between periods, can occur, and individuals should be aware that this is a common side effect that usually diminishes with time.
    3. Prolonged or heavy bleeding: While some may experience prolonged or heavy bleeding, this side effect should be discussed with a healthcare provider to ensure it is not indicative of an underlying issue.
    4. Lower abdominal pain: Lower abdominal pain may occur.
    5. Weight gain or loss: Changes in weight, either gain or loss, may be observed.
    6. Jaundice: Jaundice, characterized by yellowing of the skin or eyes, is a rare but serious side effect.
    7. Nausea and vomiting: Nausea and vomiting may occur initially but often subside. 
    8. Headache with blurred vision: Headaches with blurred vision may be experienced.
    9. Excessive hair growth: Some individuals may notice changes in hair growth patterns.
    10. Breast fullness or tenderness: Breast fullness or tenderness is a common side effect that usually resolves over time.
    11. High blood pressure: An increase in blood pressure may occur in some individuals

    Implants

    Implants are small, flexible rods or capsules that are inserted under the skin of a woman’s upper arm.

     These implants release a steady, low dose of hormones (usually a progestin hormone) into the bloodstream over an extended period. The most common types of contraceptive implants include Implanon, Jadelle, and Norplant.

    Implants are considered a reversible form of contraception, and their effectiveness is not dependent on user compliance once inserted. They are suitable for women who want a reliable, long-term birth control option without the need for daily or frequent intervention.

    Types:

    1. Implanon: A single rod capsule effective for 3 years.
    2. Jadelle: Two rods of levornogestrel each 75mg capsules providing protection for 5 years.
    3. Norplant: Consists of 6 rods each with 36mg levornogestrel capsules labelled for 5-7 years.

    Modes of Action:

    The hormonal release from these implants serves to prevent pregnancy by thickening the cervical mucus within 24 hours, hindering sperm entry into the uterus, inhibiting ovulation (the release of eggs from the ovaries), and altering the uterine lining to make it less receptive to a fertilized egg. Implants are highly effective and offer long-term contraception, ranging from three to seven years, depending on the specific type.

    Implants

    Insertion: Inner aspect of non dominant arm, 6 – 8 cm above elbow fold under local anesthesia. This is at day1, immediate after abortion or 3weeks postpartum.

    Removal: Approximately 3 to 5 years

    Advantages:

    • Very effective within 24 hours after insertion.
    • Easily reversible with no delay in returning to fertility after removal.
    • Reduces frequency and intensity of sickle cell crises.
    • Highly effective for long-term contraception.
    • Shares benefits with Depo Provera.

    Common Side Effects and Disadvantages:

    • Changes in menstruation patterns.
    • Spotting.
    • Rare instances of heavy bleeding.
    • Amenorrhea.
    • Does not protect against STIs, including HIV/AIDS.
    • Discomfort in the hand after insertion.
    • Possible weight changes (overweight or weight loss).
    • Minor surgical procedure required for both insertion and removal.

    Indications:

    • Breastfeeding post-partum mothers.
    • Adolescents.
    • Post-abortion contraception.
    • Women with sickle cell disease.
    • Women awaiting surgical contraception.
    • Women on treatment, e.g., ARVs.

    Contraindications:

    • Serious problems with the heart or blood vessels.
    • Breast cancer history.
    • Liver diseases leading to jaundice.
    • Pregnancy.

    Signs and Problems Requiring Medical Attention:

    1. Soreness at the site of insertion.
    2. Capsules coming out.
    3. Severe headaches.
    4. Heavy bleeding, exceeding the usual amount and duration.
    5. Pregnancy.
    6. Missed period after several regular cycles.

    Injectable Contraceptives

    Examples

    • Depo Provera (Depo Medroxyprogesterone acetate (DMPA), single dose of 150 mg I.M every 12 weeks. (Injecta Plan)
    • Sayana Press 104mg, 0.65ml Subcutaneously
    • Noristerat (Norethisterone) 200mg every 8 weeks for 24 weeks, then every 12 weeks.
    • Norigynon/Mesigyna (50 mg norethindrone enanthate plus 5 mg estradiol valerate) ; Both given monthly.

    These contraceptives contain a single type of hormone, progestin.

    Injectable Contraceptives depo

    Depo Provera

    Depo Provera is a hormone used for contraception. It is given by injection and its effects will last for three months at a time.

    Mode of Action

    • Inhibits ovulation.
    • Thickens cervical mucus, hindering sperm entry.
    • Thins the uterine lining, reducing chances of fertilized egg implantation.

    Indications

    • Breastfeeding mothers after 6 weeks or immediately if not breastfeeding.
    • Women needing long-term contraception.
    • Known/suspected HIV-positive women.
    • Women with sickle cell disease.
    • Women unable to use COC due to oestrogen content.
    • Women awaiting surgical contraception.

    Advantages

    • Very effective.
    • Does not suppress lactation.
    • Easy to remember return dates.
    • Private usage.
    • No oestrogen-related side effects.
    • Reduces sickle cell crisis frequency.
    • Non-interference with sex.

    Disadvantages

    • Changes in menstrual bleeding.
    • Spotting (common in the first 3 months).
    • Amenorrhea (common after 1st injection and after 9-12 months).
    • Prolonged heavy vaginal bleeding.
    • Weight changes.
    • Irreversible injection.
    • Delayed return of fertility.
    • Loss of libido.
    • Does not protect against STIs/HIV/AIDS.

    Management

    • Depo Provera 150mg deep IM into deltoid or buttock muscle.
    • No rubbing to avoid increased absorption.
    • Advise abstinence or backup FP method for the first 7 days after injection.
    • Return for the next dose 12 weeks after the injection.

    Injectable Contraceptives sayana

    Sayana Press

    Sayana Press is a contraceptive injection that women can give to themselves to prevent pregnancy. It’s given under the skin, at the front upper thighs or abdomen. The injection releases medication that runs through your bloodstream over a period of 13 weeks.

    • Sayana press ® is a single-dose container with 104 mg Medroxyprogesterone acetate (MPA) in 0.65ml suspension (104mg) formulated for subcutaneous.
    • It is administered subcutaneously into the anterior thigh or abdomen or arm.
    • The efficacy of Sayana press depends on adherence to the recommended dosage schedule of administration.

     

    Composition

    • Single-dose container with 104 mg Medroxyprogesterone acetate (MPA) in 0.65ml suspension.

    Administration

    • Subcutaneously into the anterior thigh, abdomen, or arm

    Mechanism of Action

    • Suppresses ovulation.
    • Renders endometrium unsuitable for implantation.
    • Increases cervical mucus viscosity, impeding sperm penetration.

    Indications

    Nearly all women can use it safely & effectively including women:-

    • Women whose partners have undergone vasectomy until vasectomy is effective.
    • Have or have not had children.
    • Any age including adolescents & women over 40 years old.
    • Have just had an abortion/miscarriage.
    • Breastfeeding women 6 weeks postpartum.
    • HIV infected whether or not on ART.

    Advantages and Non contraceptive benefits.

    • New formulation for S/C injection.
    • 30% low side effects compared to Depo-Provera.
    • Do not interfere with sex.
    • Private & no one else can tell that a woman is using it.
    • May help women gain weight.
    • Do not require daily action.
    • Prevents pregnancy.
    • Protects against endometrial cancer, uterine fibroids.
    • Reduces sickle cell crisis among women with sickle cell anaemia.
    • Protects against symptomatic PID & iron deficiency anaemia.

    Disadvantages

    • Weight changes.
    • No protection against STIs/HIV/AIDS.
    • Delayed fertility return.
    • Potential side effects like hypersensitivity reactions, decreased/increased appetite, loss of libido, dizziness, headache, and more.

    Problems that may need medical attention

    • Loss of bone mineral density.
    • Menstrual irregularities.
    • Thromboembolic disorders.
    • Anaphylaxis & anaphylactoid reactions.
    • Sudden partial or complete loss of vision.
    Disadvantages & Side effects
    • Weight gain or loss
    • Does not protect against STI/HIV/AIDs
    • Delayed fertility return
    • Hypersensitivity reactions
    • Decreased/increased appetite
    • Loss of libido & irritability
    • Dizziness, headache & migraine
    • Thromboembolic disorders
    • Nausea & vomiting
    • Jaundice
    • Alopecia & urticaria
    • Loss of bone mineral density
    • Back & leg pains
    • Mood changes
    • Abdominal bloating & discomfort
    Emergency Contraception / Post-Coital Contraception

    Emergency Contraception / Post-Coital Contraception

    Emergency contraception (EC) serves as a preventive measure for unintended pregnancies following unprotected sexual intercourse, condom rupture, missed pills, or sexual assault.
     It should be regarded as an emergency measure and not as a routine contraceptive method. EC does not terminate pregnancy. It encompasses hormonal, anti-progestin, and other methods.
    Types
    1. Emergency Contraceptive Pills (ECP)
    2. Progesterone-Only Pills Regimen
    When to Start?
    EC should be initiated within 3 -5 days or 72 -120 hours, with earlier administration being more effective, following unprotected sexual intercourse. Intrauterine contraceptive devices (IUCDs) with copper introduction, within a maximum period of 5 days, can prevent conception after accidental unprotected sexual exposure.
    Mechanism of Action
    • Prevents implantation
    • Failure rate is about 1%
    • Effectiveness is over 99% in preventing pregnancy
    NOTE:
    • Post-coital contraception is solely for emergency use and is not effective if used regularly, except for copper IUCDs.
    • Women seeking emergency contraception should also be counselled about regular contraceptive options, promoting consistent and correct usage. 
    • Referral to relevant services, such as HIV counselling, testing, post-exposure prophylaxis (PEP), and treatment for sexually transmitted infections (STIs), is essential. 
    • Specialized services for sexual and gender-based violence should also be considered.
    Basic Steps of Client Care for ECP
    1. Greet and introduce yourself.
    2. Maintain a respectful attitude.
    3. Ensure confidentiality of the discussion.
    4. Explain different ECP options, including usage, side effects, and the need for referral or follow-up.
    5. Encourage questions from the client.
    6. Discuss regular contraception options.
    7. Conduct counselling with active client involvement, reassurance of confidentiality, and in a private and supportive environment.
    Examples of ECP:
    • Ethinyl estradiol 2.5mg b.d X 5/7
    • Conjugated oestrogen 15mg b.d X 5/7
    • Levonorgestrel 0.75mg stat and after 12 hours.
    • Mifepristone 600 mg stat – single dose.
    • Copper IUDs inserted within 5 days.
    • Others: Postinor, Microgynon, Eugynon.
    Indications
    • Unprotected sexual intercourse
    • Rape survivors
    • Contraceptive method failure
    • Missed contraceptive pills or injections
    • Delay in taking pills
    • Sexual assault or first-time intercourse
    Contraindications
    • Pregnancy
    • After 120 hours or 5 days of unprotected sex

    Emergency Contraceptive

    Dosage

    Mechanism of Action

    Lofemenal/Microgynon 4BD for 1 day (Low Dose COC)

    4 tablets once

    Inhibits ovulation, thickens cervical mucus

    Eugynon (High Dose COC) 2BD for 1 day

    2 tablets twice

    Inhibits ovulation, thickens cervical mucus

    Regular POP (Ovrette/Microval) at Recommended Dose

    As recommended

    Alters cervical mucus, inhibits sperm function

    Levonorgestrel 2 stat

    2 tablets at once

    Delays ovulation, inhibits fertilization

    Postinar 2 BD for 1 day

    2 tablets twice

    Alters cervical mucus, inhibits sperm function

    Vikela/Levonelle-2/Norlevo Plan B

    As recommended

    Delays ovulation, inhibits fertilization

    NON HORMONAL METHODS click here

    Hormonal Contraceptive Methods Read More »

    family planning

    Family Planning

    FAMILY PLANNING

    Family planning is defined as the practice of having children by choice and not by chance.

    Family planning is defined as a process through which individuals, couples make an informed choice on how many children to have, when to have and how often to have so that each child born is expected and properly catered for in all ways.

    Family planning policy does not discriminate against men; they also have great roles to play for the success of care.

     

    Unplanned pregnancies constitute major public health problems .The United Nations International Children’s Emergency Fund (UNICEF) estimates that over 800,000 women worldwide die each year as a result of pregnancy and pregnancy-related causes and an additional 15 million women are severely disabled by pregnancy. Countries in which women utilize contraception have lower birth rates and the lowest rates of maternal mortality. Every method of birth control prescribed is safer than pregnancy.

    Benefits/Importances of Family Planning

    Benefits/Importances of Family Planning

    To the Mother

    1. Physical and Mental Recovery: Allows the mother to recover physically and mentally from the effects of previous pregnancies.
    2. Participation in Productive Activities: Offers ample time for a woman to actively participate in productive activities like farming and business.
    3. Enhanced Social Bondage: Increases social bondage between the mother and her baby.
    4. Reduced Maternal Mortality and Morbidity: Helps to reduce maternal mortality and morbidity due to pregnancy-related complications.
    5. Promotion of Marital Happiness: Promotes a happy marital life and enjoyment between the couples without fear of unwanted pregnancy.
    6. Preparation for Pregnancies: Family planning enables sexually active couples to prepare for pregnancies, optimizing fetal and maternal outcomes.
    7. Avoidance of Unwanted Pregnancies: Family planning helps avoid unwanted pregnancies, reducing complications associated with childbirth.
    8. Reduction of Maternal Complications: Reduces incidences of complications such as anaemia, poor maternal health, caesarean section, and maternal-child deaths.

    To the Child

    1. Emotional and Social Support: The child receives adequate emotional and social support, contributing to emotional maturity and stability.
    2. Healthy Nutrition: Allows adequate nutrition for the baby in the womb, resulting in a healthy newborn.
    3. Reduced Malnutrition: Reduces malnutrition by preventing early weaning and ensuring enough food for the child.
    4. Fewer Infections: The child experiences fewer infections due to a strengthened immune system.
    5. Love and Care for the Child: Enables families to concentrate on other income-generating activities, ensuring love and care for the child.
    6. Ensuring Breastfeeding: Ensures adequate breastfeeding for the child, promoting child health.

    To the Father

    1. Reduced Domestic Violence: Family planning reduces domestic violence in a home.
    2. Meeting Basic Needs: Enables the father to meet basic needs like food, medical care, etc.
    3. Cost of Living Reduction: Reduces the cost of living in a home, allowing the father to invest in productive activities.
    4. Preparation for Children: Assists couples in preparing for their children, ensuring they can provide love, care, and adequate support.
    5. Protection Against STIs: Some family planning methods are protective against HIV and other sexually transmitted infections (STIs).

    To the Community

    1. Healthy and Productive Population: Family planning contributes to a healthy and productive population, enhancing community stability and harmony.
    2. Reduced Overcrowding: Reduces overcrowding, maximizing available land for productivity.
    3. Increased Socio-economic Development: Leads to increased socio-economic development within the community.
    4. Prevention of Negative Behaviours: Reduces the presence of negative characters in the community, as parents have adequate time to provide for their children.
    5. Improvement in Standards of Living: Family planning contributes to the improvement of standards of living within communities.

    To the Nation

    1. Control of Population Growth: Reduces the rapid population growth rate at a national level.
    2. Reduced Dependence on Foreign Aids: Reduces the country’s dependence on foreign aids.
    3. Improved Government Services: Enables the government to provide better social services and infrastructures like roads and health facilities.
    4. Effective Resource Allocation: Facilitates easy budgeting for the people, as the number of resources to the population is manageable.
    5. Population Growth Prediction: Helps predict population growth, allowing for better planning and resource allocation.

    Components of Family Planning Services

    1. Counselling: Counselling is an important need for the initiation and continuation of a family planning method. Service providers must undergo training to provide comprehensive counselling about all available family planning methods. Importantly, there should be no incentives or coercion to adopt family planning or a specific contraceptive method.
    2. Provision of Contraceptives: Contraceptives should be provided to clients based on approved method-specific guidelines. Service providers delivering these methods must undergo training to ensure competency in their provision. This ensures that clients receive family planning services that align with their needs and preferences.
    3. Follow-Up and Referral System: Clients choosing a family planning method should be informed about appropriate follow-up requirements. They should be encouraged to return to the service provider if they have any concerns or issues. The established referral system should be followed by service providers when making client referrals for further assistance.
    4. Record Keeping: Family planning service providers are required to maintain comprehensive records. These records help identify each client, specify the type of contraception provided, and note any special circumstances associated with its provision. Effective record-keeping contributes to the overall management and evaluation of family planning programs.
    5. Supervision: Supervision is an essential component of program evaluation. It ensures that client needs are met, and service delivery guidelines are adhered to. Supervisors act as team members who promote staff motivation, assist in problem-solving, and ensure the rights of both service providers and clients are observed throughout the delivery of family planning services.
    6. Logistics: Maintenance of an effective organization and supply system is crucial to prevent both understocking and overstocking of family planning commodities. Staff at service delivery points must adhere to proper procedures for the storage and handling of contraceptives and other supplies to maintain the quality of services provided. This ensures that family planning services are consistently available and accessible to those in need.

    Characteristics of an Ideal Family Planning Method

    1. Effectiveness: A good family planning method should demonstrate high efficacy in preventing unintended pregnancies.
    2. Minimal Side Effects: The method should have minimal or no adverse effects on the health and well-being of the individual using it.
    3. Independence from Sexual Intercourse: The effectiveness of the method should not be relying on specific timing related to sexual activity.
    4. User Autonomy: The method should empower individuals to manage their reproductive health without requiring constant supervision or intervention from health professionals.
    5. Accessibility: It should be widely available, ensuring that individuals, regardless of geographic location or socioeconomic status, can access and utilize the method.
    6. Ease of Distribution: The method should have a distribution system that allows for easy accessibility, ensuring convenience for users.
    7. Affordability: Cost-effectiveness is crucial. A good family planning method should be affordable to a broad range of individuals, regardless of income.
    8. Cultural and Religious Acceptance: The method should be culturally and religiously sensitive, respecting diverse beliefs and practices.
    9. Reversibility: Individuals should have the option to discontinue the use of the method easily, with a quick return to fertility if desired.
    10. Educational Support: The method should come with educational resources to ensure users are well-informed about its proper use, benefits, and any potential risks.
    11. Long-Lasting: Ideally, the method should offer a duration of protection that aligns with the user’s family planning goals, whether short-term or long-term.
    12. Compatibility with Health: The method should not compromise overall health, and individuals with specific health conditions should have suitable alternatives available.
    13. Privacy and Confidentiality: The use of the method should be discreet, respecting the user’s privacy and maintaining confidentiality.
    14. Community and Partner Support: It should encourage open communication and support from partners, families, and communities.
    15. Research-Backed: The method’s safety and efficacy should be supported by scientific research and continuous monitoring.
    16. Inclusivity: The method should be inclusive, addressing the diverse needs of different populations, including adolescents, women, and men.

    Classification of family planning methods  

     There are 2 broad types of family planning:

    • Natural or Traditional or Non-hormonal methods.
    • Artificial or Hormonal methods.
    Natural/Traditional Methods

    Method

    Description

    Calendar/Rhythm

    Tracking menstrual cycles for fertility awareness. This is the only method approved in the Roman Catholic Church

    Basal Body Temperature

    Monitoring temperature variations during the menstrual cycle

    Cervical Mucus Method

    Observing changes in cervical mucus for fertility awareness

    Lactation Amenorrhea Methods

    Reliance on breastfeeding as a natural contraceptive during postpartum period

    Abstinence

    Refraining from sexual activity

    Withdrawal/Coitus Interruptus

    Withdrawing the penis before ejaculation

    Artificial Methods
    a) Barrier Methods:

    Method

    Description

    Spermicides

    Chemical substances that kill sperm

    Condoms

    Barrier devices worn over the penis or inserted into the vagina to prevent sperm from reaching the egg

    Intrauterine Contraceptive Devices (IUCDs)

    Devices placed inside the uterus to prevent pregnancy

    Diaphragm

    Shallow, dome-shaped cup placed over the cervix with spermicide

    b) Hormonal Methods:

    i. Oral Pills:

    Method

    Description

    Combined Oral Contraceptives

    Pills containing both oestrogen and progestin hormones

    Progesterone-Only Pills

    Pills containing only progestin hormone

    Emergency Contraceptive Pills

    Pills taken after unprotected sex to prevent pregnancy

    ii. Implants:

    Method

    Description

    Implanon (1 Rod Capsule)

    Subdermal contraceptive rod

    Jadelle (2 Rod Capsules)

    Subdermal contraceptive rods

    Norplant (6 Rod Capsules)

    Subdermal contraceptive rods

    iii. Injectable Contraceptives:

    Method

    Description

    Depo Provera

    Injectable contraceptive administered every three months

    Injector Plan

    Injectable contraceptive

    Sayana Press

    Injectable contraceptive

    Noristrate

    Injectable contraceptive

    c) Permanent Methods:

    Method

    Description

    Tubal Ligation (Tubectomy) for Women

    Surgical procedure to block or cut the fallopian tubes

    Vasectomy for Men

    Surgical procedure to block the vas deferens in the male reproductive system

    NON-HORMONAL FAMILY PLANNING METHODS

    They are so-called because they are not manufactured with hormone basis. 

    NATURAL NON-HORMONAL

    These include:

    Fertility awareness methods of family planning which involve identification of the fertile days of the menstrual cycle (when pregnancy is most likely to occur) and avoiding sexual intercourse (or using barrier methods ) during these days. The fertile days of the menstrual cycle can be determined by one of the following methods:

    • Calendar/Rhythm or Standard Days method, including cycle beads.
    • Basal Body Temperature
    • Cervical Mucus Method
    • Symptom- thermal ( a combination of cervical mucus and BBT methods).

    Other Non Hormonal/traditional include;

    • Lactation Amenorrhea Methods
    • Periodic abstinence, abstaining from sexual intercourse during a woman’s fertile time.
    • Withdrawal/Coitus Interruptus

    These methods, also known as fertility awareness methods, are based on understanding key physiological conditions related to reproduction, Such as;

    Lifespan of Sperm and Ovum:

    • The lifespan of a sperm is approximately 3 – 5 days in the female reproductive tract.
    • The lifespan of an ovum (egg) is around 12- 24 hours.
    • Menstrual cycles can range between 23 to 35 days, but usually 28 days.
    General Advantages:
    1. Safety and Lack of Side Effects: FAMs are generally considered safe with minimal or no side effects.
    2. Cost-Effectiveness: They are affordable, requiring no ongoing financial commitment.
    3. Acceptability Across Groups: Often acceptable to individuals and religious groups opposing modern contraceptive methods.
    4. Educational Benefits: These methods empower women with knowledge about their menstrual cycles and fertility.
    5. Couples’ Control: Couples have direct involvement and control over the method, promoting shared responsibility.
    6. Facilitates Pregnancy Planning: FAMs can be used for both family planning and to facilitate pregnancy when desired.
    7. Non-Invasive: FAMs do not involve invasive procedures or the use of synthetic substances.
    8. No Hormonal Interference: They do not interfere with hormonal balances, making them suitable for those sensitive to hormonal contraceptives.
    9. Long-Term Relevance: Useful throughout a woman’s reproductive life, fostering awareness and informed decision-making.
    General Disadvantages:
    1. Learning Curve: Some methods require substantial education and learning before effective use.
    2. Record Keeping: Users must maintain accurate records over several menstrual cycles for proper reference.
    3. Challenges with Irregular Periods: Effectiveness diminishes when menstrual cycles are irregular.
    4. Behavioural Adjustments: Requires adjustments to sexual behaviors during fertile periods.
    5. Dependency on Partner Cooperation: Success depends on the level of cooperation between partners, which can be challenging.
    6. Risk of Error: Inconsistencies in recording or misinterpretation may lead to unintentional pregnancies.
    7. Limited Protection from STIs: FAMs provide no protection against sexually transmitted infections (STIs), including HIV/AIDS.
    8. Intensive Monitoring: The method demands continuous and intensive monitoring, which may be burdensome for some users.
    Indications:

    Fertility awareness methods are suitable for any woman or couple who is willing and committed to observing, recording, and interpreting fertility signs on a daily basis. This includes:

    • Women who find other contraceptive methods unacceptable due to reasons such as religious beliefs.
    • Women who cannot use certain contraceptive methods for health reasons.
    • Couples who are open to abstaining from sexual intercourse (or using condoms) for more extended periods during each menstrual cycle.
    Contraindications:

    While there are no medical conditions that worsen with the use of fertility awareness methods, some conditions may make their application more challenging. In the presence of these conditions, the method may either be postponed or require specialized counselling to ensure correct utilization. These conditions include:

    • Breastfeeding, especially until the return of menstruation.
    • Less than three postpartum menstrual cycles.
    • Irregular vaginal bleeding.
    • Abnormal vaginal discharge.
    • Diseases that influence body temperature.
    barrier methods of family planning

    Barrier methods

    Barrier methods work by preventing the passage of sperm into the female genital tract. 

    Female barrier methods include the diaphragm, cervical cap, FemCap, and the condom to both females and males  and Spermicides 

    Condoms

    A condom is a latex sheath put on an erect penis before coitus and worn during coitus.

    Indications for Condom Use:
    1. Men Engaging in Family Planning: Condoms are an excellent choice for men who wish to actively participate in family planning.
    2. Sexually Active Adolescents: Adolescents engaging in sexual activity can benefit from the use of condoms as a reliable contraceptive and STI prevention method.
    3. Infrequent Sexual Intercourse: Couples who engage in sexual intercourse infrequently may find condoms to be a practical and effective choice.
    4. Casual Sexual Relationships: Individuals in casual sexual relationships where pregnancy is not desired can use condoms to prevent both unwanted pregnancies and sexually transmitted infections (STIs).
    5. Back-Up Contraception: Couples waiting for another contraceptive method to become effective can use condoms as a reliable back-up method.
    6. Temporary Contraception: Couples awaiting the initiation of another contraceptive method can use condoms as a temporary solution to prevent unintended pregnancies.
    Mechanism of action of condom
    • Acts as a barrier, preventing sperm from entering the female genital tract.
    •  For condoms that are coated with spermicide, the spermicide immobilizes and kills sperm.
     Advantages of male and female condom
    • Effectiveness: When used correctly, condoms provide a high level of effectiveness (95 – 97%) in preventing pregnancy.
    • STI and HIV Prevention: Condoms are crucial in preventing the spread of sexually transmitted infections (STIs), including HIV.
    • Accessibility: Condoms are easy to obtain and can be distributed widely by Community Based Health Workers and the commercial sector.
    • Dual Purpose: They serve a dual purpose of family planning and STI/HIV prevention.
    • Potential Cervical Cancer Protection: There is a probable protective effect for women against the development of Intra-epithelial Neoplasm, i.e., cervical cancer.
    • Ease of Use: Condoms are easy to use, usually inexpensive, safe, effective, and portable.
    • Sexual Enhancement: They can help some men with premature ejaculation maintain an erection.
    • Convenient Short-Term Contraception: Condoms are convenient when short-term contraception is required.
    • Safety and Lack of Side Effects: Condoms are considered safe with minimal side effects.
    Disadvantages:
    1. Allergic Reactions: Some individuals may experience allergic reactions to latex or other materials used in condoms.
    2. Sexual Enjoyment: Condoms may reduce the quality of sex for some individuals.
    3. Male Partner Cooperation: Requires cooperation from the male partner for effective use.
    4. Vulnerability to Damage: Can be damaged by exposure to oil-based lubricants, heat, humidity, or light.
    5. Decreased Sensitivity: May decrease sensitivity for men, impacting the enjoyment of intercourse.
    6. Slipping or Tearing: There is a small possibility of slipping or tearing during sexual intercourse.
    7. Storage Requirements: Condoms can deteriorate if not properly stored, e.g., in too much heat, sunlight, or humidity.
    8. Erection Challenges: Some men may struggle to maintain an erection with a condom on.

     

    Spermicides

    Vaginal spermicides come in the form of foam, cream, jelly, tablet or suppository and are inserted into the vagina just before sexual intercourse to prevent pregnancy.

    Mechanism of action of spermicide
    • Inactivates and kills sperm;
    • Blocks the path of sperm to the uterus.
    Effectiveness of spermicides
    • Fairly effective, depending on the user (79-97%);
    • If used with condom, effectiveness is 99%;
    • Effectiveness lasts only 30 to 40 minutes after insertion.
    Advantages of spermicides 
    • Over-the-Counter Availability: Spermicides can be obtained without a prescription, making them easily accessible.
    • Immediate Protection: Spermicides can be kept available for immediate use whenever needed, providing on-the-spot protection.
    • Additional Lubrication: Spermicides can offer additional lubrication during intercourse, enhancing comfort.
    • Enhanced Effectiveness with Condoms: When used in conjunction with condoms, spermicides can increase their overall effectiveness in preventing pregnancy.
    • Back-Up Option for Contraceptive Delays: Spermicides serve as a simple back-up option for women waiting to start oral contraceptives or have an IUD inserted. They are also useful for women who forget multiple contraceptive pills or run out of pills.
    • Emergency Use: In cases of a condom breakage, spermicides can be applied quickly as an emergency measure.
    Disadvantages and Side Effects:
    1. Sexual Interruption: Some forms of spermicides, such as suppositories or foaming tablets, may require a waiting period of 10 minutes for dissolving before becoming effective, potentially interrupting sexual intercourse.
    2. Application Before Each Act: Spermicides must be used before each act of sexual intercourse, requiring consistent and timely application.
    3. Post-Intercourse Wetness: Spermicides may cause increased vaginal wetness for several hours after intercourse.
    4. Sensitivity or Allergic Reactions: A few women may be sensitive or allergic to spermicides, leading to irritation and discomfort, especially with frequent use.
    5. Lower Effectiveness Rates: Spermicides are generally less effective in preventing pregnancy compared to more modern methods such as IUDs and hormonal contraceptives.
    6. Risk of Candida Vaginitis: Some women may develop Candida Vaginitis as a side effect of using spermicides.
    7. Increased Infections: Spermicides can potentially increase the risk of urinary and yeast tract infections in women.
    8. Messiness and Discomfort: Spermicides can be messy and may cause mild discomfort or minor allergic reactions in some individuals.
    Vaginal Diaphragm 

    Diaphragm is a mechanical barrier placed between the vagina and cervical canal .They are designed to fit in the cul-de-sac and cover the cervix.

    The contraceptive jelly or creams should be placed on the cervical side of the diaphragm before insertion because the device itself is ineffective. Again, this medication serves as lubricant for insertion of a device.

    The device is inserted 6 hours prior to intercourse and should be left in place 6-24 hours after intercourse 

    Advantages
    • Easy to use
    • It offers some protection against STDs 
    • Well used, it protects from conception with the failure rate as low as 6% of women per year of exposure.
    Disadvantages
    • It require fitting by a well trained medical professional
    • Fitting may loose during intercourse
    • It cannot be effective in women with significant pelvic relaxation,a sharply retroverted or anteverted uterus or shortened vagina.
    Side effects
    • Vagina irritation
    • Increased risk of urinary tract infection due to pressure of the rim against the urethra and alterations in the composition of vaginal normal flora.

    cervical cap

    Cervical Cap (CAP)

    Cervical caps are small cuplike diaphragms placed over the cervix that are held in place by suction.

    To provide a successful barrier against the sperms, they must be tightly fit over the cervix therefore, individualization is essential because of variability in cervical size.

    It has few advantages because;

    • Unpleasant odour often develops after approximately 1 day of use 
    • Dislodgment (as in diaphragm) 
    • The cup should remain in place 1 or 2 days before intercourse and should be left in place for 8 -48 hours after intercourse.
    Intrauterine Contraceptive Devices (IUCDs):

    Intrauterine Contraceptive Devices (IUCDs):

    Intrauterine Contraceptive Devices, or IUCDs, are flexible plastic devices inserted into a woman’s uterus to prevent pregnancy, usually renewed every 3-5 years. These devices are often made of copper impregnated with gold, silver, and stainless steel.

    Various Design Types:

    Copper T 380A:

    Intrauterine Contraceptive Devices, Copper T Model Tcu 380a | Mother's Garage

    • T-shaped device with copper on the stem and arms of the T.
    • Duration of effectiveness: 10 years.
    • Shelf life: 7 years.

    Multiload 375:

    • Lasts for 5 years.
    Mechanism of Action:
    • Renders the endometrium unsuitable for the implantation of a fertilized ovum.
    • Copper emits metal ions with spermicidal properties.
    Advantages:
    1. Very Effective: Provides high efficacy, ranging from 99-99.5%.
    2. Immediate Effectiveness: Works instantly upon insertion.
    3. Long-Term Method: Offers a long duration of effectiveness.
    4. No Interference with Intercourse: Does not interfere with sexual activity.
    5. Quick Return to Fertility: Fertility returns immediately upon removal.
    6. Few Side Effects: Mild side effects compared to other methods.
    7. No Client Supplies Needed: Does not require additional supplies by the client.
    Disadvantages and Side Effects:
    1. Mild Cramps: May experience mild cramps in the first 3-5 days post-insertion.
    2. Menstrual Changes: Longer and heavier menstrual blood loss in the initial 3 months.
    3. Increased Cramping Pain: Increased cramping pain during menstruation.
    4. Provider-Dependent: Insertion and removal depend on a healthcare provider.
    5. String Checks: Need to check for strings after menstruation.
    6. Increased Bleeding: May experience increased bleeding in the first few months.
    7. Spontaneous Expulsion: There is a possibility of spontaneous expulsion, especially in the first 6 months.
    8. Uterine Perforation: Very rare, occurring in 1 out of 1000 cases.
    9. Pelvic Inflammatory Diseases (PID): May increase the risk of PID.
    10. Pain and Discomfort: Pain, especially with larger devices.
    11. Menstrual Changes: Increased menstrual loss; intermenstrual spotting may occur.
    12. Expulsion Risk: Higher risk of expulsion during the first 6 months, especially during menses.
    13. Translocation Risk: Possibility of translocation to the peritoneal cavity or broad ligament.
    14. Pregnancy Risks: May increase the risk of pregnancy and ectopic pregnancy.
    15. No Protection Against STIs/HIV or Cancers: Does not provide protection against STIs, HIV, ovarian, endometrial, or cervical cancers.

    IUCDs users who develop PID should be treated with the IUCD in place if they want to continue using it. If no improvement within 72 hours, remove it.

    When to Insert an IUCD:
    • During or immediately after menstruation.
    • At a postnatal examination.
    • Immediately following delivery or any time within 46 hours after childbirth.
    • After termination of a pregnancy.
    • During the caesarean section.
    iucd reminder
    Insertion of an Intrauterine Contraceptive Device (IUD): Procedure
    Insertion of an Intrauterine Contraceptive Device (IUD): Procedure
    1. Aseptic Technique: Implement aseptic techniques, including hand washing and wearing sterile gloves.
    2. Device Preparation: Place the IUD in an introducer and plunger.
    3. Straightening: The device straightens inside the introducer.
    4. Visualization of Cervix: Insert a Cusco’s vaginal speculum to clearly visualize the cervix.
    5. Cleaning: Clean the cervix and vaginal vault with sterile swabs.
    6. Uterine Measurement: Measure the length of the uterus with a uterine sounder.
    7. Introducer Insertion: Insert the introducer into the uterus through the cervix.
    8. Plunger Action: Gently push the plunger to force the device out of the introducer into the uterus.
    9. Device Lodging: In the uterus, the device resumes its original shape and lodges against the uterine walls.
    10. String Placement: The two small strings attached to the device hang down through the cervical opening.
    11. String Cutting: Cut the string with scissors to reduce the size, leaving approximately 3cm hanging out of the cervix.
    12. Post-Insertion: After insertion, the client rests and can remain on the procedure table until ready to get dressed.
    13. String Check: The woman can feel the strings in the vagina to ensure the device is in position.
    Post-Insertion Instructions:
    1. Backup Use: Use backup contraception for a minimum of 3 days.
    2. Mild Pain: Slight pain may occur but usually does not require medication.
    3. String Check: Check the string during menstruation to ensure it is in place; return if removed or dislodged.
    4. Immediate Return for Discomfort: Return to the facility immediately in case of any discomfort.
    Removing the IUDs:
    1. Discussion with Client: Discuss side effects with the client and weigh the option of managing the problem or immediate removal.
    2. Timing for Removal: Removal is simple and can be done any time of the month, with monthly bleeding making it easier.
    Removal Procedure:
    • Explain the removal procedure to the client.
    • Ensure privacy and confidentiality.
    • Visualize cervix and UID strings with a vaginal speculum.
    • Clean cervix and vagina with antiseptic solution.
    • Instruct the client to relax and take slow breaths.
    • Gently pull the IUD strings until it comes completely out of the cervix.
    • Show the removed IUD to the client for assurance.
    • Thank the client for cooperating throughout the procedure.
    Reasons for Missed Threads in IUDs:
    1. Coiled thread inside.
    2. Thread torn through.
    3. Device expelled outside unnoticed by the client.
    4. Device perforated the uterine wall and is lying in the peritoneal cavity.
    5. Device pulled by the growing uterus in pregnancy.
    Methods of Identification:
    • History taking (exclude pregnancy).
    • Ultrasonography.
    • Hysterectomy.
    • Hysteroscopy.
    • Straight x-ray.
    Contraindications:
    • Pregnant women or those suspected to be.
    • Women with menorrhagia or abnormal bleeding.
    • Women with PID, current, or in the past 3 months.
    • Purulent per vaginal discharge, gonococcal, or chlamydial infection.
    • Malignant trophoblastic disease.
    • Pelvic tuberculosis.
    • Women with genital tract cancer.

    Surgical methods

    Male Vasectomy

    Male vasectomy  is a permanent operation in the male where a segment of vas deferens of both sides are resected and the cut ends are ligated.

    Vasectomy is a voluntary surgical procedure for permanently terminating fertility in men.

    Mode of Action

    Blocking the vas deferens (ejaculatory duct) to prevent sperm presence in the ejaculate.

    Indications

    Men certain about achieving their desired family size, seeking a highly effective permanent contraceptive method, or whose partners face unacceptable pregnancy risks.

    Contraindications

    Vasectomy should be delayed in the case of local or systemic infections.

    Benefits

    • Highly effective
    • Permanent
    • Simple surgery under local anesthesia
    • No further expense or concerns about conception
    • No long-term side effects
    • Does not interfere with sexual intercourse

    Side Effects

    • Wound infection
    • Scrotal hematoma
    • Granuloma
    • Excessive swelling
    • Pain at incision sites

    Explain to Clients

    • When to come back for follow-up visits
    • Common side effects of the method
    • What to do if there are changes in menstrual periods
    • How soon the method is effective
    • How to protect against STIs
    • How to care for the wound postoperatively

    General Instructions to Clients Using Permanent Methods

    • Inform about follow-up visit schedules
    • Explain common side effects in simple language
    • Share warning signs or possible problems requiring medical attention
    • Guide regarding changes in menstrual periods
    • Emphasize the method’s lack of protection against HIV/AIDS and STIs, advocating for backup methods like condoms
    • Provide instructions on wound care postoperatively

     

    Female -Tubal ligation

    Female Tubal Ligation  is the interruption of continuity of fallopian tubes. 

    Tubal ligation is a voluntary surgical procedure for permanently terminating fertility in women. It can be done by a mini-operation (laparatomy/laparoscopy).

    Mode of Action

    Blocking fallopian tubes by cutting, cautery, rings, or clips, preventing sperms from reaching the ovum.

    Indications

    Women certain about achieving desired family size, seeking a highly effective permanent contraceptive method, or facing unacceptable pregnancy risks. Family planning should be delayed in specific cases, such as pregnancy, postpartum complications, or certain health conditions.

    Timing of the Tubal Ligation

    • Immediately after childbirth or within the first seven days (if chosen in advance)
    • Six weeks or more after childbirth
    • Immediately after abortion (if chosen in advance)
    • Any time, provided pregnancy is ruled out (between seven days and six weeks postpartum)
    • During cesarean section

    Benefits

    • Highly effective
    • Immediate effectiveness
    • Permanent
    • Simple surgery under local anesthesia
    • No contraception-related concerns
    • No long-term side effects
    • Does not interfere with sexual intercourse

    Disadvantage

    • Does not protect against STIs/AIDS
    • Irreversible

    Side Effects

    • Wound infection
    • Post-operative fever
    • Rare bladder and intestinal injuries
    • Hematoma
    • Pain at the incision site
    • Superficial bleeding

    Challenges associated with Tubal Ligation

    • Desire for more children after the operation
    • Excessive desire for reversal
    • Disagreement to sign the informed consent form
    • External pressures
    • Depression
    • Marital problems

    General Complications

    • Obesity
    • Psychological upset
    • Chronic pelvic pain
    • Congestive dysmenorrhea
    • Menstrual abnormalities
    General Advantages 
    • Simple Surgical Procedure: The procedure is straightforward and uncomplicated.
    • Out-Patient Procedure: It can be performed as an outpatient procedure, avoiding the need for a hospital stay.
    • Few Complications: The surgery has a low incidence of complications.
    • Reversal Anastomosis: Reversal procedures, known as anastomosis, have a 50% chance of success.
    • Highly Effective: The failure rate is minimal, at 0.15%.
    • No Interference with Sexual Life: Vasectomy does not interfere with the sexual life of the individual.
    • Performed Under Anesthesia: The operation is conducted under anaesthesia, ensuring a painless experience.
    General Disadvantages
    • Lack of Protection Against HIV and STDs: Vasectomy does not provide protection against HIV and sexually transmitted diseases (STDs).
    • Costly Reversal: Reversal procedures can be expensive.
    • Consent Requirements: Obtaining consent may involve important family members in decision-making.
    • Risk of Injury to Internal Organs: There is a potential risk of injury to internal organs during the procedure.
    • Anaesthesia Risks: The use of anaesthesia carries inherent risks.
    • Post-Surgical Complications: Possible complications include infection and bleeding.
    • Additional Contraception Required: Additional contraception is needed for about 2-3 months until semen becomes free of sperm.
    • Potential for Impotency: There is a rare risk of impotence.
    • Frigidity: Frigidity, especially sexual unresponsiveness in women and an inability to achieve orgasm during intercourse, may occur.
    • Stigma: Societal stigma may be associated with the decision to undergo vasectomy.

    Important points to think about before the use of a permanent contraception

    Because male and female sterilization are permanent methods of contraception, thorough counselling procedures must be followed to ensure that the client fully understands his or her choice and to minimize chances of regret. 

    • Counselling: Thorough counselling sessions to ensure informed decision-making.
    • Reasons for Choosing Permanent Methods: Understand and evaluate the motivating factors behind the choice of permanent contraception.
    • Screening for Risk Indicators for Regret: Identify potential risk indicators such as:
    1. Young age
    2. Low parity
    3. Single-parent status
    4. Marital instability
    • Completion of Informed Consent Process: Ensure the individual fully comprehends the implications and consequences of the procedure.
    • Details of the Procedure: Provide comprehensive information about the surgical process involved in permanent contraception.
    • Possibility of Failure: Acknowledge the rare but existing possibility of the procedure not being 100% effective.
    • Positive Pregnancy Test Result: In case of a positive pregnancy test post-tubal ligation, rule out ectopic pregnancy.
    • Condom Use for STD Protection: Emphasize the continued need for condom use to safeguard against sexually transmitted diseases.

    HORMONAL CONTRACEPTIVES (click here)

    Family Planning Read More »

    Menstruation Disorders

    Menstruation Disorders

    MENSTRUATION DISORDERS

    Menstrual disorders are abnormalities in menstruation during reproductive life.

    Common disorders associated with menstruation are as follows;

    1. Amenorrhoea
    2. Dysmenorrhoea
    3. Menorrhagia
    4. Metrorrhagia
    5. Polymenorrhagia (epimenorrhoea)
    6. Dysfunctional uterine bleeding
    7. Endometriosis

    MENSTRUATION

    Menstruation is defined as the periodic physiological discharge of blood from the uterus through the vagina.

    The normal period of menstruation usually lasts 2-7 days with a total blood loss of

    10 – 80 ml is considered normal.

     

    The normal menstruation cycle has a length of 21-35 days.

     

    THE MENSTRUATION CYCLE 

    The menstrual cycle is a sequence of physiological events that occur periodically (on average every 28 days) from puberty until menopause. 

    The events occur under the influence of hormones produced by pituitary glands(Follicle Stimulating Hormone – FSH and Luteinizing hormone – LH)  and the ovaries (Progesterone & Oestrogen).

    Menstrual Cycle nurses revision uganda

    The menstrual cycle is divided into 3 phases namely:

    • Follicular phase
    • Ovulatory phase
    • Luteal phase
    Follicular phase (proliferative phase)

    This is marked by the beginning of menstruation.

    • Bleeding results from the decrease in the levels of oestrogen and progesterone from the luteal phase.
    • The reduction in oestrogen and progesterone leads to the shedding of the endometrium.
    • During this phase, Follicle stimulating hormone (FSH) from the anterior lobe of the pituitary gland rises to stimulate the growth of several ovarian follicles with each follicle containing an ovum.
    • Later, FSH levels reduce which leads to only one dominant follicle developing.
    • The dominant follicle then produces oestrogen hormone.
    The Ovulatory phase

    This begins with a sharp rise in the levels of LH and FSH.

    • The luteinizing hormone stimulates ovulation at about the 14th day of the menstrual cycle (between the 7th – 21st day depending on the cycle length).
    • The oestrogen levels reach a peak and progesterone levels begin to rise once the ovum has been released.
    • What is left behind of the dominant follicle after ovum release is referred to as the corpus luteum and it is the one that produces progesterone.
    Luteal phase (Secretory phase)

    Luteal phase usually occurs after ovulation.

    • During this phase, the endometrium begins to thicken in preparation for nourishment of an embryo in case fertilization takes place.
    • If fertilization doesn’t occur, the increasing levels of oestrogen and progesterone decrease the production of both luteinizing and follicle stimulating hormones.
    • Since the maintenance of corpus luteum depends on the luteinizing hormone, a decrease in its production causes the corpus luteum to atrophy leading to a reduction in the production of oestrogen and progesterone.
    • The thickened uterine lining then begins to slog off and menstruation begins.
    • And the follicular phase begins to complete the menstrual cycle.
    Factors that may interfere with menstrual cycle thereby causing menstrual disorders

    Factors that may interfere with menstrual cycle thereby causing menstrual disorders

    1. Physical conditions such as trauma, tumors, and diseases of the glands, ovaries, and uterus can impact the normal functioning of the reproductive system, potentially causing menstrual irregularities.

    2. Debilitating diseases such as tuberculosis (TB) and HIV/AIDS can affect overall health, potentially disrupting the menstrual cycle.

    3. Malnutrition can lead to hormonal imbalances, affecting the regularity of menstrual periods.

    4. Dysfunctional uterine bleeding, which involves abnormal bleeding patterns, can be a contributing factor to menstrual disorders.

    5. Age plays a role, as menstruation can be irregular in young girls after menarche (the first occurrence of menstruation).

    6. Pregnancy naturally alters the menstrual cycle, and complications during pregnancy can lead to menstrual irregularities.

    7. Certain drugs and exposure to X-rays, especially radiography, can impact hormone levels and disrupt the menstrual cycle.

    8. Menopause, with its gradual onset, marks the end of the reproductive years and can cause significant changes in menstrual patterns.

    9. The use of intrauterine contraceptives (IUCs) can also affect menstrual regularity in some women.

    10. Extreme stress and worries, such as those experienced during times of war or conflict, can disrupt hormonal balance and impact the menstrual cycle.

    11. Anxiety and mental health conditions can influence hormone levels, potentially leading to menstrual irregularities.

    12. Environmental changes, such as transitioning to a new school or significant shifts in routine, can impact stress levels and, in turn, affect the menstrual cycle.

    13. The stage of adolescence is a period of significant hormonal changes, and this transition can lead to menstrual irregularities as the body adjusts to these fluctuations.

    AMENORRHOEA

    AMENORRHOEA

    Click Here

    Menstruation Disorders Read More »

    anatomy and physiology of the Musculo-skeletal system

    Anatomy and Physiology of the Musculo-skeletal System

    Anatomy and Physiology of the Musculoskeletal System
    Anatomy and Physiology of the Musculoskeletal System

    The muscular-skeletal system is the system that is mainly important in locomotion, body support and makes bodies’ frame work. It consists of skeletal muscles, bones and joints.

    I. MUSCLES (ANATOMY AND PHYSIOLOGY)
    Skeletal, Smooth, and Cardiac Muscle

    Our bodies contain three distinct types of muscle tissue, each uniquely adapted to perform specific roles. While all muscle tissues share the ability to contract, they differ significantly in their location, microscopic appearance (histology), and physiological function.

    1. Skeletal Muscle:
    • Location:
      • Attached to bones (or to skin, as in facial muscles).
      • Forms the bulk of the body's muscle mass.
    • Histology (Microscopic Appearance):
      • Striated: Appears striped or banded under a microscope due to the arrangement of contractile proteins (actin and myosin).
      • Very long, cylindrical cells (fibers): Can be several centimeters long.
      • Multinucleated: Each muscle fiber contains many nuclei, located peripherally (just under the sarcolemma, or cell membrane).
      • Voluntary: Contraction is under conscious control.
    • Function:
      • Movement: Responsible for all voluntary movements of the body (e.g., walking, lifting, speaking, facial expressions).
      • Posture: Maintains body posture.
      • Stabilize Joints: Helps stabilize joints by exerting tension.
      • Heat Generation: Produces heat as a byproduct of contraction, helping to maintain body temperature.
    2. Cardiac Muscle:
    • Location:
      • Found exclusively in the wall of the heart (myocardium).
    • Histology (Microscopic Appearance):
      • Striated: Like skeletal muscle, it also appears striped due to the arrangement of contractile proteins.
      • Branched cells: Individual cells are shorter than skeletal muscle fibers and branch, forming an intricate network.
      • Uninucleated (or occasionally binucleated): Each cell usually has one (sometimes two) centrally located nuclei.
      • Intercalated Discs: Unique to cardiac muscle, these are specialized junctions between adjacent cardiac muscle cells. They contain desmosomes (to prevent cells from pulling apart) and gap junctions (to allow ions to pass quickly, enabling rapid communication and synchronized contraction).
      • Involuntary: Contraction is not under conscious control; it's regulated by the heart's intrinsic pacemaker and influenced by the autonomic nervous system.
    • Function:
      • Pump Blood: Responsible for pumping blood throughout the body, maintaining blood pressure and circulation.
    3. Smooth Muscle:
    • Location:
      • Found in the walls of hollow internal organs (viscera), except the heart.
      • Examples: Walls of the digestive tract (stomach, intestines), urinary bladder, respiratory passages (bronchi), arteries, veins, uterus, arrector pili muscles in the skin (causing "goosebumps").
    • Histology (Microscopic Appearance):
      • Non-striated: Lacks the visible banding pattern seen in skeletal and cardiac muscle because the contractile proteins are arranged more randomly.
      • Spindle-shaped cells: Elongated cells with tapered ends.
      • Uninucleated: Each cell contains a single, centrally located nucleus.
      • Involuntary: Contraction is not under conscious control; it's regulated by the autonomic nervous system, hormones, and local factors.
    • Function:
      • Peristalsis: Propels substances along internal passageways (e.g., food through the digestive tract).
      • Regulation of Organ Volume: Can maintain prolonged contractions, regulating the size of organs (e.g., constricting blood vessels, emptying the bladder).
      • Movement of Fluids: Moves fluids and other substances within the body.
      • Regulates Airflow: Adjusts the diameter of respiratory passages.
    1. The Skeletal Muscle

    Skeletal muscles are truly fascinating structures, responsible for all voluntary movements, from the subtlest facial expressions to powerful athletic feats. They are unique among muscle types due to their voluntary control and striated appearance.

    Gross Anatomy of a Skeletal Muscle

    Skeletal muscles are organs composed predominantly of muscle tissue, but they also contain connective tissues, nerves, and blood vessels. They are typically attached to bones, and this attachment is crucial for their function in generating movement.

    1. Muscle Belly: This is the fleshy, contractile part of the muscle. It contains thousands to hundreds of thousands of individual muscle fibers (cells).
    2. Attachments to Bones: Skeletal muscles connect to bones, usually at two points:
      • Origin: This is typically the less movable (or stationary) attachment point of the muscle. It often lies closer to the trunk or center of the body.
      • Insertion: This is the more movable attachment point of the muscle. When the muscle contracts, the insertion point is pulled towards the origin, causing movement at a joint.
    3. Example: For the biceps brachii muscle in your upper arm:
      • Origin: Scapula (shoulder blade)
      • Insertion: Radius (forearm bone)
      • When the biceps contracts, it pulls the radius towards the scapula, causing the elbow to bend (flex).
    4. Connective Tissue Attachments: Muscles attach to bones via specialized connective tissues:
      • Tendons: These are cord-like bundles of dense regular connective tissue. They are continuous with the connective tissue sheaths within and around the muscle and then with the periosteum (the fibrous membrane covering the bone). This direct continuity ensures that the force generated by muscle contraction is effectively transmitted to the bone, causing movement. Tendons are incredibly strong and relatively inelastic.
      • Aponeuroses: These are broad, flat sheets of dense regular connective tissue. They function similarly to tendons, serving as a flat attachment site, especially where muscles are broad and require a wide area of attachment, or where they connect to other muscles. Examples include the aponeurosis of the external oblique muscle in the abdomen, or the plantar aponeurosis in the sole of the foot.
    Hierarchical Organization of Skeletal Muscle

    Understanding the hierarchical organization of skeletal muscle is key to appreciating how force is generated and transmitted. It's like a cable, where smaller strands are bundled together to form larger, stronger cables.

    1. Entire Muscle (Organ Level):
      • This is what we commonly recognize as "a muscle" (e.g., biceps brachii, quadriceps femoris).
      • It is composed of many bundles of muscle fibers, along with connective tissue, blood vessels, and nerves.
      • The entire muscle is typically enclosed by a dense, irregular connective tissue sheath called the epimysium.
    2. Fascicle (Bundle of Muscle Fibers):
      • The entire muscle is divided into numerous smaller bundles called fascicles.
      • Each fascicle consists of anywhere from 10 to 100 or more individual muscle fibers.
      • Each fascicle is wrapped in its own connective tissue sheath, the perimysium. This compartmentalization allows for independent neural control of different parts of a muscle.
    3. Muscle Fiber / Muscle Cell (Cellular Level):
      • Within each fascicle are the individual muscle cells, which are often referred to as muscle fibers due to their elongated, cylindrical shape.
      • These are unique cells: they are very long (can be up to 30 cm in large muscles), multinucleated (containing many nuclei), and are the actual contractile units.
      • Each muscle fiber is surrounded by a delicate connective tissue layer called the endomysium.
      • The plasma membrane of a muscle fiber is called the sarcolemma, and its cytoplasm is called the sarcoplasm.
    4. Myofibril:
      • Inside each muscle fiber (muscle cell), the sarcoplasm is packed with hundreds to thousands of rod-like structures called myofibrils.
      • Myofibrils are the actual contractile elements of the muscle cell. They are composed of even smaller structures called myofilaments.
      • The characteristic "striated" or striped appearance of skeletal muscle under a microscope is due to the repeating arrangement of these myofilaments within the myofibrils.
    5. Myofilaments (Actin & Myosin):
      • These are the protein filaments that make up the myofibrils. They are the actual contractile proteins.
      • Thick filaments are primarily composed of the protein myosin.
      • Thin filaments are primarily composed of the protein actin, along with regulatory proteins troponin and tropomyosin.
      • These myofilaments are organized into functional repeating units called sarcomeres.
    Hierarchical Flowchart:
    Entire Muscle ↓ (enclosed by Epimysium) Fascicle (bundle of muscle fibers) ↓ (enclosed by Perimysium) Muscle Fiber / Muscle Cell ↓ (enclosed by Endomysium, plasma membrane is Sarcolemma) Myofibril (contains myofilaments) ↓ Myofilaments (Actin & Myosin) ↓ (organized into) Sarcomere (functional unit)
    Connective Tissue Sheaths Associated with Skeletal Muscle

    Skeletal muscles are not just bundles of contractile cells; they are highly organized structures held together and protected by various layers of connective tissue. These sheaths play vital roles in transmitting force, providing pathways for nerves and blood vessels, and maintaining the structural integrity of the muscle.

    Sheath Location Tissue Type Main Function(s)
    Epimysium Surrounds the entire muscle Dense Irregular CT Binds all fascicles, overall protection, forms tendons/aponeuroses, major vessel/nerve pathways
    Perimysium Surrounds fascicles (bundles of fibers) Dense Irregular CT Divides muscle into fascicles, provides pathways for smaller vessels/nerves
    Endomysium Surrounds individual muscle fibers Areolar (Loose) CT Electrically insulates fibers, supports capillaries/nerves, transfers force

    These connective tissue layers are continuous with each other and ultimately with the tendons, forming a continuous network that effectively transmits the force generated by the contracting muscle fibers to the bones, enabling movement.

    Microscopic Anatomy of a Skeletal Muscle Fiber (Cell)

    A skeletal muscle fiber, or muscle cell, is a highly specialized and elongated cell designed for contraction. It has several unique features that distinguish it from a typical animal cell.

    1. Sarcolemma (Plasma Membrane):
      • Description: This is the specialized plasma membrane of a muscle fiber. It is a thin, elastic membrane that encloses the sarcoplasm.
      • Function:
        • Electrical Excitability: It has voltage-gated ion channels that allow it to generate and propagate action potentials (electrical signals).
        • Invaginations (T-tubules): At numerous points, the sarcolemma invaginates deep into the muscle fiber to form structures called Transverse Tubules (T-tubules).
    2. Sarcoplasm (Cytoplasm):
      • Description: This is the cytoplasm of a muscle fiber. It contains the usual organelles found in other cells, but also has some specialized components.
      • Specialized Components:
        • Glycosomes: Granules of stored glycogen, which provide glucose for ATP production.
        • Myoglobin: A red pigment that stores oxygen, similar to hemoglobin in blood. Myoglobin efficiently stores oxygen within the muscle cell, providing an oxygen reserve for aerobic respiration during periods of high activity.
        • Mitochondria: Numerous mitochondria are packed between the myofibrils, reflecting the high energy demand of muscle contraction (producing ATP).
        • Myofibrils: The most prominent component, myofibrils are rod-like contractile elements that make up about 80% of the muscle fiber volume.
    3. Sarcoplasmic Reticulum (SR) (Endoplasmic Reticulum):
      • Description: This is a highly specialized, elaborate network of smooth endoplasmic reticulum that surrounds each myofibril like a loosely woven sleeve. It runs longitudinally along the myofibril. At the A-I band junction, it forms larger, perpendicular channels called terminal cisternae.
      • Function:
        • Calcium Storage and Release: The primary function of the SR is to store and regulate the intracellular concentration of calcium ions (Ca2+). It contains a high concentration of Ca2+ pumps that actively transport Ca2+ from the sarcoplasm into the SR, and Ca2+ release channels that open in response to electrical signals.
        • Excitation-Contraction Coupling: The release of Ca2+ from the SR is the critical step that initiates muscle contraction.
    4. T-Tubules (Transverse Tubules):
      • Description: These are deep, invaginations (inward extensions) of the sarcolemma that run perpendicular to the long axis of the muscle fiber. They are located at the A-I band junction of each sarcomere.
      • Function:
        • Rapid Impulse Transmission: T-tubules act as rapid communication channels, allowing the electrical impulse (action potential) generated on the sarcolemma to quickly penetrate deep into the muscle fiber, reaching every sarcomere.
        • Coupling with SR: Each T-tubule runs between two terminal cisternae of the SR, forming a structure called a triad. This close anatomical arrangement is crucial for excitation-contraction coupling, as the electrical signal in the T-tubule directly triggers Ca2+ release from the adjacent SR terminal cisternae.
    5. Nuclei (Multinucleated):
      • Description: Unlike most cells, skeletal muscle fibers are multinucleated, meaning they contain many nuclei. These nuclei are typically located just beneath the sarcolemma (peripherally).
      • Function: Protein Synthesis: The large number of nuclei allows for the efficient production of the vast amounts of proteins (especially contractile proteins like actin and myosin) needed for the maintenance and repair of the very long muscle fiber, as well as for muscle growth (hypertrophy).
    Structure of a Myofibril

    Myofibrils are the long, cylindrical, contractile organelles found within the sarcoplasm of a muscle fiber. It's their precise arrangement of protein filaments that gives skeletal muscle its characteristic striated appearance and enables contraction.

    1. Myofibrils and Sarcomeres:
      • Each myofibril is composed of a chain of repeating contractile units called sarcomeres.
      • A sarcomere is the fundamental functional unit of a skeletal muscle, extending from one Z disc to the next Z disc. It is the smallest unit of a muscle fiber that can contract.
      • The precise arrangement of two types of myofilaments within each sarcomere creates the striations.
    2. Myofilaments:
      • Thick Filaments (Myosin Filaments): Composed primarily of the protein myosin. Each myosin molecule has a "rod-like" tail and two globular "heads." The heads are crucial for muscle contraction, as they bind to actin and possess ATPase activity. They are found in the center of the sarcomere and do not extend the entire length of the sarcomere.
      • Thin Filaments (Actin Filaments): Composed primarily of the protein actin, which forms a double helix. Also contains two regulatory proteins:
        • Tropomyosin: A rod-shaped protein that spirals around the actin core, blocking the myosin-binding sites on actin in a relaxed muscle.
        • Troponin: A three-polypeptide complex that binds to actin, tropomyosin, and calcium ions (Ca2+). Its binding of Ca2+ causes a conformational change that moves tropomyosin away from the myosin-binding sites.
        Thin filaments extend from the Z disc toward the center of the sarcomere.
    3. Bands and Zones within a Sarcomere: The alternating dark and light bands give skeletal muscle its striated appearance.
      • Z Disc (Z Line): A coin-shaped sheet of proteins (primarily alpha-actinin) that anchors the thin filaments and connects myofibrils to one another. It defines the lateral boundaries of a single sarcomere.
      • I Band (Light Band): A lighter region on either side of the Z disc. Contains only thin filaments (actin). During contraction, the I band shortens.
      • A Band (Dark Band): A darker, central region of the sarcomere. Contains the entire length of the thick filaments (myosin). Also contains the inner ends of the thin filaments that overlap with the thick filaments. The A band's length does not change significantly during contraction.
      • H Zone (H Band): A lighter region within the center of the A band. Contains only thick filaments (myosin); there is no overlap with thin filaments in a relaxed muscle. During contraction, the H zone shortens and can even disappear as thin filaments slide past.
      • M Line: A dark line in the exact center of the H zone (and thus the A band). Consists of proteins (e.g., myomesin) that anchor the thick filaments in place and keep them aligned.

    During muscle contraction, the thin filaments slide past the thick filaments, pulling the Z discs closer together. This causes the sarcomere to shorten, and the I bands and H zones to narrow or disappear, while the A band's length remains relatively constant. This mechanism is known as the Sliding Filament Model of Contraction.

    Physiology of a Skeletal Muscle (Muscle Contraction)
    "Sliding Filament Model" of muscle contraction.

    The Sliding Filament Model is the universally accepted explanation for how skeletal muscles contract. It states that during contraction, the thin filaments (actin) slide past the thick filaments (myosin), causing the sarcomere to shorten. The myofilaments themselves do not shorten; rather, their overlap increases.

    Here's a breakdown of the key principles:

    1. Relaxed State:
      • In a relaxed muscle fiber, the thick and thin filaments overlap only slightly at the ends of the A band.
      • The H zone (containing only thick filaments) and the I band (containing only thin filaments) are at their maximum width.
      • The myosin heads are "cocked" and energized, but they are prevented from binding to actin by the regulatory protein tropomyosin, which covers the myosin-binding sites on the actin molecules.
    2. Initiation of Contraction (The Signal):
      • A nerve impulse (action potential) arrives at the neuromuscular junction (which we'll detail later).
      • This electrical signal is transmitted down the sarcolemma and into the T-tubules.
      • The signal in the T-tubules triggers the release of calcium ions (Ca2+) from the sarcoplasmic reticulum (SR) into the sarcoplasm.
    3. Role of Calcium (Ca2+) and Regulatory Proteins:
      • When Ca2+ is released into the sarcoplasm, it binds to the regulatory protein troponin.
      • Binding of Ca2+ causes troponin to change shape.
      • This shape change in troponin, in turn, pulls the tropomyosin molecule away from the active (myosin-binding) sites on the actin filament.
      • With the binding sites now exposed, the myosin heads are free to attach to actin.
    4. Cross-Bridge Formation (Myosin-Actin Binding):
      • The energized myosin heads (which have already hydrolyzed ATP into ADP and inorganic phosphate, storing the energy) bind to the exposed active sites on the actin filament, forming cross-bridges.
    5. The Power Stroke:
      • Once the myosin head is attached to actin, the stored energy is released, causing the myosin head to pivot or "bend." This bending motion is called the power stroke.
      • The power stroke pulls the thin filament (actin) toward the M line (the center of the sarcomere).
      • As the myosin head pivots, it releases ADP and inorganic phosphate.
    6. Cross-Bridge Detachment:
      • A new ATP molecule then binds to the myosin head.
      • The binding of ATP causes the myosin head to detach from the actin filament. This detachment is crucial; without new ATP, the cross-bridges would remain attached, leading to a state known as rigor mortis (stiffening after death due to lack of ATP).
    7. Cocking of the Myosin Head:
      • The newly bound ATP is immediately hydrolyzed (broken down) by the ATPase enzyme on the myosin head into ADP and inorganic phosphate (Pi).
      • This hydrolysis provides the energy to "re-cock" or re-energize the myosin head, returning it to its high-energy, ready-to-bind position.
    8. Repetition of the Cycle:
      • As long as Ca2+ is present and bound to troponin (keeping the actin binding sites exposed) and sufficient ATP is available, the cycle of cross-bridge formation, power stroke, and detachment will repeat multiple times.
      • Each cycle pulls the thin filament a little further toward the M line.
    9. Sarcomere Shortening:
      • With each power stroke, the thin filaments slide further inward.
      • This sliding action shortens the sarcomere (the distance between Z discs).
      • As all the sarcomeres in a myofibril shorten simultaneously, the entire myofibril shortens, which in turn causes the entire muscle fiber and ultimately the entire muscle to shorten, generating force and producing movement.
    Visualizing the Change during Contraction:
    • Z discs: Move closer together.
    • I bands: Shorten (may disappear in maximal contraction).
    • H zone: Shortens (may disappear in maximal contraction).
    • A band: Remains the same length (myosin filaments don't shorten).
    This repetitive cycle of binding, pulling, and detaching is the fundamental mechanism behind all skeletal muscle contractions.
    Roles of actin, myosin, tropomyosin, and troponin in muscle contraction.

    These four proteins are the molecular machinery that directly drives and regulates muscle contraction.

    1. Actin (Thin Filament Component):
      • Structure: Actin forms the "backbone" of the thin filaments. It's a globular protein (G-actin) that polymerizes to form long, fibrous strands (F-actin), which then twist together into a double helix.
      • Role in Contraction: Actin contains the active (myosin-binding) sites. It is the protein that the myosin heads attach to and pull on during the power stroke. Actin essentially provides the "track" along which myosin travels.
      • Key Action: Binds to myosin heads to form cross-bridges.
    2. Myosin (Thick Filament Component):
      • Structure: Myosin is a large motor protein that makes up the thick filaments. Each myosin molecule has a long tail and two globular heads. The heads contain an actin-binding site and an ATPase (enzyme that breaks down ATP) site.
      • Role in Contraction: Myosin is the "motor" protein. Its heads bind to actin, pivot (power stroke) to pull the actin filament, and then detach. The ATPase activity in the heads hydrolyzes ATP, providing the energy for these movements.
      • Key Action: Forms cross-bridges with actin, pulls actin filaments, hydrolyzes ATP for energy.
    3. Tropomyosin (Regulatory Protein of Thin Filament):
      • Structure: A rod-shaped protein that spirals around the actin filament, covering the active (myosin-binding) sites on the actin molecules in a relaxed muscle.
      • Role in Contraction: Its primary role is to block the myosin-binding sites on actin in a relaxed muscle. This prevents myosin from binding to actin and initiating contraction when the muscle is not stimulated.
      • Key Action: Blocks actin's active sites, preventing contraction in the absence of calcium.
    4. Troponin (Regulatory Protein of Thin Filament):
      • Structure: A complex of three globular polypeptides, each with a specific function:
        • TnI (inhibitory): Binds to actin, holding the troponin-tropomyosin complex in place.
        • TnT (tropomyosin-binding): Binds to tropomyosin, helping to position it on the actin filament.
        • TnC (calcium-binding): Binds to calcium ions (Ca2+).
      • Role in Contraction: Troponin is the calcium sensor that initiates the unblocking of actin. When calcium ions become available (released from the sarcoplasmic reticulum), they bind to the TnC subunit. This binding causes a conformational change in troponin, which then pulls tropomyosin away from the myosin-binding sites on actin.
      • Key Action: Binds calcium, causing tropomyosin to move off the actin binding sites, thereby allowing myosin to bind.
    How they interact during a full cycle:
    • Relaxed: Tropomyosin (held by troponin) blocks actin's binding sites. Myosin cannot bind.
    • Stimulated (Ca2+ present): Ca2+ binds to troponin. Troponin changes shape, pulling tropomyosin away from actin's binding sites.
    • Contraction: Myosin heads bind to exposed actin sites, perform the power stroke, and pull the actin filament.
    • Relaxation (Ca2+ removed): Ca2+ detaches from troponin. Troponin returns to its original shape, allowing tropomyosin to once again cover the actin binding sites. Myosin detaches, and the muscle relaxes.
    These four proteins work in a highly coordinated fashion, driven by the presence or absence of calcium ions, to control the fundamental process of muscle contraction and relaxation.
    Events at the neuromuscular junction (NMJ)

    The neuromuscular junction (NMJ) is the specialized synapse where a motor neuron communicates with a skeletal muscle fiber. It's the critical link that translates a nerve impulse into a muscle action potential.

    Here's the sequence of events at the NMJ:

    1. Action Potential Arrives at the Axon Terminal: A nerve impulse, or action potential (AP), travels down the motor neuron axon and reaches the axon terminal (also called the synaptic knob or terminal bouton), which is the enlarged end of the motor neuron.
    2. Voltage-Gated Calcium Channels Open:
      • The arrival of the action potential at the axon terminal depolarizes the membrane, opening voltage-gated calcium (Ca2+) channels in the presynaptic membrane (the membrane of the axon terminal).
      • Ca2+ ions, which are in higher concentration outside the cell, rush into the axon terminal.
    3. Acetylcholine (ACh) Release:
      • The influx of Ca2+ into the axon terminal triggers the fusion of synaptic vesicles (which contain the neurotransmitter acetylcholine, ACh) with the presynaptic membrane.
      • Acetylcholine (ACh) is then released into the synaptic cleft (the tiny space between the axon terminal and the muscle fiber). This release occurs via exocytosis.
    4. ACh Binds to Receptors on the Motor End Plate:
      • ACh diffuses across the synaptic cleft and binds to specific nicotinic acetylcholine receptors located on the motor end plate of the muscle fiber. The motor end plate is a specialized region of the sarcolemma that is highly folded to increase surface area and contains a high density of these receptors.
      • These receptors are ligand-gated ion channels.
    5. Ion Channels Open and Local Depolarization (End Plate Potential):
      • The binding of ACh to its receptors causes the ligand-gated ion channels to open.
      • These channels allow both sodium ions (Na+) to flow into the muscle fiber and potassium ions (K+) to flow out.
      • However, more Na+ enters than K+ leaves, resulting in a net influx of positive charge. This causes a local depolarization of the motor end plate, called an end plate potential (EPP).
    6. Generation of Muscle Action Potential:
      • If the end plate potential reaches a critical threshold, it triggers the opening of voltage-gated sodium channels in the adjacent sarcolemma (the sarcolemma immediately outside the motor end plate).
      • A rapid influx of Na+ through these voltage-gated channels generates a full-blown muscle action potential.
      • This action potential then propagates (travels) along the entire sarcolemma and deep into the muscle fiber via the T-tubules.
    7. Termination of ACh Activity:
      • To prevent continuous muscle contraction, the effects of ACh must be rapidly terminated. This is achieved by the enzyme acetylcholinesterase (AChE), which is located in the synaptic cleft and on the sarcolemma.
      • AChE breaks down ACh into its components (acetic acid and choline), rendering it inactive.
      • This rapid degradation ensures that each nerve impulse produces only one muscle action potential.
    Summary of Events at the NMJ:
    Nerve AP ➔ Ca2+ Influx into Axon Terminal ➔ ACh Release ➔ ACh Binds to Receptors on Motor End Plate ➔ Ligand-gated Channels Open (Na+ Influx > K+ Efflux) ➔ End Plate Potential ➔ Voltage-gated Na+ Channels Open (if threshold reached) ➔ Muscle Action Potential ➔ ACh broken down by AChE.
    This sequence ensures precise and controlled communication between the nervous system and the musculoskeletal system.
    2. BONES

    The skeletal system, comprised of bones, cartilage, ligaments, and other connective tissues, is far more than just a rigid framework. It's a dynamic and vital organ system with several critical functions.

    Five Main Functions of the Skeletal System:
    1. Support:
      • Description: The skeletal system provides a rigid framework that supports the body's soft tissues and organs. It acts as the internal scaffolding that holds the body upright and maintains its overall shape.
      • Example: Our legs and vertebral column support the weight of the trunk, and the rib cage supports the thoracic wall.
    2. Protection:
      • Description: Bones form protective enclosures for many of the body's vital organs, shielding them from external forces and trauma.
      • Example: The skull protects the brain, the vertebral column protects the spinal cord, and the rib cage protects the heart and lungs.
    3. Movement:
      • Description: Bones serve as levers for muscles. When muscles contract, they pull on bones, causing movement at the joints. The joints themselves act as fulcrums for these levers.
      • Example: The biceps muscle contracts to pull on the forearm bones (radius and ulna), causing the arm to flex at the elbow. Without bones, muscles would have nothing firm to pull against.
    4. Mineral Storage:
      • Description: Bone tissue acts as a reservoir for several important minerals, most notably calcium and phosphate. These minerals are essential for numerous physiological processes, including nerve impulse transmission, muscle contraction, blood clotting, and ATP production.
      • Example: When blood calcium levels drop, calcium can be withdrawn from the bones to restore homeostasis. Conversely, excess calcium can be stored in the bones. This dynamic storage helps maintain mineral balance in the blood.
    5. Hematopoiesis (Blood Cell Formation):
      • Description: Inside certain bones, primarily in the red bone marrow, the process of hematopoiesis occurs. This is the production of all blood cells, including red blood cells, white blood cells, and platelets.
      • Example: In adults, red bone marrow is found in the flat bones (like the sternum, ribs, and hip bones) and the epiphyses of long bones (like the femur and humerus).
    Classification of Bones Based on Their Shape

    Bones come in a variety of shapes and sizes, and their classification by shape often reflects their primary function. There are five main categories:

    1. Long Bones:
      • Description: Characterized by being significantly longer than they are wide. They typically have a shaft (diaphysis) and two expanded ends (epiphyses). They are primarily compact bone with some spongy bone at the ends.
      • Function: Act as levers to aid in movement and support the body's weight.
      • Examples: Femur (thigh bone), Humerus (upper arm bone), Tibia and Fibula (lower leg bones), Radius and Ulna (forearm bones), Phalanges (finger and toe bones).
    2. Short Bones:
      • Description: Roughly cube-shaped, with their length, width, and height being approximately equal. They primarily consist of spongy bone surrounded by a thin layer of compact bone.
      • Function: Provide stability and some movement, often articulating with multiple other bones.
      • Examples: Carpals (wrist bones), Tarsals (ankle bones).
    3. Flat Bones:
      • Description: Thin, flattened, and often curved. They are typically composed of two parallel plates of compact bone, with a layer of spongy bone (diploe) sandwiched between them.
      • Function: Provide broad surfaces for muscle attachment and often protect underlying soft organs.
      • Examples: Cranial Bones (skull bones, e.g., frontal, parietal), Sternum (breastbone), Scapulae (shoulder blades), Ribs.
    4. Irregular Bones:
      • Description: Have complicated, unique shapes that do not fit into the other categories. Their structure is typically a mix of compact and spongy bone.
      • Function: Serve various specialized roles, including protection, support, and providing attachment points for muscles.
      • Examples: Vertebrae (spinal bones), Pelvic Bones (hip bones, e.g., ilium, ischium, pubis), Facial Bones (e.g., sphenoid, ethmoid).
    5. Sesamoid Bones:
      • Description: Small, round, or oval bones that are embedded within tendons, often found at joints. They vary in number among individuals.
      • Function: Act to protect tendons from excessive wear and tear, and can alter the angle of muscle pull, increasing the mechanical advantage of the muscle.
      • Examples: Patella (kneecap) - the largest sesamoid bone. Small sesamoid bones are often found in the tendons of the thumb and big toe.
    Gross Anatomy of a Long Bone

    Long bones, like the femur or humerus, are exemplary for studying bone anatomy due to their distinct and easily identifiable regions.

    1. Diaphysis (Shaft):
      • Description: This is the main, elongated cylindrical shaft of a long bone. It forms the long axis of the bone.
      • Composition: Primarily composed of a thick collar of compact bone that surrounds the medullary cavity.
      • Function: Provides strength and structural support, withstands stresses along the longitudinal axis of the bone.
    2. Epiphyses (Bone Ends):
      • Description: These are the expanded, knob-like ends of a long bone, located at both proximal and distal extremities.
      • Composition: The exterior consists of a thin layer of compact bone, while the interior is filled with spongy (cancellous) bone.
      • Function: Articulate with other bones to form joints; provide an increased surface area for joint stability and muscle attachment.
    3. Metaphyses (Growth Plate Region in growing bone):
      • Description: This is the region where the diaphysis joins the epiphysis. In a growing bone, this area contains the epiphyseal plate (growth plate), a layer of hyaline cartilage where longitudinal bone growth occurs.
      • Composition: Primarily cartilage in growing bones; in adults, after growth has stopped, the epiphyseal plate ossifies and becomes the epiphyseal line, a remnant of the growth plate.
      • Function: Site of longitudinal bone growth during childhood and adolescence.
    4. Articular Cartilage:
      • Description: A thin layer of hyaline cartilage that covers the articular (joint) surfaces of the epiphyses.
      • Composition: Hyaline cartilage, a smooth, slippery tissue.
      • Function: Reduces friction and absorbs shock at movable joints, allowing for smooth movement between bones. It lacks a perichondrium and is avascular (receives nutrients from synovial fluid).
    5. Periosteum:
      • Description: A tough, fibrous membrane that covers the outer surface of the entire bone, except where articular cartilage is present. It is richly supplied with blood vessels, lymphatic vessels, and nerves.
      • Composition:
        • Outer fibrous layer: Dense irregular connective tissue, providing protection and attachment for tendons and ligaments.
        • Inner osteogenic layer: Contains osteoprogenitor cells (bone stem cells), osteoblasts (bone-forming cells), and osteoclasts (bone-resorbing cells).
      • Function: Protects the bone. Serves as an attachment point for tendons and ligaments. Plays a crucial role in bone growth in width (appositional growth) and in bone repair. Contains nerve fibers, which makes bone pain very acute.
    6. Endosteum:
      • Description: A delicate connective tissue membrane that lines the inner surfaces of the medullary cavity, covering the trabeculae of spongy bone and lining the canals that pass through compact bone.
      • Composition: Contains osteoprogenitor cells, osteoblasts, and osteoclasts.
      • Function: Involved in bone growth, repair, and remodeling.
    7. Medullary Cavity (Marrow Cavity):
      • Description: The hollow central cavity within the diaphysis of long bones.
      • Composition: In adults, it contains yellow bone marrow, which is primarily adipose (fat) tissue, serving as an energy reserve. In infants and children, and in some adult bones (like the sternum and hip bones), it contains red bone marrow, which is the primary site of hematopoiesis (blood cell formation).
      • Function: Stores bone marrow.
    Compact (Cortical) Bone and Spongy (Cancellous/Trabecular) Bone

    All bones are made of both compact and spongy bone, but their relative proportions and arrangements differ depending on the bone's shape and function.

    Feature Compact Bone Spongy Bone
    Appearance Dense, solid, smooth Porous, network-like, trabecular
    Structural Unit Osteon (Haversian System) Trabeculae (no osteons)
    Location Outer layer of all bones; diaphysis of long bones Interior of bones; epiphyses of long bones
    Marrow Medullary cavity (in diaphysis) Spaces between trabeculae
    Weight Heavier Lighter
    Function Strength, protection, withstands stress Lightness, marrow storage, stress distribution
    Microscopic Anatomy of Compact Bone

    The microscopic structure of compact bone is highly organized around its fundamental unit: the osteon.

    1. Osteon (Haversian System): The primary structural and functional unit of compact bone. It is an elongated cylinder oriented parallel to the long axis of the bone, acting like a tiny weight-bearing pillar.
    2. Central Canal (Haversian Canal): Runs through the core of each osteon. Contains blood vessels (arterioles and venules), nerve fibers, and lymphatic vessels that supply nutrients to and remove waste from the bone cells.
    3. Lamellae: Concentric rings (like growth rings on a tree trunk) of bone matrix that surround the central canal.
      • Concentric Lamellae: Form the main bulk of the osteon.
      • Interstitial Lamellae: Found between intact osteons.
      • Circumferential Lamellae: Extend around the entire circumference of the diaphysis.
    4. Lacunae: Small, hollow spaces or cavities located at the junctions between the lamellae. Each lacuna houses a single mature bone cell called an osteocyte.
    5. Canaliculi: Tiny, hair-like canals that radiate out from the lacunae, connecting them to each other and to the central canal. They allow osteocytes to communicate and facilitate transport of nutrients.
    6. Osteocytes: Mature bone cells, derived from osteoblasts, that reside in the lacunae. They maintain the bone matrix and act as stress sensors.
    7. Osteoblasts: Bone-forming cells found on the surface of bone tissue. They synthesize and secrete the organic components of the bone matrix (osteoid).
    8. Osteoclasts: Large, multinucleated cells found on bone surfaces. They resorb (break down) bone matrix by secreting acids and enzymes.
    Organic and Inorganic Components of Bone Matrix
    1. Organic Components (Approx. 35% of bone mass):
    • Primary Substance: Osteoid – the unmineralized organic part of the matrix.
    • Composition:
      • Collagen fibers (Type I): Provide flexibility and tensile strength (resist stretching).
      • Ground substance: A gel-like material contributing to resilience.
    • Contribution to Bone Properties: Flexibility and Tensile Strength.
    2. Inorganic Components (Approx. 65% of bone mass):
    • Primary Substance: Mineral salts, primarily calcium phosphates.
    • Composition:
      • Hydroxyapatite: Calcium phosphate crystals that are extremely hard and dense.
      • Other mineral salts: Calcium carbonate, magnesium phosphate, etc.
    • Contribution to Bone Properties: Hardness and Compressional Strength (resist squeezing).
    Analogy for Bone Structure:
    Think of reinforced concrete:
    - The steel rebar provides the tensile strength and flexibility (like collagen fibers).
    - The concrete provides the compressional strength and hardness (like hydroxyapatite crystals).
    Intramembranous and Endochondral Ossification

    Ossification (osteogenesis) is the process of bone tissue formation.

    Feature Intramembranous Ossification Endochondral Ossification
    Initial Structure Fibrous connective tissue membrane Hyaline cartilage model
    Bones Formed Flat bones of skull, mandible, clavicles Most other bones (long, short, irregular bones)
    Mechanism Bone forms directly from mesenchymal tissue Cartilage model is replaced by bone tissue
    Growth Plates Not directly involved Involves epiphyseal plates for longitudinal growth
    Process of Bone Remodeling

    Bone remodeling is a lifelong process involving bone resorption (removal) and bone formation. It occurs in packets called basic multicellular units (BMUs).

    1. Resorption Phase (Osteoclast Activity): Osteoclasts migrate to the bone surface, create a sealed compartment, and secrete lysosomal enzymes and hydrochloric acid to dissolve the bone matrix.
    2. Reversal Phase: Osteoclasts undergo apoptosis or detach. Macrophages clean up debris.
    3. Formation Phase (Osteoblast Activity): Osteoblasts arrive, secrete osteoid, and mineralization occurs. Osteoblasts become trapped and differentiate into osteocytes.
    Key Hormones Involved in Calcium Homeostasis
    Hormone Source Stimulus for Release Effect on Bone Overall Effect on Blood Calcium
    PTH Parathyroid Glands Low blood Ca²⁺ Stimulates osteoclast activity Increases
    Calcitonin Thyroid Gland (C cells) High blood Ca²⁺ Inhibits osteoclast activity Decreases
    Stages of Bone Fracture Repair
    1. Hematoma Formation (Immediate - Days 1-5): Blood vessels rupture, forming a clot (hematoma). Inflammation initiates.
    2. Fibrocartilaginous Callus Formation (Days 3-21): New capillaries grow. Fibroblasts and chondroblasts create a soft callus of collagen and cartilage to bridge bone ends.
    3. Bony Callus Formation (Weeks 3-4): Osteoblasts convert the soft callus into a hard, bony callus (spongy bone).
    4. Bone Remodeling (Months to Years): Excess material is removed by osteoclasts. Compact bone is laid down to restore the original shape and strength.
    3. JOINTS (ARTICULATIONS)

    Joints are the sites where two or more bones meet. They bind bones together and allow mobility.

    Structural Classification
    1. Fibrous Joints:
    • Bones joined by dense fibrous connective tissue. No joint cavity.
    • Most are immovable (synarthrotic).
    • Subtypes: Sutures (skull), Syndesmoses (tibia/fibula), Gomphoses (teeth).
    2. Cartilaginous Joints:
    • Bones united by cartilage. No joint cavity.
    • Allow limited movement (amphiarthrotic) or are immovable.
    • Subtypes: Synchondroses (epiphyseal plates), Symphyses (pubic symphysis).
    3. Synovial Joints:
    • Bones separated by a fluid-filled joint cavity.
    • All are freely movable (diarthrotic).
    • Examples: Shoulder, elbow, hip, knee.
    Features of a Synovial Joint
    1. Articular Cartilage: Hyaline cartilage covers bone ends. Reduces friction, absorbs shock.
    2. Joint (Synovial) Cavity: Potential space filled with synovial fluid.
    3. Articular Capsule: Double-layered (Outer fibrous layer, Inner synovial membrane).
    4. Synovial Fluid: Viscous fluid for lubrication, nutrient distribution, and shock absorption.
    5. Reinforcing Ligaments: Connect bone to bone, providing stability.
    6. Nerves and Blood Vessels: Detect pain/position and supply nutrients.

    Additional Structures: Articular Discs (Menisci), Bursae, and Tendon Sheaths.

    Types of Movements Allowed by Synovial Joints
    • Gliding (Translational): Flat surfaces slip over one another (e.g., wrist bones).
    • Angular: Flexion, Extension, Hyperextension, Abduction, Adduction, Circumduction.
    • Rotation: Turning of a bone around its own long axis.
    • Special Movements: Supination/Pronation, Dorsiflexion/Plantar Flexion, Inversion/Eversion, Protraction/Retraction, Elevation/Depression, Opposition.
    Major Types of Synovial Joints
    Joint Type Articulating Surfaces Movement Type Axes Examples
    Plane Flat/slightly curved Gliding Nonaxial Intercarpal, vertebral facets
    Hinge Cylinder in trough Flexion/Extension Uniaxial Elbow, knee, fingers
    Pivot Rounded in ring Rotation Uniaxial Proximal radioulnar, atlantoaxial
    Condylar Oval condyle in depression Flexion/Ext, Abd/Add Biaxial Wrist, knuckles
    Saddle Saddle-shaped Flexion/Ext, Abd/Add Biaxial Carpometacarpal of thumb
    Ball-and-Socket Spherical head in cup Universal movement Multiaxial Shoulder, hip
    Main Joint Disorders and Diseases
    1. Arthritis:
      • Osteoarthritis (OA): Wear-and-tear, degenerative. Breakdown of articular cartilage.
      • Rheumatoid Arthritis (RA): Autoimmune. Immune system attacks synovial membranes.
      • Gouty Arthritis (Gout): Uric acid crystals deposit in joints.
    2. Bursitis: Inflammation of a bursa.
    3. Tendonitis: Inflammation of a tendon.
    4. Sprains: Ligaments stretched or torn.
    5. Dislocations: Bones forced out of alignment.
    DISEASES AFFECTING SKELETAL MUSCLES
    1. Muscular Dystrophies
    • Description: Genetic diseases characterized by progressive weakness and degeneration of skeletal muscles due to lack of specific proteins (like dystrophin).
    • Types:
      • Duchenne (DMD): Severe, early onset, primarily affects males.
      • Becker (BMD): Milder, later onset.
    2. Myasthenia Gravis
    • Description: Autoimmune disease characterized by fluctuating muscle weakness and fatigue.
    • Pathophysiology: Antibodies attack acetylcholine receptors at the NMJ.
    • Symptoms: Drooping eyelids, double vision, difficulty swallowing.
    3. Fibromyalgia
    • Description: Chronic disorder characterized by widespread musculoskeletal pain, fatigue, and sleep issues.
    4. Muscle Spasms/Cramps
    • Causes: Dehydration, electrolyte imbalance, fatigue, nerve compression.
    5. Strains (Pulled Muscles)
    • Definition: Injury to a muscle or tendon (overstretched or torn).
    • Grading: Mild, Moderate, Severe (rupture).
    6. Rhabdomyolysis
    • Description: Rapid breakdown of damaged skeletal muscle tissue releasing myoglobin into the bloodstream.
    • Clinical Implication: Myoglobin is toxic to kidneys, leading to acute kidney injury.
    7. Compartment Syndrome
    • Description: Painful condition caused by pressure buildup within a confined muscle compartment.
    • Intervention: Fasciotomy (surgical emergency) to relieve pressure.

    DISEASES AFFECTING SKELETAL MUSCLES

    MYASTHENIA GRAVIS

    anatomy myasthenia-gravis

    This is another autoimmune disease predominantly affecting females. There is un usual fatigue due to lack of acetylcholine receptor at the myoneural junctions which impair muscle contraction.

    Signs and symptoms
    • The onset is gradual.
    • Excessive fatigue particularly towards end of the day with drooping of eye lids
    • Frequent falls
    • Difficult in chewing and swallowing
    • Involvement of respiratory muscles may lead to respiratory failure
    • A weak cough reflex may lead to accumulation of secretions and infections
    Treatment and management
    1. Short acting anticholine esterase drugs like edrophonium
    2. Long acting ant cholinesterase drugs e.g. neostigmine or pyrisostigmine
    3. Thymectomy and steroids also provide relief.
    4. Exercises

    MYOSITIS (MYOPATHY)

    Myositis or myopathy refers to a group of primary diseases of muscles; Myositis (inflammation of muscles) can be genetically diseases.

    Progressive muscular atrophy is a group of hereditary disorder characterized by progressive delegation of muscles without involvement of bones.

    The wasting and weakness of muscles is symmetrically without any sensory loss. The affected muscles are large, firm but weak.

    The child walks with a waddling giant like that of the duck

    When rising from a supine lying position, in bed, the child rolls on his face (prone position) and then uses his arms to push his body up (tripod sign). Death in second decade is usual due to involvement of respiratory muscles.

    Fibrositis – rheumatism (fibrocystic)

    Fibrositis and muscular Rheumatism are terms used to describe recurring pains, stiffness in the muscles or the back, various parts of the body being involved from time to time.

    The disease does not progress and such vague symptoms are attributable to emotional stress.

    Treatment

    Is usually symptomatic, heat and massages may be helpful and aspirin or one of the NSAIDS can be prescribed.

    Anatomy and Physiology of the Musculo-skeletal System Read More »

    Hydrocele

    Hydrocele

    HYDROCELE

    A hydrocele is a fluid collection within the tunica vaginalis of the scrotum or along the spermatic cord.

    A hydrocele is accumulation of serous fluid within the tunica vaginalis that produces swelling in the inguinal region or scrotum.

    It often presents as painless swelling in the scrotum. Provided there is no hernia present, hydrocoeles below the age of 1 year usually resolve spontaneously.

     

    In infants it is usually as a  result of incomplete closure of the processus vaginalis. It may or may not be associated with inguinal hernia. In older boys and men it may be idiopathic.

     

    Anatomy of the Scrotum.

    Anatomy of the Scrotum.

    Scrotum, is a thin external sac of skin that is divided into two compartments; each compartment contains one of the two testes, the glands that produce sperm, and one of the epididymis, where the sperm is stored.

    • The function of the scrotum is to protect the testes and to keep them at a temperature below the normal body temperature. The scrotum thus protrudes from the body wall. When contracted, it conserves heat; while relaxed it is smooth and elongated, permitting the circulation of air that effects cooling. The relatively cool temperature of the scrotum is thought to be important for the production of viable sperm.
    • A vertical septum of subcutaneous tissue in the center divides it into two parts, each containing one testis.
    • Smooth muscle fibers, called the dartos muscle, in the subcutaneous tissue contract to give the scrotum its wrinkled appearance. When these fibers are relaxed, the scrotum is smooth.
    • The cremaster muscle consists of skeletal muscle fibers and controls the position of the scrotum and testes. When it is cold or a man is sexually aroused, this muscle contracts to pull the testes closer to the body for warmth.
    Etiology/Causes of a Hydrocele

    Etiology/Causes of a Hydrocele

    The causes of hydrocele can be categorized into four main factors:

    • Excessive production of fluid within the sac: This occurs when there is an overproduction of fluid within the sac surrounding the testicle e.g. in acute/chronic epididymo-orchitis.
    • Defective absorption of fluid: This refers to a situation where the normal absorption of fluid within the sac is impaired, leading to the accumulation of fluid e.g. in testicular tumors, Hematocele.
    • Interference with lymphatic drainage of scrotal structures: Certain conditions, such in case of elephantiasis, torsion of testis, can disrupt the normal drainage of lymphatic fluid from the scrotal area, resulting in the development of a hydrocele.
    • Connection with a hernia of the peritoneal cavity: In the congenital variety, a hydrocele may be associated with a hernia of the peritoneal cavity, leading to the presentation of a hydrocele of the cord e.g. in patent tunica vaginalis.
    Risk Factors
    • Direct Injury or inflammation of the testes
    • Prematurity
    • Testicular tumors
    • Infections in the testicle or the epididymitis

    Pathophysiology

    • During the seventh month of fetal development, the testicles move from the abdomen into the scrotum.
    • When the testicle travels downward, a remnant piece of peritoneum wrapped around the testicle, called the  tunica vaginalis and this allows fluid present in the abdominal cavity to surround the testicle.
    • This sac usually closes before birth, preventing additional fluid from going from the abdomen into the scrotum, and the fluid is gradually absorbed within the first year of life.
    • When the sac remains open tunica vaginalis is patent and connects with the general peritoneal cavity leading to development of a communicating Hydrocele.
    • The communication is usually too small to allow herniation of intra-abdominal contents. Digital pressure on the Hydrocele does not usually empty it, but the Hydrocele fluid may drain into the peritoneal cavity when the child is lying down.
    types of hydrocele

    Types of hydrocele

    Non-communicating Hydrocele

    • Here there is no connection between the abdominal cavity and the sac around the testicle in the scrotum.
    • This type of Hydrocele is often found in newborns and these often resolve or go away over time.
    • It may take up to one year for this to happen, but as long as the swelling is decreasing, it can be safely observed.

    Communicating Hydrocele

    • Here the sac does not close and this means that the fluid around the testicle can flow back up into the abdomen.
    • It is noticeable that the Hydrocele looks smaller early in the day and larger in the evening; the pressure changes cause the fluid to flow back into the abdomen.
    CLASSIFICATIONS OF HYDROCELES

    CLASSIFICATIONS OF HYDROCELES

     Primary hydrocele: A primary hydrocele is characterized by a soft, painless swelling that is usually large in size and makes it difficult to feel the testis. Transillumination can demonstrate the presence of fluid. Although these hydroceles are often asymptomatic, their large size can cause inconvenience and, if left untreated, may lead to atrophy of the testis due to compression or obstruction of blood supply. Early diagnosis during a complete physical examination may reveal small hydroceles in which the testis can be easily palpated within a lax hydrocele. However, in cases where the hydrocele sac is dense, ultrasound imaging is necessary to visualize the testis and reveal any underlying abnormalities. Primary hydroceles are usually painless, similar to testicular tumors.

    A common method of diagnosing a primary  hydrocele is through transillumination, where shining a strong light through the enlarged scrotum will pass light in the case of a primary hydrocele, while a tumor will not, except in the case of a malignancy with reactive hydrocele.

    Congenital Hydrocele:

    Its subdivided into four types.

    Congenital Hydrocele:

    • Occurs when the processus vaginalis, a tube-like structure connecting the abdomen to the scrotum, remains open and communicates with the peritoneal cavity.
    • This allows peritoneal fluid to move, but the opening is usually too small to allow intra-abdominal contents to herniate through.
    • When pressure is applied to the hydrocele, it usually does not empty, but the fluid may drain into the peritoneal cavity when the individual is lying down.
    • The swelling cannot be felt above the inguinal ring, resembling a hernia.

    Infantile Hydrocele:

    • Occurs when the processus vaginalis becomes closed at the level of the deep inguinal ring, but the portion beyond it remains open, allowing fluid to accumulate.
    • This condition is not exclusive to infants and can also occur in adults.
    • The swelling cannot be felt above the inguinal ring.

    Encysted Hydrocele of the Cord:

    • In this type, both the proximal and distal portions of the processus vaginalis become closed off, while the central portion remains open, leading to the accumulation of fluid within it.
    • This results in a smooth oval swelling near the spermatic cord, which can be mistaken for an inguinal hernia.
    • When the testis is gently pulled downwards, the swelling moves downwards and becomes less mobile.

    Vaginal Hydrocele (in females):

    • In females, a related condition known as a “hydrocele of the canal of Nuck” can occur.
    • This occurs when the canal of Nuck, the equivalent structure to the processus vaginalis in males, fails to close properly, leading to the development of a hydrocele.
    • This condition may present as a swelling in the groin or labia majora.

    Secondary hydrocele: A secondary hydrocele arises from an underlying condition, such as infections (e.g., filariasis, tuberculosis of the epididymis, syphilis), trauma or injury (e.g., post herniorrhaphy hydrocele or malignancy).

    •  Secondary hydroceles are generally smaller, with the exception of those caused by filariasis, which can lead to very large hydroceles. 
    • Testicular infarction, microlithiasis of the testicle, and lithiasis of tunica vaginalis can also contribute to the development of secondary hydroceles.
    • Testicular diseases, including cancer, trauma (e.g., hernia), and orchitis (inflammation of the testis), can result in secondary hydroceles. They may also occur in infants undergoing peritoneal dialysis. It is important to note that a hydrocele is not a cancerous condition, but clinical evaluation is needed if a testicular tumor is suspected, as there are no documented cases associating hydroceles with testicular cancer in the world literature.

    Secondary hydroceles are most commonly linked with acute or chronic epididymo-orchitis and are also observed with testicular torsion and certain testicular tumors. Commonly, a secondary hydrocele is soft and moderately sized, and the underlying testis can be felt. The secondary hydrocele usually resolves when the primary condition is treated.

    Other predisposing factors for secondary hydroceles include acute/chronic epididymo-orchitis, testicular torsion, testicular tumors, hematocele, filarial hydrocele, post herniorrhaphy, and hydrocele of a herniated sac.

    Diagnosis and Investigations

    Through Clinical Presentation: A primary hydrocele is described as having the following characteristics/presentations.

    Clinical Presentation.
    1. Fluctuating Size: The swollen area may vary in size, being smaller in the morning and larger later in the day. This fluctuation is known as a positive fluctuation test.
    2. Discomfort: Patients may experience discomfort due to the heaviness of the swollen scrotum.
    3. Scrotal Swelling: Hydroceles can present as painless unilateral or bilateral scrotal swelling.
    4. Transillumination: When examined with a focused beam of light, the scrotum transilluminates, displaying a uniform glow without any internal shadows. Transillumination positive.
    5. Impulse on Coughing: In most cases, the impulse on coughing is negative, although it may be positive in congenital hydroceles.
    6. Reducibility: Hydroceles are usually non-reducible, meaning they cannot be easily pushed back into the abdomen. Reducibility absent.
    7. Palpable Fullness: Upon examination, hydroceles present as a soft, non-tender fullness within the scrotum, which can be felt. Testis cannot be palpated separately. (exception – funicular hydrocele, encysted hydrocele)
    Investigations and Diagnostic Findings
    • Laboratory studies. laboratory studies may be indicated to exclude other surgical or medical conditions that may be in the differential diagnosis.
    • Ultrasonography. Ultrasonography provides excellent detail of the testicular parenchyma; spermatoceles can be clearly distinguished from hydroceles on sonograms, a testicular tumor can also be identified.
    • Duplex ultrasonography. Duplex studies  provide  information regarding testicular blood flow when a hydrocele may be associated with chronic torsion.
    • Plain abdominal radiography. Plain radiography may be useful for distinguishing an acute hydrocele from a hernia.

    Management and Treatment of Hydroceles

    1. Observation for Infants: Most hydroceles appearing in the first year of life often resolve without treatment and therefore require only observation.
    2. Surgical Removal: Hydroceles that persist after the first year or occur later in life may require surgical removal through a procedure known as hydrocelectomy, as they have little tendency towards regression. The method of choice for surgical removal is an open operation under general or spinal anesthesia for adults, and general anesthesia for children. Local infiltration anesthesia is not recommended due to its inability to relieve abdominal pain caused by traction on the spermatic cord.
    3. Aspiration Precautions: If a testicular tumor is suspected, a hydrocele should not be aspirated, as this can lead to the dissemination of malignant cells. Ultrasonography should be used to clinically exclude the presence of a tumor. If no tumor is present, the hydrocele fluid can be aspirated with a needle and syringe.
    4. Post-operative Care: After surgery, the scrotum should be supported, and ice bags can be used to alleviate pain. Regular changes of surgical dressings, observation of drainage, and monitoring for complications are necessary to prevent re-operation.
    5. Complications Management: In cases with the presence of complications, open operation with or without orchiectomy may be preferred, depending on the severity of the complications.
    6. Jaboulay’s Procedure: After aspiration of a primary hydrocele, fluid reaccumulates over the following months, necessitating periodic aspiration or operation. For younger patients, operation is usually preferred, while the elderly or unfit can have aspirations repeated whenever the hydrocele becomes uncomfortably large. Sclerotherapy is an alternative method, involving the injection of 6% aqueous phenol with 1% lidocaine for analgesia, which can inhibit reaccumulation. Multiple treatments may be necessary.
    7. Aspiration and Sclerosing Agents: Aspiration of the hydrocele contents and injection with sclerosing agents, sometimes with tetracyclines, can be effective but is often very painful. However, these alternative treatments are generally regarded as unsatisfactory due to the high incidence of recurrences and the frequent necessity for repetition of the procedure.

    Surgical Management.

    The surgical management of hydroceles can be approached in several ways, including inguinal, scrotal, and sclerotherapy methods.

    • Inguinal Approach: This method involves ligation of the processus vaginalis high within the internal inguinal ring and is mostly the preferred procedure for pediatric hydroceles. In cases where a testicular tumor is detected on testicular ultrasonography, an inguinal approach with high control/ligation of the cord structures is necessary.
    • Scrotal Approach: The scrotal approach includes excision or eversion and suturing of the tunica vaginalis and is recommended for chronic noncommunicating hydroceles. However, this approach should be avoided if there is any suspicion of underlying malignancy.
    • Sclerotherapy: An additional adjunctive, if not definitive procedure is scrotal aspiration and sclerotherapy of the scrotum using tetracycline or doxycycline solutions. It’s important to note that recurrence after sclerotherapy is common, as is significant pain and epididymal obstruction, making this treatment a last resort in poor surgical candidates with symptomatic hydroceles and in men in whom fertility is no longer an issue.
    • Hydrocelectomy: This surgical procedure aims to excise the hydrocele sac or reconfigure the remnant of the tunica vaginalis to allow lymphatic drainage via scrotal lymphatics. This method may be considered in cases where other surgical approaches have not been successful.
    Nursing Interventions

    The nursing interventions appropriate for the child are:

    1. Health education. Provide preoperative education, including a visit with OR personnel before surgery when possible. Discuss anticipated things that may concern the patient, such as masks, lights, IVs, BP cuff, electrodes, the feel of oxygen cannula or mask on nose or face, autoclave and suction noises, and the possibility of the child crying. Additionally, involve the child in age-appropriate discussions about the surgical procedure and encourage the expression of feelings and concerns.
    2. Pre, Intra and Post operative care:

    Pre-Operative Care:

    • Patient Assessment: Conduct a thorough assessment of the patient’s medical history, current health status, and any allergies. This includes obtaining baseline vital signs, laboratory tests, and diagnostic imaging as required.
    • Education: Provide the patient with information about the upcoming surgery, including preoperative instructions, potential risks, and what to expect during the recovery period.
    • Medication Management: Review the patient’s current medications and ensure appropriate management, including any required adjustments or discontinuations prior to surgery.
    • Psychological Support: Offer emotional support and address any anxiety or concerns the patient may have about the surgery.
    • Preparing the Surgical Site: Ensure the surgical site is properly prepared and sterile, including hair removal if necessary.

    Intra-Operative Care:

    • Patient Positioning: Assist with positioning the patient on the operating table to ensure optimal access for the surgical team.
    • Monitoring: Continuously monitor the patient’s vital signs, including heart rate, blood pressure, oxygen saturation, and ECG, and respond to any changes promptly.
    • Sterile Technique: Assist the surgical team in maintaining a sterile environment and provide the necessary equipment and supplies as required.
    • Anesthesia Management: Collaborate with the anesthesiologist to ensure the patient’s comfort and safety during the administration of anesthesia.
    • Communication: Facilitate effective communication between the surgical team and other healthcare professionals, and provide support and reassurance to the patient throughout the procedure.

    Post-Operative Care:

    • Recovery Monitoring: Monitor the patient’s vital signs, pain levels, and consciousness as they recover from anesthesia.
    • Pain Management: Administer prescribed pain medications and assess the patient’s pain levels regularly, providing comfort measures as needed.
    • Wound Care: Monitor the surgical site for any signs of infection or complications, and provide appropriate wound care as directed by the surgical team.
    • Mobilization: Encourage early mobilization and assist the patient with repositioning to prevent complications such as deep vein thrombosis and pressure ulcers.
    • Patient Education: Provide the patient and their family with postoperative instructions, including information on medication management, activity restrictions, and signs of potential complications.
    • Emotional Support: Offer emotional support to the patient and their family, addressing any concerns and providing reassurance during the recovery process.

    3. Reduce risk for infection. Verify that preoperative skin, scrotal, and bowel cleansing procedures have been completed as needed depending on the specific surgical procedure. Apply a sterile dressing to prevent environmental contamination of the fresh wound. Administer antibiotics as indicated and ensure proper hand hygiene and aseptic techniques during care.

    4. Monitor fluid volume. Measure and record intake and output, including tubes and drains. Monitor vital signs, noting changes in blood pressure, heart rate and rhythm, and respirations. Gradually resume oral intake as indicated, ensuring the child remains well-hydrated.

    5. Relief from pain. Regularly evaluate the child’s pain, noting its characteristics, location, and intensity on a 0–10 scale. Assess and address any anxiety or fear related to the procedure. Identify and address any causes of discomfort other than the operative procedure. Provide additional comfort measures, such as backrubs, heat or cold applications, and age-appropriate distraction techniques. Administer pain medication as prescribed and assess the effectiveness of pain relief measures. Encourage the child to communicate their pain and comfort needs.

    6. Promote mobility. Encourage early mobilization and ambulation as tolerated postoperatively to prevent complications such as deep vein thrombosis and promote circulation and respiratory function.

    7. Monitor for complications. Assess for signs of postoperative complications such as infection, bleeding, or adverse reactions to anesthesia or medications. Monitor surgical incision sites for signs of inflammation, drainage, or other abnormalities.

    8. Encourage adequate nutrition. Provide the child with a balanced and nutritious diet to support the healing process. Offer small, frequent meals if the child’s appetite is reduced and encourage fluid intake to prevent dehydration.

    9. Collaborate with the interdisciplinary team. Work closely with the surgical team, child life specialists, and other healthcare professionals to ensure comprehensive care for the child. Communicate any concerns or changes in the child’s condition promptly.

    10. Provide age-appropriate activities. Offer age-appropriate activities and play opportunities to promote the child’s emotional well-being and assist with their recovery. Arrange for appropriate entertainment and distraction to alleviate anxiety and boredom during hospitalization.

    Complications of Hydroceles

    Complications of Hydroceles

    1. Hematocele Formation: Hematocele, a collection of blood within the sac, can occur due to spontaneous bleeding into the sac or as a result of trauma. If not drained, it may lead to the formation of a clotted hematocele.
    2. Calcification of the Sac: The sac may calcify, leading to the formation of a clotted hydrocele, often resulting from a slow, painless ooze of blood into the tunica vaginalis. This can make it difficult to differentiate from a testicular tumor.
    3. Postherniorrhaphy Hydrocele: A relatively rare complication of inguinal hernia repair, possibly due to disruption of the lymphatics draining the scrotal contents.
    4. Infection and Pyocele: Infection may lead to the formation of pyocele, a collection of pus within the sac.
    5. Testicular Atrophy: Long-standing cases of hydrocele may lead to atrophy of the testis.
    6. Rupture: Rupture of the sac may occur due to trauma or spontaneously. In some cases, absorption of the fluid may lead to a cure.
    7. Herniation: In long-standing cases, the hydrocele sac may herniate through the dartos muscle.

    Test Questions

    1. Which of the following applies to the defect emerging from residual peritoneal fluid confined within the lower segment of the processus vaginalis?

    A. Inguinal hernia
    B. Incarcerated hernia
    C. Communicating hydrocele
    D. Noncommunicating hydrocele

    1. Answer: D. Noncommunicating hydrocele

    • Option D: With a noncommunicating hydrocele, most commonly seen at birth, residual peritoneal fluid is trapped within lower segment of the processus vaginalis (the tunica vaginalis). There is no communication with the peritoneal cavity and the fluid usually is absorbed during the first months after birth.
    • Option A: An inguinal hernia arises from the incomplete closure of the processus vaginalis leading to the descent of an intestinal portion.
    • Option B: Incarceration occurs when the hernia becomes tightly caught in the hernia sac.
    • Option C: A communicating hydrocele usually is associated with an inguinal hernia because the processus vaginalis remains open from the scrotum to the abdominal cavity.

    2. An infant with hydrocele is seen in the clinic for a follow-up visit at 1 month of age. The scrotum is smaller than it was at birth, but fluid is still visible on illumination. Which of the following actions is the physician likely to recommend?

    A. Massaging the groin area twice a day until the fluid is gone.
    B. Referral to a surgeon for repair.
    C. No treatment is necessary; the fluid is reabsorbing normally.
    D. Keeping the infant in a flat, supine position until the fluid is gone.

     

    2. Answer: C. No treatment is necessary; the fluid is reabsorbing normally.

    • Option C: A hydrocele is a collection of fluid in the scrotum that results from a patent tunica vaginalis; illumination of the scrotum with a pocket light demonstrates the clear fluid; in most cases, the fluid reabsorbs within the first few months of life and no treatment is necessary.
    • Options A and D: Massaging the area or placing the infant in a supine position would have no effect.
    • Option B: Surgery is not indicated.

    3. Nurse Jeremy is evaluating a client’s fluid intake and output record. Fluid intake and urine output should relate in which way?

    A. Fluid intake should be double the urine output.
    B. Fluid intake should be approximately equal to the urine output.
    C. Fluid intake should be half the urine output.
    D. Fluid intake should be inversely proportional to the urine output.

     

    3. Answer: B. Fluid intake should be approximately equal to the urine output.

    • Option B: Normally, fluid intake is approximately equal to the urine output. Any other relationship signals an abnormality.
    • Option A: Fluid intake that is double the urine output indicates fluid retention
    • Option C: Fluid intake that is half the urine output indicates dehydration.
    • Option D: Normally, fluid intake isn’t inversely proportional to the urine output.

    4. When explaining to the parents of a child with hydrocele about the possible cause of the condition, the nurse bases this explanation on the interpretation that hydrocele is most likely the result of which of the following:

    A. Blockage in the inguinal canal.
    B. Failure of the upper part of the processus vaginalis to atrophy.
    C. A patent processus vaginalis that results in the collection of fluid along the spermatic cord.
    D. An obliterated processus vaginalis that allows fluid to accumulate in the scrotal sac.

     

    4. Answer:  C. A patent processus vaginalis that results in the collection of fluid along the spermatic cord.

    • Option C: A hydrocele is a fluid collection within the tunica vaginalis of the scrotum or along the spermatic cord.
    • Options A, B, C: These processes does not occur in hydrocele.

    5. Shortly after an infant is returned to his room following hydrocele repair, the infant’s mother tells the nurse that the child’s scrotum looks swollen and bruised. Which of the following responses by type nurse is the most appropriate?

    A. “Let me see if the doctor has ordered aspirin for him. If he did, I’ll get it right away.”
    B. “Why don’t you wait in his room? Then you can ask me any questions when I get there.”
    C. “What you are describing is unusual after this type of surgery. I’ll let the doctor know.”
    D. “This is normal after this type of surgery. Let’s look at it together just to be sure.”

     

    5. Answer: D. “This is normal after this type of surgery. Let’s look at it together just to be sure.”

    • Option D: Swelling and bruising of the surgical site is a usual occurrence right after the surgery. Elevation of the scrotal area and anti-inflammatory agents can be administered as ordered by the physician.
    • Option A: Aspirin is not the drug of choice given for pediatric patients.
    • Option B: Answering questions could relieve the anxiety felt by the family and the patient.
    • Option C: Swelling and bruising are normal occurrences for the patient after the surgery.

    Hydrocele Read More »

    Acute Glomerulonephritis

    Acute Glomerulonephritis

    Acute Glomerulonephritis (AGN) Lecture Notes
    Acute Glomerulonephritis (AGN)

    Acute Glomerulonephritis (AGN) is an inflammatory condition affecting the glomeruli of the kidneys. The glomeruli are tiny filtering units within the kidneys responsible for removing waste products and excess fluid from the blood, while retaining important substances like proteins and blood cells.

    In AGN, these glomeruli become inflamed, as a result of an immune reaction. This inflammation damages the filtering membranes, leading to:

  • Decreased Glomerular Filtration Rate (GFR): The kidneys' ability to filter blood is impaired, leading to the accumulation of waste products.
  • Increased Permeability of the Glomerular Capillaries: This allows substances that should normally be retained (like red blood cells and protein) to leak into the urine.

    • The term "acute" indicates that the onset is often sudden and the condition develops rapidly, usually over days to weeks. While various forms of glomerulonephritis exist, AGN specifically refers to this sudden onset inflammatory process.

    Common Etiologies (Causes) of Acute Glomerulonephritis

    AGN is most frequently triggered by an immune response to an infection elsewhere in the body. The body produces antibodies to fight the infection, but in some cases, these antibodies or immune complexes (antigen-antibody complexes) mistakenly attack or get deposited in the glomeruli, causing inflammation.

    1. Post-Streptococcal Glomerulonephritis (PSGN):
  • Most Common Cause: This is by far the most common cause of AGN, especially in children aged 2-12 years.
  • Preceding Infection: It occurs following an infection with specific nephritogenic (kidney-damaging) strains of Group A Beta-Hemolytic Streptococcus (GABHS).
    • Pharyngitis (Strep Throat): Usually precedes PSGN by about 1-2 weeks (average 10 days).
    • Skin Infection (Impetigo or Pyoderma): Can also precede PSGN by about 3-6 weeks (average 3 weeks).
  • Mechanism: It is thought to be caused by the deposition of immune complexes containing streptococcal antigens (like SpeB, formerly known as nephritis-associated plasmin receptor or NAPlr) in the glomeruli, activating the complement system and initiating an inflammatory cascade.
    • 2. Other Bacterial Infections:

    Less common than PSGN, but other bacterial infections can also trigger AGN, including:

  • Staphylococcal infections (e.g., endocarditis, shunt infections).
  • Pneumococcal infections.
  • Gram-negative septicemia.
    • 3. Viral Infections:

    Certain viral infections have been implicated, though less frequently:

  • Hepatitis B and C.
  • HIV.
  • Epstein-Barr virus (EBV).
  • Cytomegalovirus (CMV).
  • Varicella (chickenpox).
    • 4. Parasitic Infections:

    Malaria and toxoplasmosis can occasionally lead to AGN.

    5. Systemic Autoimmune Diseases:

    (Less common for "acute" onset but can present as glomerulonephritis): While these usually cause chronic glomerulonephritis, their initial presentation can sometimes mimic AGN:

  • Systemic Lupus Erythematosus (SLE): Lupus nephritis.
  • IgA Nephropathy (Berger's Disease): Can present with recurrent episodes of gross hematuria, often triggered by upper respiratory tract infections. While it can be acute, it's distinct from PSGN in its immune mechanism and recurrence.
  • Henoch-Schönlein Purpura (HSP): A vasculitis that can involve the kidneys (HSP nephritis).
  • Anti-glomerular Basement Membrane (Anti-GBM) Disease (Goodpasture's Syndrome): A severe, rapidly progressive form.
  • ANCA-associated vasculitis (e.g., Granulomatosis with Polyangiitis, Microscopic Polyangiitis).
    • Pathophysiology of Acute Glomerulonephritis

    The core of AGN pathophysiology, particularly in the most common form (PSGN), involves a interplay of the immune system and the delicate structure of the glomeruli

    I. The Initiating Event: Infection
  • Preceding Infection: The process begins with an infection, most commonly by nephritogenic strains of Group A Beta-Hemolytic Streptococcus (GABHS) in the throat (pharyngitis) or skin (impetigo/pyoderma).
  • Latency Period: There's a characteristic latency period between the initial infection and the onset of AGN symptoms:
    • 1-2 weeks after strep pharyngitis.
    • 3-6 weeks after strep impetigo.
  • Why the delay? This delay is crucial because it allows time for the immune response to develop, antibodies to be produced, and immune complexes to form.
    • II. Immune Response and Antigen-Antibody Complex Formation
  • Antigen Release: During the streptococcal infection, bacterial antigens (e.g., streptococcal pyrogenic exotoxin B - SpeB/NAPlr) are released into the bloodstream.
  • Antibody Production: The host's immune system recognizes these antigens as foreign and produces specific antibodies (e.g., anti-SpeB).
  • Immune Complex Formation: These antibodies bind to the streptococcal antigens, forming antigen-antibody complexes (immune complexes) in the circulation.
    • III. Glomerular Deposition and Immune Activation

    This is the critical step where the kidney damage occurs. There are two main theories for how these immune complexes or antigens cause glomerular injury:

  • Circulating Immune Complex Deposition (Traditional Theory):
    • Immune complexes formed in the bloodstream circulate and become trapped in the glomerular basement membrane (GBM) or between the endothelial cells and the GBM.
    • The size and charge of the complexes, as well as the unique structure of the glomerulus, determine their deposition.
  • In Situ Immune Complex Formation / Antigen Planting (Newer Understanding):
    • It's now believed that streptococcal antigens (like SpeB) have a strong affinity for glomerular components (e.g., plasmin).
    • These antigens "plant" themselves directly onto the GBM or other glomerular structures.
    • Subsequently, circulating antibodies (e.g., anti-SpeB) then bind to these planted antigens in situ within the glomerulus, forming immune complexes directly at the site of injury. This is thought to be a more significant mechanism.
    • IV. Complement Activation and Inflammation

    Once the immune complexes are deposited (or formed in situ), they activate the complement system – a cascade of proteins that are part of the innate immune response.

  • Complement Activation: Activation of the complement system (specifically the alternative pathway) leads to a reduction in serum complement component C3 levels, which is a hallmark finding in PSGN.
  • Inflammatory Cascade: Complement activation, along with the direct presence of immune complexes, triggers a robust inflammatory response within the glomerulus:
    • Recruitment of Inflammatory Cells: Neutrophils, monocytes, and macrophages are attracted to the glomeruli.
    • Release of Inflammatory Mediators: These cells release cytokines, chemokines, proteases, and reactive oxygen species.
    • Cell Proliferation: Glomerular endothelial and mesangial cells proliferate.
    • V. Glomerular Damage and Clinical Manifestations

    The inflammation and cellular proliferation lead to structural and functional changes in the glomeruli:

  • Glomerular Swelling and Hypercellularity: The glomeruli become enlarged and congested with inflammatory cells and proliferating intrinsic glomerular cells. This effectively narrows the lumen of the glomerular capillaries.
  • Decreased Glomerular Filtration Rate (GFR):
    • The swelling and cellular proliferation reduce the surface area available for filtration and impede blood flow through the glomeruli.
    • This leads to a reduced GFR, causing:
      • Oliguria: Decreased urine output.
      • Azotemia: Accumulation of nitrogenous waste products (urea, creatinine) in the blood.
      • Fluid Retention: Leading to edema (periorbital, peripheral) and hypertension.
  • Increased Capillary Permeability:
    • The inflamed and damaged glomerular basement membrane becomes "leaky."
    • This allows red blood cells to pass into the urine, causing hematuria (microscopic or macroscopic, resulting in "cola-colored" or "smoky" urine).
    • Protein also leaks into the urine, causing proteinuria, though typically not in the nephrotic range (usually <3.5 g/day).
    • In summary:
    • Following an occurrence of a streptococcal infection which can either be sore throat or a skin infection, there follows an immune response which is mounted against the streptococcal infection (a specific antibody is produced against streptococci)
    • These antibodies destroy the glomerulus because it resembles the antigens of the streptococci.
    • This usually occurs 2-3 weeks after the streptococcal infection has taken place. This is characterized by diffused inflammation of the renal cortex (glomeruli) of both kidneys.
    • The destruction of the glomerulus permits the red blood cells which is passed in urine as haematuria and pus-cells, RBC casts.
    • The destruction further causes reduction in the filtration process
    • Reduced ultra filtration stimulates angiotensin I release which in turn is changed to angiotensin II which causes constriction of arterioles, hence increasing total arteriolar resistance, leading to elevation of blood pressure.
    • Angiotensin ii release further causes production of aldosterone which causes reabsorption of sodium and water, leading to increase in cardiac output and elevation of blood pressure.
    Clinical Manifestations (Signs and Symptoms) of AGN

    Symptoms typically appear 1-2 weeks after a streptococcal throat infection or 3-6 weeks after a streptococcal skin infection.

    1. Edema (Swelling):
      • Periorbital Edema: Often the first and most noticeable sign, particularly in the morning. Puffiness around the eyes.
      • Peripheral Edema: Swelling of the face, hands, and feet (pitting edema may be present).
      • Generalized Edema (Anasarca): In severe cases.
      • Cause: Fluid retention due to decreased GFR and impaired sodium and water excretion by the damaged kidneys.
    2. Hypertension (High Blood Pressure):
      • Common and Potentially Severe: Occurs in 60-80% of patients.
      • Cause: Fluid overload (due to sodium and water retention) and activation of the renin-angiotensin-aldosterone system.
      • Risk: Can lead to serious complications like hypertensive encephalopathy, seizures, and cardiac failure.
    3. Hematuria (Blood in Urine):
      • Gross Hematuria: Visible "cola-colored," "smoky," "rusty," or reddish-brown urine due to the presence of red blood cells (RBCs) and RBC casts. This is a hallmark sign and occurs in about 30-50% of cases.
      • Microscopic Hematuria: Always present, even if urine appears normal. Detected on urinalysis.
      • Cause: Increased permeability of the damaged glomerular capillaries, allowing RBCs to leak into the renal tubules.
    4. Oliguria (Decreased Urine Output):
      • Variable: Present in about 50% of patients.
      • Severity: Can range from mild reduction to severe oliguria.
      • Cause: Markedly reduced GFR.
    5. Non-Specific Symptoms:
      • Fatigue, Lethargy, Malaise: Due to fluid retention and accumulation of waste products.
      • Anorexia, Nausea, Vomiting: May occur due to azotemia.
      • Abdominal Pain or Flank Pain: Less common, but can occur due to kidney swelling.
      • Headache: Often associated with hypertension.
      • Shortness of Breath/Dyspnea: If significant fluid overload leads to pulmonary edema or cardiac congestion.
    Diagnostic Criteria

    Diagnosis of AGN, especially PSGN, relies on a combination of clinical presentation, laboratory findings, and often evidence of a preceding streptococcal infection.

    1. Urinalysis:
  • Hematuria: Presence of red blood cells (>5 RBCs/HPF) is constant. Red blood cell casts are highly characteristic and confirm a glomerular origin of hematuria.
  • Proteinuria: Mild to moderate proteinuria (usually <3.5 g/day). May see 1+ to 3+ protein on dipstick.
  • Specific Gravity: Often elevated due to oliguria.
    • 2. Blood Tests:
  • Elevated Blood Urea Nitrogen (BUN) and Creatinine: Indicate reduced GFR and kidney dysfunction.
  • Serum Electrolytes: May show normal or slight derangements, including hyperkalemia in severe oliguria. Sodium levels are typically normal or slightly low due to dilution from fluid retention.
  • Complement Levels:
    • C3 (Complement Component 3): Crucial diagnostic marker. Serum C3 levels are typically depressed (low) in 90% of PSGN cases, usually for 6-8 weeks, returning to normal thereafter. This indicates activation and consumption of the complement system.
    • C4 levels are usually normal or only slightly reduced, which helps differentiate PSGN from other forms of glomerulonephritis where both C3 and C4 might be low (e.g., lupus nephritis).
  • Evidence of Preceding Streptococcal Infection:
    • Antistreptolysin O (ASO) Titer: Elevated in 80% of patients following streptococcal pharyngitis. Titer peaks at 3-5 weeks after infection.
    • Anti-DNase B Titer (ADB): More sensitive than ASO for skin infections (impetigo) and elevated in both pharyngitis and skin infections.
    • Streptozyme Test: Detects multiple streptococcal antibodies.
    • Note: Throat cultures may be negative by the time AGN symptoms appear as the infection might have resolved.
    • 3. Other Tests (If Indicated):
  • Renal Ultrasound: Usually normal in AGN, but can help rule out other causes of kidney disease or obstruction. May show enlarged kidneys due to edema.
  • Chest X-ray: May show signs of pulmonary edema or cardiomegaly if there is significant fluid overload and cardiac compromise.
  • Kidney Biopsy: Rarely needed for typical PSGN. It is reserved for atypical presentations, rapidly worsening renal function, absence of evidence of strep infection, or persistently low C3 levels beyond 8 weeks (suggesting other forms of glomerulonephritis).
    • Differential Diagnoses for AGN

    When a patient presents with symptoms suggestive of acute glomerulonephritis (edema, hypertension, hematuria, oliguria), clinicians must consider a range of other conditions that can cause similar signs. Differentiating between these conditions is essential, as their etiologies, prognoses, and treatments can vary significantly.

    I. Other Forms of Glomerulonephritis
    1. IgA Nephropathy (Berger's Disease): Often presents with recurrent episodes of gross hematuria, typically occurring concurrently with or within 1-2 days of an upper respiratory tract or gastrointestinal infection (synpharyngitic hematuria).
      • Distinguishing Features from PSGN:
        • Timing: Hematuria is simultaneous or very soon after infection, not weeks later.
        • Complement: Normal C3 levels.
        • Pathology: IgA deposits in the mesangium on kidney biopsy (though biopsy usually not done for initial differentiation).
    2. Membranoproliferative Glomerulonephritis (MPGN) / C3 Glomerulopathy: Can present with acute nephritic syndrome, often with persistent hypocomplementemia.
      • Distinguishing Features from PSGN:
        • Complement: C3 levels are persistently low (beyond 8-12 weeks), often accompanied by other complement abnormalities.
        • Etiology: Can be primary or secondary to autoimmune diseases, chronic infections (e.g., Hepatitis C), or inherited complement disorders. Often requires kidney biopsy for definitive diagnosis.
    3. Lupus Nephritis (Systemic Lupus Erythematosus - SLE): Patients with SLE can develop various forms of glomerulonephritis, including acute nephritic syndrome.
      • Distinguishing Features from PSGN:
        • Systemic Symptoms: Presence of other systemic manifestations of SLE (arthralgia, rash, serositis, neurological symptoms).
        • Serology: Positive ANA, anti-dsDNA antibodies.
        • Complement: Both C3 and C4 levels are typically low.
    4. ANCA-Associated Glomerulonephritis (e.g., Granulomatosis with Polyangiitis, Microscopic Polyangiitis):
      • Presentation: Can cause rapidly progressive glomerulonephritis (RPGN), which includes acute nephritic features. Often presents with severe kidney failure.
      • Distinguishing Features from PSGN:
        • Systemic Symptoms: May have pulmonary (hemoptysis), sinus, or skin involvement.
        • Serology: Positive ANCA (anti-neutrophil cytoplasmic antibodies).
        • Complement: Normal C3 and C4 levels.
    5. Anti-Glomerular Basement Membrane (Anti-GBM) Disease (Goodpasture's Syndrome): Rapidly progressive glomerulonephritis, often with pulmonary hemorrhage.
      • Distinguishing Features from PSGN:
        • Serology: Positive anti-GBM antibodies.
        • Complement: Normal C3 and C4 levels.
    Medical Management and Treatment Strategies for AGN

    The management of Acute Glomerulonephritis (AGN), particularly PSGN, is primarily supportive, as there is no specific cure for the glomerular inflammation itself. The goals of treatment are to:

    1. Manage symptoms (edema, hypertension).
    2. Prevent complications (hypertensive encephalopathy, fluid overload, acute kidney injury).
    3. Eradicate any residual streptococcal infection (though this does not alter the course of AGN).
    4. Monitor for recovery.
    I. General Supportive Measures and Monitoring
  • Hospitalization: Most children with AGN, especially with significant hypertension, oliguria, or fluid overload, require initial hospitalization for close monitoring and management. Criteria for hospitalization: significant edema, hypertension, oliguria, or evidence of cardiac involvement.
  • Rest: Bed rest is typically recommended during the acute phase to reduce metabolic demands and promote recovery, especially if there is significant edema or hypertension. Activity can be gradually increased as symptoms improve.
  • Strict Monitoring:
    • Vital Signs: Frequent monitoring of blood pressure (crucial!), heart rate, respiratory rate, and temperature.
    • Fluid Balance: Strict intake and output (I&O) measurements are essential. Daily weights are the most sensitive indicator of fluid balance.
    • Physical Assessment: Daily assessment for edema, signs of fluid overload (e.g., crackles in lungs, increased work of breathing, jugular venous distension), and neurological status (for hypertensive encephalopathy).
    • Laboratory Monitoring:
      • Daily or every-other-day BUN, creatinine, and electrolytes (especially potassium, sodium).
      • Urinalysis for specific gravity, protein, and hematuria.
      • C3 levels (to monitor recovery – should normalize within 6-8 weeks).
    • II. Fluid and Electrolyte Management
  • Fluid Restriction: Crucial for managing edema and hypertension. Fluid intake is typically restricted to insensible losses (e.g., 400 ml/m2/day or 300 ml/day for young children) plus urine output from the previous day. Avoidance of excessive IV fluids. Oral fluids are preferred if tolerated.
  • Sodium Restriction: Dietary sodium restriction (e.g., 2-4 g/day or 1-2 mEq/kg/day) is essential to reduce fluid retention and help control hypertension and edema.
  • Potassium Restriction: May be necessary if oliguria is severe, as hyperkalemia can be a life-threatening complication. Foods high in potassium should be avoided.
    • III. Pharmacological Management
  • Antihypertensive Medications:
    • Goal: Prompt and effective control of hypertension is paramount to prevent complications like hypertensive encephalopathy, seizures, and cardiac failure.
    • First-line agents:
      • Calcium Channel Blockers: (e.g., Nifedipine, Amlodipine) are often preferred for their rapid onset and effectiveness.
      • ACE Inhibitors: (e.g., Enalapril) or Angiotensin Receptor Blockers (ARBs) may also be used, but with caution in patients with significant renal impairment or hyperkalemia, as they can further reduce GFR or increase potassium.
    • Diuretics:
      • Loop Diuretics: (e.g., Furosemide) are effective in reducing fluid overload, which in turn helps lower blood pressure and edema. Often used in conjunction with antihypertensives, especially if signs of volume overload are present.
    • Severe Hypertension/Hypertensive Crisis: IV agents like Labetalol or Sodium Nitroprusside may be used in an ICU setting for rapid blood pressure control.
  • Diuretics:
    • Furosemide: Widely used to manage fluid overload, edema, and hypertension. It enhances sodium and water excretion.
  • Antibiotics (for residual infection):
    • Although AGN is an immune-mediated disease and antibiotics do not alter the course of established glomerulonephritis, a 10-day course of Penicillin (or Erythromycin if penicillin allergic) is recommended if there is still evidence of a streptococcal infection (e.g., positive throat culture, recent uncompleted treatment for pharyngitis).
    • Eradicate streptococcal causes by oral antibiotic therapy; Penicillin is indicated in nonallergic patients e.g. Phenoxy methyl penicillin 500mg qid. Child: 10 – 20mg per dose Or Amoxicillin 500mg tds. Child: 15mg/kg per dose. If allergic to penicillin give erythromycin every 6hours. Child: 15mg/kg per dose
    • This is important to prevent further spread of the nephritogenic strain and to treat any ongoing infection, potentially reducing the risk of recurrence in vulnerable individuals (though recurrence of PSGN is rare).
  • Other Medications:
    • Anticonvulsants: If seizures occur secondary to hypertensive encephalopathy, anticonvulsants (e.g., benzodiazepines, phenytoin) may be necessary to control them.
    • IV. Dialysis (for Severe Acute Kidney Injury)

    Indications: Dialysis (peritoneal dialysis or hemodialysis) may be required in a small percentage of patients with severe AGN who develop:

    • Severe, refractory fluid overload.
    • Life-threatening hyperkalemia.
    • Severe metabolic acidosis.
    • Uremic encephalopathy.
    • This is a temporary measure until kidney function recovers.
    V. Long-Term Follow-up
    1. Monitoring for Recovery:
      • Regular follow-up is essential to ensure complete resolution of AGN and to monitor for any long-term complications.
      • Blood Pressure: Should be monitored for at least 6-12 months.
      • Urinalysis: Hematuria may persist for several months (up to 1-2 years), and microscopic hematuria can be common. Proteinuria should resolve.
      • Renal Function: BUN and creatinine should normalize.
      • C3 Levels: Should normalize within 6-8 weeks. Failure to normalize C3 may suggest an alternative diagnosis (e.g., MPGN, lupus nephritis) and might warrant further investigation, including renal biopsy.
    2. Education: Parents and older children need to understand the importance of ongoing monitoring and to recognize signs of recurrence (though rare for PSGN) or complications.
    Potential Complications of Acute Glomerulonephritis (AGN)

    While the prognosis for typical PSGN is generally excellent, especially in children, the acute phase of AGN can be associated with significant and potentially life-threatening complications. These complications primarily arise from the severely impaired kidney function, fluid overload, and uncontrolled hypertension.

    I. Cardiovascular Complications (Due to Fluid Overload and Hypertension)
    1. Hypertensive Encephalopathy: This is a serious and potentially life-threatening complication of severe, uncontrolled hypertension. The rapid rise in blood pressure overwhelms the brain's autoregulatory mechanisms, leading to cerebral edema.
      • Clinical Manifestations: Severe Headache, Vomiting, Lethargy, Confusion, Disorientation, Visual Disturbances (e.g., blurred vision, diplopia), Seizures (Focal or Generalized), Coma.
      • Intervention: Requires immediate and aggressive control of blood pressure, often with intravenous antihypertensive medications in an intensive care setting.
    2. Congestive Heart Failure (CHF) / Pulmonary Edema: Severe fluid overload resulting from the kidneys' inability to excrete sodium and water can lead to increased intravascular volume, taxing the heart and causing fluid to accumulate in the lungs.
      • Clinical Manifestations: Dyspnea (shortness of breath), Tachypnea (rapid breathing), Orthopnea (difficulty breathing except in an upright position), Cough (often with frothy sputum), Crackles (rales) on lung auscultation, Tachycardia, Gallop rhythm, Peripheral edema, Jugular venous distention.
      • Intervention: Diuretics (e.g., IV Furosemide), oxygen therapy, and sometimes positive pressure ventilation.
    II. Renal Complications
    1. Acute Kidney Injury (AKI) / Acute Renal Failure: While reduced GFR is inherent in AGN, severe, prolonged impairment can lead to full-blown AKI.
      • Clinical Manifestations: Severe Oliguria or Anuria (absence of urine production), Rapidly rising BUN and Creatinine, Significant Electrolyte Disturbances, Metabolic Acidosis.
      • Intervention: Strict fluid and electrolyte management, aggressive diuretic therapy, and if conservative measures fail, dialysis (peritoneal or hemodialysis) may be necessary as a temporary measure until renal function recovers.
    2. Electrolyte Imbalances:
      • Hyperkalemia: A particularly dangerous complication, especially with severe oliguria. The kidneys cannot excrete potassium, leading to dangerously high levels, which can cause life-threatening cardiac arrhythmias.
      • Hyponatremia: Can occur due to dilution from excessive fluid retention relative to sodium.
      • Hyperphosphatemia and Hypocalcemia: Less common acutely but can develop with more prolonged or severe renal failure.
      • Metabolic Acidosis: Due to impaired acid excretion by the kidneys.
      • Intervention: Dietary restrictions, fluid management, specific medications (e.g., potassium binders, insulin/glucose for hyperkalemia), and dialysis if severe.
    III. Infectious Complications
    • Secondary Infections: Patients with significant fluid overload, edema, and compromised immunity can be more susceptible to secondary infections (e.g., cellulitis in edematous areas, pneumonia).
    IV. Neurological Complications (Beyond Hypertensive Encephalopathy)
    • Seizures: Primarily due to hypertensive encephalopathy but can also be exacerbated by severe electrolyte disturbances (e.g., hyponatremia) or uremia.
    V. Long-Term Complications (Rare for typical PSGN, but important to monitor)
    1. Persistent Hypertension: While most children's blood pressure normalizes, a small percentage may develop persistent hypertension that requires ongoing management.
    2. Persistent Proteinuria/Hematuria: Microscopic hematuria can persist for up to 1-2 years. Persistent nephrotic-range proteinuria or significant persistent hematuria beyond typical resolution times should raise suspicion for other forms of glomerular disease or indicate incomplete recovery.
    3. Chronic Kidney Disease (CKD) / End-Stage Renal Disease (ESRD):
      • Extremely rare in children with typical PSGN. The vast majority (over 95%) recover completely.
      • However, in adults or in atypical/severe cases, or if the underlying glomerulonephritis is not PSGN (e.g., MPGN, rapidly progressive glomerulonephritis), there is a risk of progression to CKD or ESRD.
      • Persistent low C3 levels beyond 8-12 weeks are a red flag for a different underlying diagnosis or a less favorable prognosis.
    Prognosis
    Prognosis in Children with PSGN
    1. Excellent Short-Term Prognosis:
      • Complete Recovery: The vast majority of children (95-98%) with typical PSGN experience a complete and sustained recovery of renal function.
      • Resolution of Symptoms: Clinical symptoms such as edema, hypertension, and gross hematuria typically resolve within a few days to weeks.
      • Laboratory Normalization:
        • C3 levels usually normalize within 6-8 weeks. Failure to normalize within this timeframe should prompt re-evaluation and consideration of alternative diagnoses or persistent glomerular disease.
        • BUN and creatinine normalize as GFR improves.
        • Proteinuria resolves within 6 months.
        • Microscopic hematuria can be the most persistent finding, sometimes lasting up to 1-2 years, but typically without long-term consequence if other parameters are normal.
    2. Low Risk of Long-Term Complications:
      • Chronic Kidney Disease (CKD) / End-Stage Renal Disease (ESRD): Progression to CKD or ESRD is extremely rare (less than 1-2%) in children with classic PSGN.
      • Recurrence: Recurrence of PSGN is also very rare, as the initial infection typically confers type-specific immunity.
    Prognosis in Adults with PSGN

    The prognosis for PSGN in adults is generally considered less favorable than in children.

    • Higher Risk of Chronic Kidney Disease: Adults have a higher incidence of persistent renal abnormalities (e.g., persistent proteinuria, hypertension) and a greater risk (up to 10-20%) of progressing to chronic kidney disease. The reasons for this difference are not fully understood but may relate to pre-existing renal damage, co-morbidities, or a less robust recovery capacity.
    Prognosis for Other Forms of AGN (Not PSGN)

    When AGN is caused by conditions other than PSGN, the prognosis varies widely and can be more guarded.

    1. Rapidly Progressive Glomerulonephritis (RPGN): Conditions like Anti-GBM disease, severe ANCA-associated vasculitis, or severe lupus nephritis can present as RPGN.
      • Prognosis: Without prompt and aggressive immunosuppressive therapy (and sometimes plasma exchange), these conditions can rapidly lead to ESRD within weeks to months. The long-term outcome depends on the severity, response to treatment, and early diagnosis.
    2. IgA Nephropathy: While it can cause acute nephritic episodes, it is typically a chronic, slowly progressive disease.
      • Prognosis: Approximately 20-40% of patients with IgA nephropathy will progress to ESRD over 10-20 years. Factors like persistent hypertension, severe proteinuria, and specific pathological findings influence prognosis.
    3. Membranoproliferative Glomerulonephritis (MPGN) / C3 Glomerulopathy: These are often chronic conditions that can lead to significant renal impairment and progression to ESRD in a substantial proportion of patients, especially if associated with persistent hypocomplementemia.
    Factors Influencing Prognosis

    Several factors can influence the long-term outcome of AGN:

    1. Age: Children generally have a better prognosis than adults for PSGN.
    2. Etiology: PSGN has a better prognosis than many other forms of acute glomerulonephritis.
    3. Severity of Initial Presentation:
      • Severe oliguria, anuria, or the need for dialysis during the acute phase can indicate more extensive renal damage and may be associated with a slightly higher risk of long-term sequelae.
      • The presence of crescentic changes on kidney biopsy (indicating severe glomerular injury) is a poor prognostic indicator.
    4. Persistent Abnormalities:
      • Persistent hypertension: A significant risk factor for progressive renal damage.
      • Persistent proteinuria: Especially in the nephrotic range, indicates ongoing glomerular damage.
      • Failure of C3 levels to normalize: Suggests alternative or chronic glomerular disease.
    5. Comorbidities: Underlying chronic diseases can worsen the prognosis.
    Nursing Diagnoses and Nursing Interventions
    I. Excess Fluid Volume
    • Related to: Compromised regulatory mechanisms (renal impairment leading to decreased glomerular filtration rate), sodium and water retention.
    • As evidenced by: Edema (periorbital, peripheral, sacral), elevated blood pressure, dyspnea, orthopnea, weight gain, oliguria, jugular venous distention, crackles on lung auscultation.
    Intervention Detail/Rationale
    Assess and Monitor Fluid Balance
    • Strict Intake and Output (I&O): Meticulously measure all oral and intravenous fluid intake and urine output.
    • Daily Weights: Weigh the patient at the same time each day, using the same scale and clothing. Daily weight is the most accurate indicator of fluid status.
    • Assess Edema: Regularly assess for edema (location, pitting, severity) and measure abdominal girth or extremity circumference.
    • Auscultate Lungs: Listen for crackles or diminished breath sounds, indicating pulmonary congestion.
    • Monitor Vital Signs: Pay close attention to blood pressure and heart rate.
    Fluid Restriction
    • Collaborate with the healthcare provider to establish appropriate fluid restrictions (e.g., insensible losses plus previous day's urine output).
    • Educate the patient/family on the importance of fluid restriction and creative ways to manage thirst (e.g., ice chips, sour candies).
    Sodium Restriction
    • Provide a low-sodium diet; educate the patient/family on food choices to avoid high-sodium items.
    • Avoid adding salt to food.
    Administer Diuretics
    • Administer prescribed loop diuretics (e.g., Furosemide) as ordered.
    • Monitor effectiveness (increased urine output, decreased edema, weight loss).
    • Monitor for adverse effects: electrolyte imbalances (hypokalemia), dehydration, ototoxicity (if given rapidly IV).
    Positioning
    • Elevate the head of the bed for dyspnea/orthopnea.
    • Position edematous extremities to promote venous return.
    Skin Care
    • Inspect skin regularly, especially over bony prominences and edematous areas, for breakdown.
    • Provide meticulous skin care to prevent pressure ulcers.
    II. Risk for Injury (Hypertensive Encephalopathy/Seizures)
    • Related to: Severe, uncontrolled hypertension, cerebral edema.
    • As evidenced by: (Potential for) severe headache, visual disturbances, altered mental status, seizures.
    Intervention Detail/Rationale
    Blood Pressure Monitoring
    • Monitor blood pressure frequently (e.g., every 1-4 hours during the acute phase, or more often if unstable).
    • Use appropriate cuff size.
    • Report significant elevations immediately to the healthcare provider.
    Administer Antihypertensives
    • Administer prescribed antihypertensive medications (e.g., nifedipine, labetalol, enalapril) promptly as ordered.
    • Monitor for effectiveness and adverse effects (e.g., hypotension).
    Neurological Assessment
    • Perform regular neurological assessments (level of consciousness, orientation, pupil reaction, motor function) to detect early signs of cerebral edema or impending seizure.
    • Report changes in mental status, severe headache, or visual disturbances.
    Seizure Precautions
    • Implement seizure precautions (pad side rails, ensure suction and oxygen are readily available).
    • If a seizure occurs, maintain airway, protect from injury, and document event (time, duration, type of movements).
    Quiet Environment
    • Provide a calm, quiet, and dimly lit environment to reduce stimulation and promote rest, especially if the patient has a headache or photophobia.
    III. Inadequate protein energy nutritional intake
    • Related to: Anorexia, nausea, vomiting, dietary restrictions (sodium, potassium, protein if severe AKI).
    • As evidenced by: Weight loss (though masked by edema), verbalization of poor appetite, aversion to food.
    Intervention Detail/Rationale
    Assess Dietary Intake Monitor food preferences and intake. Note any nausea or vomiting.
    Dietary Restrictions Collaborate with a dietitian to plan meals that adhere to prescribed restrictions (low sodium, possibly low potassium, low protein if severe azotemia). Educate patient/family on dietary modifications.
    Small, Frequent Meals Offer small, frequent, appealing meals to improve intake. Provide food when the patient is least nauseated.
    Oral Hygiene Provide good oral hygiene before meals to enhance appetite.
    Monitor Lab Values Monitor BUN, creatinine, albumin, and electrolyte levels.
    IV. Risk for Infection
    • Related to: Compromised immune response (due to underlying disease process), tissue edema, potential for invasive procedures.
    • As evidenced by: (Potential for) fever, localized pain, redness, swelling, abnormal white blood cell count.
    Intervention Detail/Rationale
    Monitor for Signs of Infection Regularly assess temperature, observe for chills, localized pain, redness, or swelling. Monitor white blood cell count.
    Antibiotic Administration Administer prescribed antibiotics (if there is evidence of ongoing streptococcal infection) as ordered. Educate on the importance of completing the full course.
    Strict Asepsis Maintain strict aseptic technique for all invasive procedures (IV insertion, catheter care).
    Hand Hygiene Promote frequent and meticulous hand hygiene for patients, staff, and visitors.
    Skin Integrity Maintain skin integrity, especially in edematous areas, to prevent breakdown and entry points for bacteria.
    V. Activity Intolerance
    • Related to: Generalized weakness, fatigue, effects of disease process (edema, hypertension).
    • As evidenced by: Verbal reports of fatigue, weakness, dyspnea on exertion, increased heart rate/blood pressure with activity.
    Intervention Detail/Rationale
    Assess Activity Level Monitor patient's tolerance to activity.
    Promote Rest Encourage bed rest during the acute phase, gradually increasing activity as tolerated and symptoms improve. Provide periods of uninterrupted rest.
    Assist with ADLs Assist with activities of daily living (ADLs) as needed to conserve energy.
    Gradual Mobilization Gradually increase activity as vital signs stabilize and symptoms resolve.
    VI. Inadequate health Knowledge (Patient/Family)
    • Related to: Unfamiliarity with the disease process, treatment regimen, dietary restrictions, and potential complications.
    • As evidenced by: Questions about the disease, incorrect understanding of instructions, non-adherence to regimen.
    Intervention Detail/Rationale
    Educate on AGN Explain AGN in simple terms, including its cause (e.g., strep infection), why it happened, and what to expect during recovery. Emphasize that for PSGN, full recovery is expected.
    Treatment Plan Education Explain all medications (purpose, dose, side effects). Reinforce dietary and fluid restrictions. Discuss the importance of daily weights and I&O if monitoring at home.
    Signs of Complications Teach signs and symptoms of worsening condition or complications (e.g., severe headache, visual changes, decreased urine output, increased edema, difficulty breathing) and when to seek medical attention.
    Long-Term Follow-up Explain the importance of regular follow-up appointments and laboratory tests (blood pressure checks, urinalysis, blood tests) to monitor recovery and detect any potential long-term issues.
    Written Materials Provide written educational materials to reinforce verbal teaching.

    Acute Glomerulonephritis Read More »

    Want notes in PDF? Join our classes!!

    Send us a message on WhatsApp
    0726113908

    Scroll to Top
    Enable Notifications OK No thanks